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 This dissertation focuses on the synthesis of dauer pheromone analogs for biological 
evaluation, the development of visible light promoted O-glycosylation methods and the 
development of an Ir(ppy)3 catalyzed C-H hydroxylation method. Chapter 1 describes the synthesis 
of dauer pheromone analogs. C.elegans is a small nematode that enters a dauer stage when 
encountering unfavorable environmental conditions. The dauer stage is initiated by the nematodes 
chemosensation of the dauer pheromone caused by the down regulation biochemical pathways 
TGF-β and IGF-1. These biochemical pathways are also seen in Homo Sapiens and play a role in 
a number of biological processes. Understanding how these pathways work in C.elegans can give 
us a better understanding of how they function in humans. In order to see the effect structure has 
on binding to the GCPR’s that initiate dauer formation a series of dauer pheromone analogs 
differing in chain length and degree of unsaturation were synthesized. These analogous were then 
tested to see there dauer inducing activity to give a structure to activity relationship.  
 Chapter 2 centers upon the development of an alpha selective glycosylation of alcohols 
with selenoglycosides using visible light. Selenoglycosides are highly stable glycosyl donors. 
There stability is useful in oligosaccharide synthesis. This stability, however, requires harsh 
reaction conditions to activate them. The development of a mild and easily performed O-
glycosylation method using selenoglycosides is described here. 
 Chapter 3 focuses on the development of a metal free, visible light promoted O-
glycosylation method using thioglycosides. Thioglycosides like selenoglycosides are commonly 
used in oligosaccharide synthesis. The harsh reaction conditions used to activate them has been a 
long standing issue in the carbohydrate community. The development of a mild, catalyst free O-
glycosylation method using thioglycosides is described here. The method uses 4-methoxyphenyl-
xii 
 
3-butenylthioglucoside donors in the presence of easily handled and bench stable Umemoto’s 
reagent to provide good yields of disaccharides, it is selective for the β-anomer when using the 
glycosyl donor with an acetate group at the 2- position, and the method is orthogonal.  
 Chapter 4 details the development of a C-H hydroxylation method using fac-Ir(ppy)3 
catalyst. 1-6 and 1-7-hydrogen atom transfers from unactivated aliphatics were performed with the 
aid of a Tzo directing group. The resulting radical then underwent redox chemistry followed by 
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Justin R. Ragains, Ascaroside activity in Caenorhabditis elegans is highly dependent on chemical 
structure*, 2/11/2013]. It is reprinted by permission of [Elsevier.]” 
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CHAPTER 1: SYNTHESIS AND BIOLGICAL EVALUATION OF ASCAROSIDES FOR 
DAUER FORMATION IN C.ELEGANS 
1.1       Introduction 
 The study of model organisms can provide a deeper understanding of biology. One of these 
model organisms, C.elegans, was popularized by Sydney Brenner, who won the Nobel Prize in 
2002 for his work on the genetics of organ development and programmable cell death in 
C.elegans.1 C.elegans (shown in Figure 1.1) is a small (approximately 1mm in length in 




Figure 1.1 Caenorhabditis elegans16 
associated with C.elegans under a microscope.3 The nematode consists of an inner tube and outer 
tube with a pseudocoelom between.4 The inner tube contains the reproductive and alimentary 
systems. The outer tube is comprised of the cuticle and the hypodermis, nervous and excretory 
system, and muscles. The pseudocoelom serves multiple functions, acting as an immune and 
circulatory system while facilitating intracellular signaling and nutrient dispersion.4,5   
 C.elegans is an excellent model organism. It is easy to grow and cultivate in a laboratory 
and feeds on bacteria.2,6 It has a short generation time (2-3) days and life span (2-3 weeks), contains 
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exactly 959 somatic cells (in adult hermaphrodites) and a genome size of 100Mb.2  While it is a 
relatively simple organism, studies on C.elegans biological process can lead to a better 
understanding of similar process in Homo Sapiens. C.elegans  has 20,000 genes compared to 
23,000 in Homo Sapiens.2,7 The C.elegans genome  bears an approximately 60-80% homology to 
that of humans.2,7  The similarity of  C.elegans to other species can be seen by the higher behavioral 
processes it exhibits such as responding to sensory cues, learning, and memory.2,7 
1.1.1 Life Cycle 
 C.elegans has a short life span (2-3 weeks) (shown in Figure 1.2) in which the worm goes 
through several changes.2 The life cycle starts with an egg in the adult hermaphrodite’s uterus that 
goes through four larvae stages (L1-L4) after fertilization and egg laying. The sexually mature 
adult directly proceeds L4. This life cycle is normal for C.elegans under favorable conditions 
(sufficient food supply, low population density and ideal temperatures). If these conditions change 
early in the C.elegans L1 larvae stage, chemical cues sensed by neurons in the head of the worm 




trigger a process called dauer diapause. The L1 larvae enter an alternate larva stage known as the 
dauer larva.8,9 In the non-ageing dauer phase, C.elegans show increased longevity (they are able 
to survive up to 4 months compared to the typical 2-3 week life span).9,10  The nematode is 
completely motionless at this stage and does not feed while it is protected from environmental 
factors via a tough cuticle. When environmental conditions are once again favorable, the worm 
senses chemical cues and responds by exiting the dauer stage and entering the L4 larvae stage in 
route to adulthood.9,10 
1.1.2    Dauer Diapause 
 Dauer diapause is of significant importance to developmental biology. Interest in this 
phenomenon is due to the two pathways that regulate dauer formation: transforming growth factor 
beta (TGF-β) and insulin-like growth factor 1 (IGF-1).11 These two biochemical pathways are 
highly conserved in higher organisms, and are known to have an effect on metabolism, growth, 
development, aging, they also play a role in several diseases.12  The study of these pathways 
provides scientists with a better understanding of how theses biological pathways work in Homo 
sapiens, possibly leading to multiple medical advances. C.elegans provides an ideal platform to 
exam these biological pathways with no ethical concerns restricting their use. 
 Down regulation of (TGF-β) and (IGF-1), which trigger dauer formation, is caused by the 
sensory neurons located in the head of the worm that sense ascarosides excreted by the worm.13 A 
series of the dauer formation-triggering ascarosides that are excreted (as determined with dauer 
formation assays) are shown in Figure 1.3. Five ascarosides comprise the known dauer pheromone 
asc-C6-MK, asc-ΔC9, asc-ωC3, IC-asc-C5 and asc-C7-PABA.14,15,16,17 The first four ascarosides 
were discovered by bioassay-guided fractionation of extracts from worm cultures, and were 
structurally characterized with multiple techniques including NMR spectroscopy and mass 
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spectrometry. These ascarosides were all shown to promote dauer formation with EC50 values of 
120 nM, 370 nM, 240 nM and 5 nM, respectively. Unlike the first four ascarosides, asc-C7-PABA 
was discovered with comparative metabolic studies using NMR spectroscopy. As seen from the 
EC 50 values, IC-asc-C5 shows the highest activity for dauer formation but only up to a certain 
concentration at which point it starts to inhibit its own activity. While asc-ωC3 is not as potent, it 
works synergistically with asc-ΔC9, asc-C6-MK, and IC-asc-C5, to cause dauer formation.15 
 The ascarosides that comprise the dauer pheromone share similarities in their structure. 
Each ascaroside has the ascarylose sugar moiety shown in Figure 1.4. While the moiety remains 
the same for all the ascarosides, there is variability in the head group, fatty acid side chain and 
terminus group. Two of the most commonly occurring head groups are the free hydroxyl group 
Figure 1.3: Ascaroside components of the dauer pheromone 
 




and indole-3-carbonyl (IC). The fatty acid side chain is linked with either a ω-linkage when R = H 
or a (ω-1) linkage when R = Me. In addition to the linkage, the side chain can vary in length and 
degree of unsaturation. The terminus groups include a carboxylic acid, methyl ketone (MK) and 
para-aminobenzonic acid (PABA) group. Variability in structure between the ascarosides can have 
a drastic effect on the ability to promote dauer formation as shown with the EC50 values. 
 Dauer formation in C.elegans is attributed to the chemosensation of the dauer pheromone.  
The dauer pheromone, is excreted constitutively.8,9 Nematodes like C.elegans use several chemical 
cues to gather information about their environment. One of these cues is a yet- unidentified “food 
signal”. This “food signal” gives information about food availability in the area and is an antagonist 
of the dauer pheromone. Dauer formation of C.elegans and the length of time spent in the dauer 
form is dependent on the balance between the dauer pheromone and this “food signal”.13                                                                                         
 1.1.3    IGF-1 and TGF-β Pathways 
The dauer pheromone functions by binding to the G coupled protein receptors (GCPRs) in 
C.elegans. The binding occurs when the chemosensory neurons in the head of the worm are 
exposed to the pheromone.18 Dauer pheromone ascarosides bind to the GCPRs to induce dauer 
formation as has been observed during several experimental studies.19-25 In one study when two 
alpha subunits of GCPRs gpa-2 and gpa-3 were upregulated, dauer formation was observed.19 
However, when these subunits were altered, no dauer formation was seen. There are five major 
neurons that express the GCPRs. The neurons that mediate the chemosensation of the dauer 
pheromone are ADF, ASG, ASI, ASJ and ASK. Two of these neurons, ASI and ASJ, are known 
to down regulate the highly conserved pathways IGF-1 and TGF-β.20 These pathways that are 
operative in C.elegans, as stated earlier, have homologs in Homo sapiens. There are various 
biological processes in which IGF-1 and TGF-β play a role and understanding of how these 
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pathways work may be key to slowing the aging process and treating diseases. IGF-1 has been 
shown to have an effect on the aging process of different organisms. In two separate experiments 
wherein the IGF-1 receptor in C.elegans and mice were altered, the aging process was 
decelerated.21 IGF-1 levels have also been shown to have an effect on cancer growth. The decrease 
of IGF-1 levels was shown to decrease the growth of colorectal carcinoma, breast cancer and 
melanoma cancer cells in one study.22 It has also been shown that the down regulation of IGF-1 
through diet correlates to a lower cancer risk.23 
 The TGF-β pathway plays a role in various diseases like cancer and Alzheimer’s disease.24 
The effect of TGF-β on cancer can be as both a suppressant and promoter depending on the type 
of cancer.25 In gastric and pancreatic cancer TGF-β acts as a suppressant as the shutdown of the 
TGF-β pathway is observed in this form of cancer. By contrast, the role as a promoter is observed 
in breast cancer, where the up regulation of the pathway increases tumor growth. A High 
concentration of TGF-β has also been seen in the blood and cerebral fluid of patients suffering 
from Alzheimer’s disease.24 The IGF-1 and TGF-β pathways play vital roles in biological process. 
Understanding how these pathways work may be key to slowing the aging process and treating 
diseases. Studying the effect that these pathways have on C.elegans and extrapolating the 
observations to higher organisms is one way of advancing this understanding. As showm the up- 
and down regulation of IGF-1and TGF-β play many important biological roles. Further 
understanding of how the biochemical pathways are up and down regulated could lead to better 
understanding of their biological roles. This could be performed by subjecting C.elegans to analogs 
of ascarosides know to down regulate IGF-1 and TGF-β (which result in dauer formation). 
Examination of the amount of dauer inducing activity of each analog could be directly correlated 
to that compound’s ability to regulate IGF-1 and TGF-β. 
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1.2  Results and Discussion  
 Analogs of the dauer pheromone that we synthesized contain the ascarylose sugar moiety 
that is seen in the naturally occurring ascarosides. Our structural manipulations were made on the 
fatty acid side chain by varying the length and degree of unsaturation. The terminus of the side 
chain can also designated as a methyl ketone or carboxylic acid. In order to establish a structure-
activity relationship (SAR), a variety of analogs is needed. The degree of dauer inducing activity 
of these analogs may hinge on the structural modification of the naturally occurring ascarosides. 
In order to determine the dauer-formation activity, each analog was synthesized and submitted to 
dauer formation assays.26 This would show the variability in dauer inducing activity based on 
manipulation of the fatty acid side chain length and unsaturation. The results of these assays will 
tell us whether the GCPRs that bind the ascaroside are selective toward specific side chain 
modifications or if the ascarylose moiety itself is necessary and sufficient for activity.  
 Multiple series of analogs with varying structural modifications were synthesized. The 
series of analogs that I synthesized are derivatives of the naturally-occurring pheromone shown in  
Figure 1.5. Analogs have fatty acid side chain lengths of four to eight carbons. Saturated and 




EC50= 240 nM 




 The synthesis of each analog began with a Lewis acid-promoted glycosylation of dibenzoyl 
ascarylose with terminal alkene-bearing alcohols (containing one to five methylene carbons) to 
produce intermediate compounds represented by structure 1 (Scheme 1.1) in moderate to excellent 
yields. Selectivity for the desired α anomer is achieved due to the neighboring group participation 
shown in Scheme 1.2. The dryness of the solvent was of great importance as yields increased when 
using DCM dried by a solvent system compared to that of typical reagent grade solvent. 
 
Scheme 1.2 Neighboring group participation 
 The glycosylated products were then subjected to olefin cross metathesis using methyl 
acrylate and the Grubbs catalyst to obtain intermediate 2 (Scheme 1.1). The reaction was 
performed in refluxing dichloromethane to increase the reactivity. In order to obtain the saturated 
versions of these compounds, intermediate 2 was subjected to hydrogenation using a 1 atm of 
hydrogen (in a balloon) with palladium on activated carbon in ethyl acetate to give intermediates 
3 in high yield (Scheme 1.3). Intermediates 2 and 3 were then subjected to basic hydrolysis using 
1M lithium hydroxide and tert-butyl alcohol to give the carboxylic acid-bearing terminus analogs 
4 and 5 (Scheme 1.3). Moderate yields were obtained after purification with HPLC. 




Scheme 1. 3 Completion of Analog Series 
 Once all of the analogs were synthesized and fully characterized by 1H and 13C NMR along 
with high resolution mass spectrometry and polarimetry, they were screened in dauer formation 
assays to determine the amount of dauer producing activity of each analog.26 The assays were 
performed by taking a mixture of each of the synthesized ascaroside analogs at concentrations of 
220 nM and 6000 nM with nematode growth media agar and heat treated E.coli. The mixture was 
poured onto a plate and allowed to set. Adult C.elegans then laid eggs on the set mixture which 
was then incubated for approximately 3 days at 25°C. After removal of the adults, this provided 
50-100 larvae on each plate. The number of dauers was then determined by their small size and 
lack of pharyngeal pumping. The percentage of dauers formed was then determined. The 
concentration of the ascaroside analogs was specifically chosen. The 220 nM would help us 
identify potent analogs while the 6000 nM concentration would help us identify analogs with poor 
activity or a paradoxical inhibitory effect. 
 When comparing the activity of the dauer pheromone analogs to that of the naturally 
occurring dauer pheromones (Figure 1.6), it is clearly seen that the analogs display significantly 
less dauer inducing activity. The low amount of dauer inducing activity of the dauer pheromone 
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analogs is interesting since their structure only slightly differs from the natural dauer pheromones. 
The ascarosides I synthesized (asc-ωΔC4 through asc-ωΔC7) which differ from the natural 
ascaroside asc-ωC3 in chain length and degree of unsaturation and asc-ωC4 through asc-ωC7 
which differ only in chain length all have significantly less dauer inducing activity. The only two 
compounds that did show some activity at the 6000 nM concentration were asc-ωC4 and asc-
ωΔC5. The asc-ωC4 analog is one carbon longer than the naturally occurring pheromone and we 
hypothesize that its activity is due to the analog mimicking the asc-ωC3. The asc-ωΔC5 analog, 
however, cannot be explained so simply since it differs in chain length by two carbons and in 
degree of unsaturation. The activity may be due to low GCPR affinity for the unnatural ascarosides 
that I synthesized. This established a flag pole SAR where activity is greatly diminished if there is 
any deviation from the natural ascarosides, which themselves show a significant amount of dauer 
inducing activity. The high selectivity of the GPCRs makes sense when considering that, in nature,  
 
Figure 1.6 Initiation of dauer formation by ascarosides 
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C.elegans occupy the same habitat as other nematodes that also use ascarosides for signalling.27 
The selectivity of the GCPRs prevents cross talk from other species. 
1.3 Conclusion 
 I synthesized multiple analogs in order to establish a structure-activity relationship. This 
showed the variability in dauer inducing activity based on manipulation of the fatty acid side chain 
length and unsaturation. The analogs I synthesized varied in chain length and degree of 
unsaturation. Once highly pure samples of these analogs were obtained, their dauer inducing 
activity was determined. None of the analogs showed any significant dauer inducing activity 
despite their similarites to the naturally occurring dauer pheromone ascarosides. This suggests that 
the G protein-coupled receptors are highly selective in what ascarosides they bind. This selectivity 
is beneficial to prevent species cross talk since other nematodes use similar ascarosides for 
signaling. 
1.4 Experimental 
1.4.1 General Methods 
 Reagents were purchased from Sigma Aldrich and used as received.  Flash column 
chromatography was performed using 60Å silica gel purchased from Sigma Aldrich. 1H NMR and 
13C NMR spectroscopy were performed on a Bruker AV-400, DPX 400, DPX 250 and AV- 500 
spectrometer. HPLC purifications were conducted with a Waters Breeze 2 system equipped with 
an XBridge C18 semi-preparative column (5 lm, 10 x 100 mm) with gradient runs of H2O in 
CH3CN. Mass spectra were obtained using an Agilent 6210 electrospray time-of-flight mass 
spectrometer. Optical rotation measurements were obtained using a JASCO P-2000 polarimeter.  
Analytical and preparative TLC were conducted on aluminum sheets (Merck, silica gel 60, F254). 
Compounds were visualized by UV absorption (254 nm) and staining with anisaldehyde. All 
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glassware was flame-dried under vacuum and backfilled with dry nitrogen prior to use. Deuterated 
solvents were obtained from Cambridge Isotope Labs. All solvents were purified according to the 
method of Grubbs.1 
1.4.2 Experimental procedures and tabulated data 
Representative procedure for Glycosylation 1 (n=1): 
 
 A suspension of 400 mg (1.122 mmol) dibenzoyl ascarylose, 0.12 mL (1.8 mmol) allyl 
alcohol and 120 mg 4Å molecular sieves in 12 mL CH2Cl2 was cooled to 0
oC.  To this suspension 
was added 0.61 mL (4.8 mmol) BF3.OEt2 at once.  The resulting suspension was stirred at 0
oC for 
4 h.  12 mL saturated NaHCO3 solution was then added.  Upon cessation of effervescence, the 
aqueous layer was separated from the organic layer and then extracted with 3x10mL CH2Cl2.  The 
resulting organic extracts were dried over MgSO4 and filtered to obtain 514.5 mg of oil after 
evaporation of solvent.  Silica gel column chromatography (39 g silica gel, gradient run from 5% 
EtOAc in hexanes to 15% EtOAc) afforded 420.8 mg (95%) of a colorless syrup. . [α]D
25= 2.6, c 
1.33; HRMS (m/z): [M+Na] calcd. For C23H24O6Na 419.1465, found 419.1473; 
1H NMR (250 
MHz, Chloroform-d) δ 8.13 (d, J = 7.01, 1.5 Hz, 2H), 8.05 (d, J = 7.01, 1.5 Hz, 2H), 7.65 – 7.52 
(m, 2H), 7.52 – 7.37 (m, 4H), 6.10 – 5.87 (m, 1H), 5.38 (dq, J = 17.2, 1.6 Hz, 1H), 5.31 – 5.13 (m, 
3H), 4.91 (s, 1H), 4.29 (ddt, J = 12.9, 5.2, 1.5 Hz, 1H), 4.21 – 4.02 (m, 2H), 2.46 (dt, J = 14.3, 4.0 
Hz, 1H), 2.26 (ddd, J = 13.8, 11.3, 3.2 Hz, 1H), 1.32 (d, J = 6.2 Hz, 3H). 13C NMR (62.5 MHz, 
CDCl3) δ 165.4, 165.3, 133.6, 133.04, 132.98, 129.8, 129.7, 129.6, 129.4, 128.2, 117.3, 95.4, 70.3, 




Synthesis of 1, (n=2) glycosylation: 
 
 Started with 400 mg (1.129 mmol) dibenzoyl ascarylose (1), 0.16 mL (1.796 mmol) 3-
buten-1-ol, 130 mg 3Å molecular sieves, and 0.61 mL (4.838 mmol) BF3•OEt2 in 12 mL CH2Cl2. 
Purified to obtain 429.8 mg (93%) of a colorless oil. [α]D
25= 8.3, c 0.4; HRMS (m/z): [M+Na] 
calcd. for C24H26O6Na 433.1622, found 433.1629; 
1H NMR (250 MHz, Chloroform-d) δ 8.12 (d, 
7.0 Hz 2H), 8.03 (d, 7.0 Hz 2H), 7.54 (dt, J = 7.1, 3.6 Hz, 2H), 7.43 (td, J = 7.6, 4.5 Hz, 4H), 5.87 
(ddt, J = 17.0, 10.2, 6.7 Hz, 1H), 5.31 – 5.15 (m, 3H), 5.10 (dd, J = 10.2, 1.9 Hz, 1H), 4.87 (s, 1H), 
4.11 (dd, J = 9.8, 6.0 Hz, 1H), 3.81 (dt, J = 9.6, 6.8 Hz, 1H), 3.58 (dt, J = 9.7, 6.6 Hz, 1H), 2.41 (q, 
J = 6.9 Hz, 3H), 2.22 (ddd, J = 13.9, 11.3, 3.1 Hz, 1H), 1.31 (d, J = 6.2 Hz, 3H). 13C NMR (62.5 
MHz, CDCl3) δ 165.4, 165.3, 134.6, 133.00, 132.94, 129.7, 129.6, 129.4, 128.2, 116.6, 96.1, 70.3, 
66.9, 66.6, 33.8, 29.5, 17.7. 
Synthesis of 1, (n=3) glycosylation: 
 
 Started with 300 mg (0.842 mmol) dibenzoylascarylose, 0.14 mL (1.3 mmol) 4-penten-1-
ol, 90 mg 3Å molecular sieves, and 0.46 mL (3.6 mmol) BF3·OEt2 in 9 mL CH2Cl2. Purified to 
obtain 256.2 mg (72%) of a colorless oil. [α]D
25= 11.7, c 0.61; HRMS (m/z): [M+Na] calcd. For 
C25H28O6Na 447.1778, found 447.1780; 
1H NMR (400 MHz, Chloroform-d) δ 8.00 (d, 2H), 7.93 
(d, 2H), 7.54 – 7.44 (m, 2H), 7.36 (td, J = 7.6, 5.4 Hz, 4H), 5.83 – 5.69 (m, 1H), 5.14 – 5.03 (m, 
2H), 5.03 – 4.87 (m, 2H), 4.72 (s, 1H), 3.97 (dq, J = 9.5, 6.2 Hz, 1H), 3.68 (dt, J = 9.6, 6.5 Hz, 
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1H), 3.42 (dt, J = 9.6, 6.3 Hz, 1H), 2.31 (dt, J = 13.4, 3.9 Hz, 1H), 2.17 – 2.04 (m, 3H), 1.74 – 1.60 
(m, 2H), 1.19 (d, J = 6.1 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 165.7, 165.6, 138.0, 133.23, 
133.15, 130.0, 129.9, 129.8, 129.6, 128.4, 115.0, 96.4, 70.6, 67.1, 66.7, 30.3, 29.7, 28.7, 17.9. 
Synthesis of 1, (n=4) glycosylation: 
 
 Started with 300 mg (0.842 mmol) dibenzoylascarylose, 0.16 mL (1.3 mmol) 5-hexen-1-
ol, 90 mg 3Å molecular sieves, and 0.46 mL (3.6 mmol) BF3•OEt2  in 9 mL CH2Cl2. Purified to 
obtain 262.6 mg (71%) of a colorless oil. [α]D
25= 7.7, c 0.48; HRMS (m/z): [M+Na] calcd. For 
C26H30O6Na 461.1935, found 461.1945;  
1H NMR (400 MHz, Chloroform-d) δ 8.11 (d, 2H), 8.04 
(d, 2H), 7.64 – 7.52 (m, 2H), 7.51 – 7.42 (m, 4H), 5.84 (ddt, 1H), 5.24 – 5.12 (m, 2H), 5.10 – 4.94 
(m, 2H), 4.83 (s, 1H), 4.07 (dq, J = 9.8, 6.3 Hz, 1H), 3.77 (dt, J = 9.7, 6.6 Hz, 1H), 3.52 (dt, J = 
9.7, 6.4 Hz, 1H), 2.42 (dt, J = 13.6, 3.9 Hz, 1H), 2.21 (ddd, J = 13.9, 11.4, 3.2 Hz, 1H), 2.17 – 2.07 
(m, 2H), 1.68 (dq, J = 9.2, 6.5, 5.6 Hz, 2H), 1.59 – 1.46 (m, 2H), 1.30 (d, J = 6.2 Hz, 3H). 13C 
NMR (100 MHz, CDCl3) δ 165.9, 165.8, 138.8, 133.5, 133.4, 130.1, 130.0, 129.8, 128.6, 114.9, 
96.6, 70.8, 67.92, 67.94, 33.7, 30.0, 29.2, 25.7, 18.1. 
Synthesis of 1, (n=5) glycosylation: 
 
 Started with 300 mg (0.842 mmol) dibenzoylascarylose, 0.18 mL (1.3 mmol) hept-6-en-1-
ol, 90 mg 3Å molecular sieves, and 0.46 mL (3.6 mmol) BF3·OEt2  in 9 mL CH2Cl2. Purified to 
obtain 271.8 mg (71%) of a colorless oil. [α]D
25= 5.7, c 0.48; HRMS (m/z): [M+Na] calcd. For 
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C27H32O6Na 475.2091, found 475.2091;
 1H NMR (250 MHz, Chloroform-d) δ 8.03 (d, J = 7.0, 1.5 
Hz, 2H), 7.96 (d, J = 7.0, 1.4 Hz, 2H), 7.57 – 7.43 (m, 2H), 7.43 – 7.28 (m, 4H), 5.75 (ddt, J = 
16.9, 10.1, 6.7 Hz, 1H), 5.19 – 5.02 (m, 2H), 5.02 – 4.80 (m, 2H), 4.75 (s, 1H), 3.99 (dq, J = 9.7, 
6.2 Hz, 1H), 3.68 (dt, J = 9.6, 6.7 Hz, 1H), 3.43 (dt, J = 9.6, 6.5 Hz, 1H), 2.33 (m, 1H), 2.13 (ddd, 
J = 13.8, 11.3, 3.1 Hz, 1H), 2.01 (tdd, J = 7.0, 5.3, 2.2 Hz, 2H), 1.59 (dd, J = 13.2, 6.5 Hz, 2H), 
1.47 – 1.26 (m, 4H), 1.22 (d, J = 6.2 Hz, 3H). 13C NMR (100 MHz CDCl3,) δ 178.0, 100.5, 71.0, 
69.6, 68.5, 68.4, 36.1, 35.2, 30.7, 30.3, 27.3, 26.2, 18.2. 
Representative procedure for cross metathesis 2 (n=1): 
 
 To a solution of 262.8 mg (.663 mmol) terminal alkene 1 (n=1) and 0.30 mL (3.3 mmol) 
of methyl acrylate in 22.2 mL CH2Cl2 was added 56.3 mg (66.3 µmol) Grubbs 2
nd generation 
ruthenium catalyst at once. The resulting solution was allowed to stir at reflux for 4 h. The reaction 
mixture was concentrated to 167.6 mg of maroon oil. Column chromatography (12 g silica gel, 
gradient run from 50% DCM in hexanes to pure DCM) afford 112.4 mg (37%) of a colorless oil. 
[α]D
25= 4.5, c 0.5; HRMS (m/z): [M+Na] calcd. For C25H26O8Na 477.1531, found 477.1520; 
1H 
NMR (250 MHz, Chloroform-d) δ 8.10 (d, J = 7.25 Hz, 2H), 8.03 (d, 7.25 Hz, 2H), 7.64 – 7.51 
(m, 2H), 7.51 – 7.37 (m, 4H), 7.02 (dt, J = 15.7, 4.3 Hz, 1H), 6.16 (dt, J = 15.7, 2.0 Hz, 1H), 5.32 
– 5.11 (m, 2H), 4.89 (s, 1H), 4.45 (ddd, J = 16.0, 4.3, 2.1 Hz, 1H), 4.24 (ddd, J = 16.1, 4.6, 2.1 Hz, 
1H), 4.13 – 3.98 (m, 1H), 3.76 (s, 3H), 2.46 (dt, J = 13.6, 4.0 Hz, 1H), 2.23 (ddd, J = 14.0, 11.3, 
3.2 Hz, 1H), 1.29 (d, J = 6.2 Hz, 3H). 13C NMR (62.5 MHz, CDCl3) δ 166.4, 165.50, 165.46, 143.3, 




 Synthesis of 2, n=2 cross metathesis: 
 
 Started with 429.8 mg (1.047 mmol) 1 (n=2), 0.47 mL (5.2 mmol) methyl acrylate, and 
88.9 mg (104 µmol) Grubbs second generation catalyst in 36.6 mL CH2Cl2. Purified to obtain 
258.8 mg (53%) of a colorless oil. [α]D
25= 11.2, c 0.2; HRMS (m/z): [M+Na] calcd. For 
C26H28O8Na 491.1676, found 491.1672; 
1H NMR (250 MHz, Chloroform-d) δ 8.09 (d, J = 7.2, 1.4 
Hz, 2H), 8.02 (d, J = 7.25 Hz, 2H), 7.62 – 7.49 (m, 2H), 7.49 – 7.35 (m, 4H), 7.00 (dt, J = 15.7, 
7.0 Hz, 1H), 5.94 (m, 1H), 5.28 – 5.08 (m, 2H), 4.84 (s, 1H), 4.04 (m, 1H), 3.86 (dt, J = 9.8, 6.5 
Hz, 1H), 3.71 (s, 3H), 3.63 (dt, J = 9.8, 6.2 Hz, 1H), 2.62 – 2.47 (m, 2H), 2.41 (dt, J = 13.5, 4.0 
Hz, 1H), 2.17 (ddd, J = 13.9, 11.4, 3.2 Hz, 1H), 1.28 (d, J = 6.2 Hz, 3H). 13C NMR (62.5 MHz, 
CDCl3) δ 166.5, 165.5, 165.4, 145.2, 133.1, 133.0, 129.73, 129.67, 129.6, 129.4, 128.3, 122.8, 
96.2, 70.2, 66.8, 65.6, 51.3, 32.2, 29.5, 17.7. 
Synthesis of 2, (n=3) cross metathesis: 
 
      Started with 218.7 mg (0.515 mmol) 1 (n=3), 0.22 mL (2.6 mmol) methyl acrylate, and 51.5 
mg (60.7µmol) Grubbs second generation catalyst in 18.4 mL CH2Cl2. Purified to obtain 110.1 mg 
(44%) of a colorless oil. [α]D
25= 2.7, c 0.2; HRMS (m/z): [M+Na] calcd. For C27H30O8Na 
505.1833, found 505.1856; 1H NMR (400 MHz, Chloroform-d) δ 8.11 (d, 2H), 8.05 (d, 2H), 7.63 
– 7.53 (m, 2H), 7.47 (td, J = 7.5, 4.8 Hz, 4H), 7.03 (dt, J = 15.9, 6.9 Hz, 1H), 5.90 (d, J = 15.6 Hz, 
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1H), 5.24 – 5.14 (m, 2H), 4.83 (s, 1H), 4.06 (dt, J = 9.5, 6.0 Hz, 1H), 3.80 (dt, J = 9.7, 6.5 Hz, 3H), 
3.74 (s, 1H), 3.54 (dt, 1H), 2.48 – 2.32 (m, 2H), 2.27 – 2.15 (m, 2H), 1.85 (p, J = 6.8, 5.7 Hz, 2H), 
1.30 (d, J = 6.3 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 167.0, 165.71, 165.6, 148.6, 133.3, 133.2, 
130.0, 129.9, 129.61, 128.5, 128.4, 121.4, 96.4, 70.48, 70.46, 66.9, 51.4, 29.7, 29.0, 28.0, 17.9. 
Synthesis of 2, (n=4) cross metathesis: 
 
 Started with 100 mg (0.228 mmol) 1 (n=4), 0.10 mL (1.1 mmol) methyl acrylate, and 19.4 
mg (22.8 µmol) Grubbs second generation catalyst in 8.4 mL CH2Cl2. Purified to obtain 60.6 mg 
(53%) of a colorless oil.  [α]D
25= 4.1, c 0.48; HRMS (m/z): [M+Na] calcd. For C27H32O6Na 
519.1989, found 519.1996. 1H NMR (400 MHz, Chloroform-d) δ 8.11 (d, J = 8.4, 1.6 Hz, 2H), 
8.05 (d, 2H), 7.64 – 7.54 (m, 2H), 7.47 (ddd, J = 8.8, 7.1, 5.2 Hz, 4H), 7.01 (dt, J = 15.7, 7.0 Hz, 
1H), 5.88 (dt, J = 15.6, 1.6 Hz, 1H), 5.25 – 5.13 (m, 2H), 4.83 (s, 1H), 4.06 (dq, J = 9.9, 6.2 Hz, 
1H), 3.78 (dt, J = 9.8, 6.3 Hz, 1H), 3.73 (s, 3H), 3.52 (dt, J = 9.8, 6.1 Hz, 1H), 2.48 – 2.37 (m, 1H), 
2.29 (qd, J = 7.1, 1.6 Hz, 2H), 2.21 (ddd, J = 13.5, 11.3, 3.1 Hz, 1H), 1.74 – 1.56 (m, 4H), 1.30 (d, 
J = 6.2 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 167.0 165.7, 165.6, 149.0, 133.24, 133.16, 130.0, 
129.84, 129.79, 129.6, 128.4, 121.3, 96.4, 70.5, 67.4, 66.8, 51.4, 31.9, 29.7, 28.9, 24.7, 17.9. 
Synthesis of 2, (n=5) cross metathesis: 
 
 Started with 271.8 mg (0.6010 mmol) 1 (n=5), 0.27 mL (3.0 mmol) methyl acrylate, and 
51 mg (60 µmol) Grubbs second generation catalyst in 23 mL CH2Cl2. Purified to obtain 163.2 mg 
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(53%) of a colorless oil. [α]D
25= 3.8, c 1.5; HRMS (m/z): [M+Na] calcd. For C29H34O8Na 
533.2146, found 533.2157; 1H NMR (250 MHz, Chloroform-d) δ 8.11 (d, J = 7.0, 1.5 Hz, 2H), 
8.04 (d, J = 7.0, 1.4 Hz, 2H), 7.68 – 7.52 (m, 2H), 7.52 – 7.38 (m, 4H), 6.99 (dt, J = 15.7, 6.9 Hz, 
1H), 5.85 (dt, J = 15.6, 1.6 Hz, 1H), 5.28 (s, 1H), 5.18 (ddd, J = 9.9, 5.2, 3.7 Hz, 2H), 4.82 (s, 1H), 
4.05 (dq, 1H), 3.85 – 3.73 (m, 1H), 3.71 (s, 3H), 3.50 (dt, J = 9.7, 6.4 Hz, 1H), 2.42 (dt, J = 13.4, 
4.0 Hz, 1H), 2.33 – 2.11 (m, 3H), 1.68 (dd, J = 11.7, 4.8 Hz, 2H), 1.50 (ddt, J = 13.8, 10.2, 5.9 Hz, 
4H), 1.30 (d, J = 6.2 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 167.1, 165.7, 165.6, 149.3, 133.24, 
133.16, 130.0, 129.9, 129.8, 129.6, 128.4, 121.0, 96.3, 70.6, 67.6, 66.7, 51.4, 32.1, 29.7, 29.7, 29.2, 
27.8, 25.7, 17.9. 
Representative procedure for 3 (n=1) hydrogenation: 
 
A suspension of 89.7 mg (0.197 mmol) unsaturated ester 2 (n=1) and 9.3 mg 10% 
palladium on activated carbon in 9ml EtOAc was vacuum purged and back filled with H2 gas . The 
resulting suspension was allowed to stir at 25°C for 24 h. The reaction mixture was filtered through 
celite and concentrated to obtain 85.7 mg (95%) of a colorless oil that required no further 
purification. [α]D
25= 5.8, c 0.2; HRMS (m/z): [M+Na] calcd. For C25H28O8Na 479.1676, found 
479.1700; 1H NMR (250 MHz, Chloroform-d) δ 8.10 (d, J = 7.0, 1.4 Hz, 2H), 8.04 (d, J = 7.1, 1.4 
Hz, 2H), 7.65 – 7.51 (m, 2H), 7.51 – 7.38 (m, 4H), 5.27 – 5.09 (m, 2H), 4.82 (s, 1H), 4.14 – 3.97 
(m, 1H), 3.82 (dt, J = 9.8, 6.2 Hz, 1H), 3.70 (s, 3H), 3.54 (dt, J = 9.7, 6.1 Hz, 1H), 2.55 – 2.34 (m, 
3H), 2.19 (ddd, J = 13.8, 11.3, 3.2 Hz, 1H), 1.99 (h, J = 6.5 Hz, 2H), 1.29 (d, J = 6.2 Hz, 3H). 13C 
NMR (62.5 MHz, CDCl3) δ 173.8, 165.6, 165.5, 133.14, 133.07, 129.8, 129.73, 129.68, 129.5, 
128.3, 96.3, 70.4, 67.2, 66.7, 51.4, 33.6, 29.6, 28.8, 21.7, 17.8. 
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Synthesis of 3, (n=2) hydrogenation: 
 
Started with 131.1 mg (0.2800 mmol) 2 (n=2) 13.5 mg palladium on activated carbon 10% 
palladium in 13.4 mL ethyl acetate. Purified to obtain 120.1 mg (91%) colorless oil. [α]D
25= 12.4, 
c 0.3; HRMS (m/z): [M+Na] calcd. For C26H30O8Na 493.1833, found 493.1826 
1H NMR (250 
MHz, Chloroform-d) δ 8.10 (d, 2H), 8.03 (d, J = 7.0, 1.6 Hz, 2H), 7.64 – 7.51 (m, 2H), 7.44 (ddd, 
J = 8.8, 6.9, 3.6 Hz, 4H), 5.27 – 5.09 (m, 2H), 4.82 (s, 1H), 4.14 – 3.99 (m, 1H), 3.78 (dt, J = 9.4, 
6.0 Hz, 1H), 3.67 (s, 3H), 3.51 (dt, J = 9.7, 5.7 Hz, 1H), 2.50 – 2.31 (m, 3H), 2.20 (ddd, J = 13.9, 
11.3, 3.1 Hz, 1H), 1.75 (ddt, J = 12.3, 7.9, 4.7 Hz, 4H), 1.29 (d, J = 6.2 Hz, 3H). 13C NMR (62.5 
MHz, CDCl3) δ 173.8, 165.6, 165.5, 133.14, 133.07, 129.8, 129.7, 129.7, 129.5, 128.3, 96.3, 70.4, 
67.2, 66.7, 51.4, 33.6, 29.6, 28.8, 21.7, 17.8. 
Synthesis of 3, (n=3) hydrogenation: 
 
Started with 52 mg (0.11 mmol) 2 (n=3) 5.3 mg palladium on activated carbon 10% 
palladium in 5.3 mL ethyl acetate. Purified to obtain 45.5 mg (87%) colorless oil. [α]D
25= 6.1, c 
0.4; HRMS (m/z): [M+Na] calcd. For C27H32O8Na 505.1833, found 505.1856; 
1H NMR (400 
MHz, Chloroform-d) δ 8.11 (d, J = 7.1, 1.4 Hz, 2H), 8.04 (d, 2H), 7.58 (dddd, J = 6.9, 5.2, 2.6, 1.3 
Hz, 2H), 7.46 (ddd, J = 8.7, 7.0, 5.0 Hz, 4H), 5.24 – 5.12 (m, 2H), 4.82 (s, 1H), 4.06 (dq, J = 9.6, 
6.2 Hz, 1H), 3.77 (dt, J = 9.6, 6.6 Hz, 1H), 3.68 (s, 3H), 3.51 (dt, J = 9.6, 6.4 Hz, 1H), 2.47 – 2.32 
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(m, 3H), 2.20 (ddd, J = 13.8, 11.4, 3.1 Hz, 1H), 1.77 – 1.62 (m, 4H), 1.45 (tt, J = 9.8, 6.2 Hz, 2H), 
1.30 (d, J = 6.3 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 174.1, 165.7, 165.6, 133.23, 133.16, 
130.0, 129.9, 129.8, 129.6, 128.4, 96.4, 70.6, 67.6, 66.8, 51.5, 34.0, 29.73, 29.68, 29.2, 25.8, 24.7, 
17.9 
Synthesis of 3, (n=4) hydrogenation: 
 
 Started with 103.4 mg (0.208 mmol) 2 (n=4) 10.6 mg palladium on activated carbon 10% 
palladium in 10.6 mL ethyl acetate. Purified to obtain 84.4 mg (81%) colorless oil. [α]D
25= 2.8, c 
0.3; HRMS (m/z): [M+Na] calcd. For C28H34O8Na 521.2146, found 521.2163; 
1H NMR (400 
MHz, Chloroform-d) δ 8.11 (d, 2H), 8.04 (d, 2H), 7.64 – 7.54 (m, 2H), 7.52 – 7.42 (m, 4H), 5.24 
– 5.12 (m, 2H), 4.82 (s, 1H), 4.06 (dq, J = 9.8, 6.3 Hz, 1H), 3.76 (dt, J = 9.7, 6.7 Hz, 1H), 3.67 (s, 
3H), 3.50 (dt, J = 9.7, 6.5 Hz, 1H), 2.41 (dt, J = 13.7, 4.0 Hz, 1H), 2.34 (t, J = 7.5 Hz, 2H), 2.21 
(ddd, J = 13.8, 11.4, 3.2 Hz, 1H), 1.67 (dq, J = 11.0, 7.0, 6.5 Hz, 4H), 1.41 (tdd, J = 10.6, 7.3, 4.2 
Hz, 4H), 1.30 (d, J = 6.3 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 167.5, 166.0, 165.9, 133.5, 
133.4, 130.2, 130.09, 130.06, 129.8, 128.7, 96.6, 70.8, 68.0, 67.0, 51.7, 34.2, 30.0, 29.5, 29.2, 26.1, 
25.1, 18.1. 
Synthesis of 3, (n=5) hydrogenation: 
 
Started with 52 mg (0.10 mmol) 2 (n=5), 5.3 mg palladium on activated carbon 10% 
palladium in 5.3 mL ethyl acetate. Purified to obtain 50 mg (96%) colorless oil. [α]D
25= 4.3, c 0.2; 
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HRMS (m/z): [M+Na] calcd. For C29H36O8Na 535.2302, found 535.2315; 
1H NMR (400 MHz, 
Chloroform-d) δ 8.11 (d, J = 7.2, 1.4 Hz, 2H), 8.04 (d, 2H), 7.64 – 7.53 (m, 2H), 7.47 (td, J = 7.5, 
5.0 Hz, 4H), 5.25 – 5.11 (m, 2H), 4.82 (s, 1H), 4.06 (dt, J = 9.6, 6.1 Hz, 1H), 3.75 (dt, J = 9.7, 6.7 
Hz, 1H), 3.67 (s, 3H), 3.50 (dt, J = 9.5, 6.4 Hz, 1H), 2.42 (dt, J = 13.5, 4.1 Hz, 1H), 2.33 (t, J = 7.5 
Hz, 2H), 2.27 – 2.15 (m, 1H), 1.74 – 1.60 (m, 4H), 1.47 – 1.32 (m, 6H), 1.32 – 1.23 (m, 3H). 13C 
NMR (100 MHz,  CDCl3) δ 174.3, 165.7, 165.7, 133.24, 133.17, 130.0, 129.9, 129.8, 129.6, 128.4, 
96.4, 70.6, 67.9, 66.7, 51.5, 34.1, 29.74, 29.7, 29.4, 29.1, 26.0, 24.9, 17.9. 
Representative procedure for 4 (n=1) hydrolysis: 
 
To a solution of 44.3 mg (0.0970 mmol) methyl ester 2 (n=1) in 7.8 mL of tBuOH was 
added 7.8 mL 1M LiOH at once. The resulting solution was allowed to stir at 25°C for 24 h. The 
solution was then acidified with 1M HCl until a pH of 3. The organic layer was then separated 
from the aqueous. The aqueous layer was then extracted 4 x 10 mL DCM. The combined organic 
layers were washed with brine, dried with Na2SO4 and filtered. Evaporation of solvent afforded 
20.1 mg of an oil. HPLC purification on reverse phase column (gradient run pure CH3CN to water) 
afforded 7 mg (31%) colorless oil. [α]D
25= -100.2, c 0.1; HRMS (m/z): [M+Na] calcd. For 
C10H16O6Na 255.0839, found 255.0841; 
1H NMR (400 MHz, Methanol-d4) δ 6.89 (dt, J = 15.6, 
4.5 Hz, 1H), 6.04 (d, J = 15.6, 2.1 Hz, 1H), 4.57 (s, 1H), 4.34 (ddd, J = 16.0, 4.3, 2.1 Hz, 1H), 4.16 
(ddd, J = 16.0, 4.7, 2.0 Hz, 1H), 3.83 (q, J = 2.6 Hz, 1H), 3.54 (dq, J = 9.9, 5.0, 4.2 Hz, 2H), 3.34 
(s, 1H), 1.98 (dt, J = 13.0, 3.6 Hz, 1H), 1.80 (ddd, J = 13.4, 10.6, 3.1 Hz, 1H), 1.23 (d, J = 5.6 Hz, 




Synthesis of 4, (n=2) unsaturated hydrolysis: 
 
 Started with 102.1 mg (0.2180 mmol) 2 (n=2) and 17.9 mL (1N) LiOH in 17.9 mL of tert-
Butanol. Purified to obtain 23 mg (43%) colorless oil. [α]D
25= -53.8, c 0.3; HRMS (m/z): [M+Na] 
calcd. For C11H18O6Na 269.0996, found 269.1003; 
1H NMR (400 MHz, Methanol-d4) δ 6.96 (dt, 
J = 15.7, 6.9 Hz, 1H), 5.88 (d, J = 15.7 Hz, 1H), 4.52 (s, 1H), 3.86 – 3.72 (m, 2H), 3.54 (ddt, J = 
14.9, 10.5, 5.3 Hz, 3H), 3.35 – 3.25 (m, 1H), 2.50 (q, J = 6.5 Hz, 2H), 1.94 (dt, J = 13.0, 3.8 Hz, 
1H), 1.75 (ddd, J = 13.2, 10.5, 3.2 Hz, 1H), 1.22 (d, J = 5.7 Hz, 3H). 13C NMR (100 MHz, MeOD) 
δ 170.1, 147.7, 124.4, 100.7, 71.3, 69.45, 68.44, 66.9, 36.1, 33.6, 18.2. 
Synthesis of 4, (n=3) unsaturated hydrolysis: 
 
 Started with 38.9 mg (0.0810 mmol) 2 (n=3) and 6.9 mL (1N) LiOH in 6.9 mL of tert-
Butanol. Purified to obtain 7.5 mg (36%) colorless oil. [α]D
25= -65.5, c 0.4; HRMS (m/z): [M+Na] 
calcd. For C12H20O6Na 283.1152, found 283.1163; 
1H NMR (400 MHz, Methanol-d4) δ 6.97 (dt, 
J = 15.6, 7.0 Hz, 1H), 5.83 (dt, J = 15.6, 1.5 Hz, 1H), 4.50 (s, 1H), 3.78 (td, J = 3.1, 1.5 Hz, 1H), 
3.73 (dt, J = 9.8, 6.3 Hz, 1H), 3.61 – 3.39 (m, 3H), 2.33 (qt, J = 7.1, 1.6 Hz, 2H), 2.01 – 1.90 (m, 
1H), 1.83 – 1.70 (m, 3H), 1.23 (d, J = 5.9 Hz, 3H). 13C NMR (100 MHz, MeOD) δ 170.4, 150.4, 




Synthesis of 4, (n=4) unsaturated hydrolysis: 
 
Started with 42 mg (0.082 mmol) 2 (n=4) and 7.4 mL (1N) LiOH in 7.4 mL of tert-Butanol. 
Purified to obtain 8.5 mg (36%) colorless oil. [α]D
25= -49.0, c 0.2; HRMS (m/z): [M-H]- calcd. For 
C13H22O6Na  273.1344, found 273.1343; 
1H NMR (400 MHz, Methanol-d4) δ 6.92 (dt, J = 15.6, 
7.0 Hz, 1H), 5.81 (d, J = 15.6 Hz, 1H), 4.49 (s, 1H), 3.76 (td, J = 3.1, 1.5 Hz, 1H), 3.70 (dt, J = 
9.9, 6.1 Hz, 1H), 3.60 – 3.38 (m, 3H), 2.25 (qd, J = 7.0, 1.6 Hz, 2H), 1.99 – 1.89 (m, 1H), 1.76 
(ddd, J = 13.1, 10.9, 3.1 Hz, 1H), 1.60 (tdd, J = 11.9, 8.5, 5.3 Hz, 4H), 1.22 (d, J = 5.9 Hz, 3H). 
13C NMR (100 MHz, MeOD) δ 170.6, 150.5, 100.6, 71.1, 69.6, 68.5, 68.12, 49.6, 36.2, 33.0, 30.3, 
26.2, 18.3. 
Synthesis of 4, (n=5) unsaturated hydrolysis: 
 
 Started with 47.3 mg (0.0930 mmol) 2 (n=5) and 8.4 mL (1N) LiOH in 8.4 mL of tert-
Butanol. Purified to obtain 19.1 mg (72%) colorless oil. [α]D
25= -67.1, c 0.6; HRMS (m/z): [M+Na] 
calcd. For C14H24O6Na 311.1465, found 311.1466; 
1H NMR (400 MHz, Methanol-d4) δ 6.95 (dt, 
J = 15.6, 7.0 Hz, 1H), 5.81 (dt, J = 15.6, 1.7 Hz, 1H), 4.50 (s, 1H), 3.77 (q, J = 2.8 Hz, 1H), 3.69 
(dt, J = 9.7, 6.5 Hz, 1H), 3.62 – 3.47 (m, 2H), 3.43 (dt, J = 9.7, 6.2 Hz, 1H), 2.24 (qd, J = 7.1, 1.6 
Hz, 2H), 1.95 (dt, J = 13.0, 3.7 Hz, 1H), 1.76 (ddd, J = 13.3, 10.8, 3.1 Hz, 1H), 1.70 – 1.57 (m, 
2H), 1.57 – 1.35 (m, 4H), 1.23 (d, J = 5.8 Hz, 3H). 13C NMR (100 MHz, MeOD) δ 170.5, 150.0, 
122.9, 100.6, 71.1, 69.5, 68.5, 68.3, 36.13, 33.2, 30.5, 29.1, 27.1, 18.3. 
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Synthesis of 5, (n=1) saturated hydrolysis: 
 
Started with 48.6 mg (0.106 mmol) 3 (n=1) and 8.5 mL (1N) LiOH in 8.5 mL of tert-
Butanol. Purified to obtain 7 mg (28%) colorless oil. [α]D
25= -88.5, c 0.2; HRMS (m/z): [M+Na] 
calcd. For C11H20O6Na 257.0996, found 257.1004; 
1H NMR (400 MHz, Methanol-d4) δ 4.49 (s, 
1H), 3.76 (tt, J = 3.9, 1.9 Hz, 1H), 3.74 – 3.68 (m, 1H), 3.60 – 3.39 (m, 3H), 2.37 (t, J = 7.3 Hz, 
2H), 1.99 – 1.82 (m, 3H), 1.76 (ddd, J = 13.2, 10.9, 3.1 Hz, 1H), 1.21 (d, J = 5.9 Hz, 3H). 13C NMR 
(100 MHz, MeOD) δ 177.8, 100.6, 71.1, 69.5, 68.5, 67.5, 36.1, 32.3, 26.4, 18.23. 
Synthesis of 5, (n=2) saturated hydrolysis: 
 
Started with 40.3 mg (0.0950 mmol) 3 (n=2) and 7.8 mL (1N) LiOH in 7.8 mL of tert-
Butanol. Purified to obtain 5.8 mg (23%) colorless oil. [α]D
25= -64.8, c 0.3; HRMS (m/z): [M+Na] 
calcd. For C11H20O6Na 271.1152, found 271.1143; 
1H NMR (400 MHz, Methanol-d4) δ 4.50 (s, 
1H), 3.77 (q, J = 2.6 Hz, 1H), 3.72 (dd, J = 9.8, 6.2 Hz, 1H), 3.62 – 3.38 (m, 3H), 2.32 (t, J = 6.7 
Hz, 2H), 1.95 (dt, J = 13.0, 3.8 Hz, 1H), 1.83 – 1.76 (m, 1H), 1.76 – 1.56 (m, 5H), 1.23 (d, J = 5.9 
Hz, 3H). 13C NMR (100 MHz, MeOD) δ 177.8, 100.4, 70.9, 69.4, 68.3, 67.9, 36.0, 34.9, 30.1, 
23.1, 18.1. 




Started with 40.3 mg (0.08300 mmol) 3 (n=3) and 7.1 mL (1N) LiOH in 7.1 mL of tert-
Butanol. Purified to obtain 6.3 mg (29%) colorless oil. [α]D
25= -74.9, c 0.3; HRMS (m/z): [M+Na] 
calcd. For C12H22O6Na 285.1309, found 285.1301; 
1H NMR (400 MHz, Methanol-d4) δ 4.50 (s, 
1H), 3.76 (q, J = 2.8 Hz, 1H), 3.69 (dt, J = 9.7, 6.5 Hz, 1H), 3.53 (tdd, J = 13.9, 7.6, 3.9 Hz, 2H), 
3.42 (dt, J = 9.6, 6.1 Hz, 1H), 2.29 (t, J = 7.4 Hz, 2H), 1.95 (dt, J = 13.2, 3.8 Hz, 1H), 1.77 (ddd, J 
= 13.3, 10.8, 3.1 Hz, 1H), 1.70 – 1.56 (m, 4H), 1.44 (ddd, J = 10.8, 8.7, 5.0 Hz, 2H), 1.22 (d, J = 
5.9 Hz, 3H). 13C NMR (100 MHz, MeOD) δ 178.0, 100.6, 71.1, 69.6, 68.5, 68.3, 36.2, 35.3, 30.5, 
27.1, 26.1, 18.2. 
Synthesis of 5, (n=4) saturated hydrolysis: 
 
Started with 53 mg (0.11 mmol) 3 (n=4) and 9.4 mL (1N) LiOH in 9.4 mL of tert-Butanol. 
Purified to obtain 12.7 mg (43%) colorless oil. [α]D
25= -63.0, c 0.2; HRMS (m/z): [M-H]- calcd. 
For C13H24O6Na 275.1500, found 275.1497; 
1H NMR (400 MHz, Methanol-d4) δ 4.48 (s, 1H), 
3.75 (td, J = 3.1, 1.4 Hz, 1H), 3.68 (dt, J = 9.7, 6.6 Hz, 1H), 3.60 – 3.45 (m, 2H), 3.41 (dt, J = 9.6, 
6.2 Hz, 1H), 2.28 (t, J = 7.4 Hz, 2H), 1.99 – 1.89 (m, 1H), 1.76 (ddd, J = 13.3, 10.9, 3.1 Hz, 1H), 
1.61 (ddt, J = 10.3, 7.3, 4.5 Hz, 4H), 1.47 – 1.32 (m, 4H), 1.22 (d, J = 5.9 Hz, 3H). 13C NMR (100 




Synthesis of 5, (n=5) (saturated hydrolysis): 
 
Started with 34 mg (0.066 mmol) 3 (n=5) and 6 mL (1N) LiOH in 6 mL of tert-Butanol. 
Purified to obtain 6.7 mg (35%) colorless oil. [α]D
25= -71.6, c 0.3; HRMS (m/z): [M+Na] calcd. 
For C14H26O6Na 313.1622, found 313.1617; 
1H NMR (400 MHz, Methanol-d4) δ 4.49 (s, 1H), 
3.76 (td, J = 3.1, 1.5 Hz, 1H), 3.68 (dt, J = 9.7, 6.6 Hz, 1H), 3.61 – 3.45 (m, 2H), 3.42 (dt, J = 9.7, 
6.2 Hz, 1H), 2.28 (t, J = 7.4 Hz, 2H), 1.98 – 1.91 (m, 1H), 1.77 (ddd, J = 13.4, 10.8, 3.1 Hz, 1H), 
1.60 (qd, J = 8.2, 7.7, 5.3 Hz, 4H), 1.45 – 1.32 (m, 6H), 1.22 (d, J = 5.9 Hz, 3H). 13C NMR (100 
MHz, MeOD) δ 178.0, 100.5, 71.0, 69.6, 68.5, 68.4, 36.1, 35.2, 30.7, 30.3, 27.3, 26.2, 18.2. 
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CHAPTER 2: ALPHA SELECTIVE GLYCOSYLATION OF ALCOHOLS WITH 
SELENOGLYCOSIDES USING VISIBLE LIGHT 
2.1 Introduction 
 Oligosaccharides are involved in the structural modification of proteins, lipids, and 
secondary metabolites. They are also used as molecular recognition elements in biological 
processes such as cell-cell recognition, cellular adhesion, and cellular transport.1 Developing 
methods to synthesize oligosaccharides would provide an efficient way to access the saccharide 
region of glycoproteins.1 The synthesis of these oligosaccharides is a complex task due to the 
multiple glycosidic linkages in the oligosaccharides. This has led to the development of multiple 
glycosylation methods in attempt to address problems related to yields, stereoselectivity, mildness 
and orthogonality.  
 The stereoselective formation of the glycosidic bond is crucial to the synthesis of 
oligosaccharides.  Glycosidic bonds are formed when a nucleophile displaces a leaving group (x) 
that is attached to the anomeric carbon (the carbon directly attached to the leaving group X in 
Scheme 2.1) of a carbohydrate donor. The glycosyl donor is the compound that “donates” the 
anomeric carbon and the glycosyl acceptor is the nucleophile that attaches to the anomeric carbon. 
If the nucleophile is an alcohol “ROH”, the process is termed O-glycosylation. In many 
glycosylation methods, a promoter is also used in catalytic to stoichiometric amounts to drive the 
reaction forward.2 
2.1.1 Possible Mechanisms of Glycosylation 
 While there are many mechanistic considerations in O-glycosylation two commonly 
proposed chemical glycosylations mechanisms are shown in Scheme 2.1. The first mechanism 
proceeds by a SN1 pathway in which the glycosyl donor undergoes the loss of its leaving group  
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Scheme 2.1 General glycosylation mechanisms 
(which is activated by a promoter) to form the oxacarbenium ion. This oxacarbenium ion is then 
attacked from either face by the glycosyl acceptor to form the glycosidic bond.2 The second 
mechanism is more SN2
 like as it proceeds with inversion. The glycosyl donor undergoes the loss 
of its leaving group (that is activated by a promoter) to form an ion pair in which the negatively 
charged leaving group is in close proximity to the positively charged carbon. The glycosyl acceptor 
then attacks this partially positively charged carbon forming the glycosidic bond.2 For the purposes 
of this dissertation, when the glycosidic C-C bond and the bond at the C5-C6 position are trans to 
one another it said to be in the alpha configuration. However, if the bonds are cis to one another it 
is in the beta configuration. The mechanism of the glycosylation gives us important information 
about the reaction. Understanding the multiple factors taking place in the mechanism can explain 
the stereoselectivity of the reaction. 
2.1.2 Anomeric Effect 
 While there are multiple factors that contribute to the stereochemical outcome of 
glycosylation two major contributors are the “anomeric effect” (commonly observed when the 
system is in equilibrium) and “neighboring group” participation. The Edward-Lemieux effect 
(“anomeric effect”) seen in Figure 2.1 is a stereoelectronic effect that describes the preference of 
a substituent next  
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to a heteroatom (mainly oxygen) in a cyclohexane ring to be in the axial position rather than the 
sterically less demanding equatorial position.3  Hyperconjugation (Figure 2.1) and the overall 
dipole observed are two plausible explanations for why the anomeric  effect is observed. The 
hyperconjugation is seen between the lone pair on the oxygen in the ring and the σ* orbital of the 
C-X bond.4 This hyperconjugation gives increased stability to the molecule due to electron 
delocalization. Substituents in the axial position also confer a reduced molecular dipole moment 
for the system.4 When the substituent is in the axial position, the dipoles associated with the C-X 
and C-O bonds oppose each other. The opposite scenario is seen when substituents are in the 
equatorial position.  
2.1.3 Neighboring Group Participation  
 Neighboring group participation can also affect the stereochemical outcome of O-
glycosylation. This is observed when an oxacarbenium ion is blocked from attack by a nucleophile 
from one face due to a protecting group (usually a carboxyl protecting group) such as acetate or 
benzoyl which donate a lone pair of electrons from the carbonyl oxygen to form an onium ion 
(Scheme 2.2).5,6 This results in the formation of the new C-O bond in the equatorial (beta) position 
upon attack of alcohol.   
 
Scheme 2.2 Neighboring group participation 




2.1.4 Solvent effects 
 Choice of solvent is an important factor to consider when performing an O-glycosylation, 
since the overall rate and stereochemical outcome of the reaction can be heavily influenced by the 
solvent (Scheme 2.3 and Scheme 2.4). Solvents of low polarity like diethyl ether and 
dichloromethane are commonly used while  
 
Scheme 2.3 Effect of diethyl ether on glycosylation 
polar aprotic solvents like acetonitrile and nitromethane are also common. Interaction of solvent 
with the oxacarbenium intermediate can have a significant effect on the stereochemical outcome 
of a glycosylation. Acetonitrile and ether are two solvents that are known to interact with the 
oxacarbenium ion (shown in Scheme 2.3) influencing the glycosylation to form beta and alpha 
linkages respectfully.7,8 The use of ether as solvent promotes addition of a solvent molecule via an 
SN1 type pathway where ether attacks the oxonium intermediate forming a beta linkage (reverse 
anomeric effect) that is then attacked by a glycosyl acceptor (via an SN2 pathway) to form the 
Scheme 2.4 Effect of acetonitrile on glycosylation 
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alpha linkage as shown in Scheme 2.3 .7 Acetonitrile, a polar aprotic solvent, also attacks the 
oxacarbenium ion forming the α-nitrilium ion that is attacked by a glycosyl acceptor to form the 
major  β-glycoside (Scheme 2.4).8 
2.1.5 Glycosyl donor 
 The overall reactivity associated with a glycosylation can be enhanced by various 
parameters. One of these parameters is the structure of the glycosyl donor. The protecting groups 
on the donor have a significant effect on the donor’s reactivity due to the stability of the charged 
oxacarbenium intermediate that the protecting groups can perturb through electron withdrawal or 
release. Glycosyl donors have been placed into three categories (shown in Figure 2.2) based on  
 
Figure 2.2 Reactivity of glycosyl donors 
the nature of their protecting groups. Disarmed donors, which are the least reactive, are those with 
ester protecting groups. The ester groups are electron withdrawing destabilize the oxacarbenium 
ion. Armed donors are more reactive than disarmed donors and typically have ether protecting 
groups. The ether protecting groups are electron donating, providing stabilization to the 
oxacarbenium ion. The most reactive are the superarmed donors which have sterically demanding 
groups like TBS that induce twist boat conformation placing C-O bonds in an axial position. This 
gives increased stability to the aforementioned oxacarbenium ion through electrostatic 




 Glycosyl donor reactivity can also be tuned by the nature of the leaving group at the 
anomeric carbon.9 Different leaving groups require different reaction conditions to promote their 
activation.  The ability to tune the reactivity of glycosyl donors gives carbohydrate chemists the 
ability to perform multiple glycosylations in the same reaction flask since the order of events can 
be predicted based on relative donor reactivity (shown in Scheme 2.5). For example, a trisaccharide 
can be formed in one pot using protecting groups (armed/disarmed donors) to control the order of 
events in the reaction.9 Development of glycosyl donors that are easy to access, highly stable 
toward protecting group manipulation, and have a specific mild set of activation conditions are the 
subject of intensive investigation to further the utility of one-pot and multistep oligosaccharide 
synthesis. 
2.1.6 Glycosyl acceptor 
 The reactivity of the acceptor is based largely on the nucleophilicity of the alcohol in O-
glycosylation. In the case of an alcohol acceptor, a primary alcohol is generally more nucleophilic 
than a secondary alcohol. Alcohols in the equatorial position are more reactive than alcohols in the 
axial position, which is important to consider since protecting groups can change the conformation 
of the ring between 4C1 and 
1C4 (Figure 2.3) changing the spatial orientation of the alcohol. 
Carbohydrate acceptors with sterically demanding protecting groups also have diminished 
nucleophilicity. Finally, Electron withdrawing protecting groups lower the overall reactivity of the 
acceptor.9 




2.2 Glycosylation Methods 
2.2.1 Koenigs-Knorr and Glycosyl Fluorides 
 Glycosylation method development has been ongoing for over a century and has seen 
significant progress. One of the earliest methods that is still used today is the Koenigs-Knorr 
method.10 The reaction is performed with glycosyl chloride and bromide donors which are 
activated with a halophilic Lewis acid (usually a silver or mercury salt). The activated donors then 
undergo a SN2 reaction with a nucleophile (alcohol) to give an O-glycosidic linkage. While often 
useful, the Koenigs-Knorr reaction suffers from multiple disadvantages such as instability of 
glycosyl halides (resulting in short shelf life) and the use of stoichiometric quantities of toxic 
mercury and silver salts to promote the reaction.11 The issue of instability of glycosyl halides was 
somewhat resolved in 1981 when Mukaiyama introduced a Lewis acid catalyzed O-glycosylation 
using glycosyl fluorides as donors (Scheme 2.6).10,11 The stability of the carbon-fluorine bond is 
the reason for the increased stability of the molecule. While the stability was a welcome 
Figure 2.3 4C1 and 
1C4 chair conformations 
 
 
Scheme 2.6 Koenigs-Knorr and Glycosyl Fluoride Examples 
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improvement, the overall reactivity of the glycosyl fluorides is significantly hampered relative to 
the other glycosyl halides.10,11 
2.2.2 n-pentenyl glycosides  
 The use of n-pentenyl glycosides as glycosyl donors, pioneered by Frasier-Reid, was first 
reported in 1988 (Scheme 2.7). This involved glycosyl donor with an n-pentenyl chain which could 
be activated in the presence of a halonium ion source.12 Upon activation by the halonium ion, the 
lone pair of electrons on the anomeric oxygen atom cyclize resulting in a positively charged 
heterocyclic ring. The ring could then be displaced by the lone pair of electrons on pyran oxygen 
to produce an oxacarbenium ion intermediate which can then be intercepted by a glycosyl acceptor. 
The stability of these glycosyl donors allows them to be used in a wide variety of reaction 
conditions. This stability, however, is also a hindrance to this method which requires the use of 
harsh reagents like molecular bromine for activation.13 
2.2.3 Trichloroacetimidates 
 Another approach for glycosylation first reported in the 1980s by Schmidt was the use of 
trichloroacetimidates as glycosyl donors. Trichloroacetimidates are activated under mild acidic 
conditions and are easily generated by treating hemiacetalic sugars with trichloroacetonitrile in the 
presence of base (Scheme 2.8).14 Trichloroacetimidates are excellent leaving groups and can lead 
Scheme 2.7 n-pentenyl glycoside-based glycosylation mechanism 
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to the selective formation of either alpha or beta glycosidic linkages depending on the reaction.  
                                                                                                                                                  
Scheme 2.8 Mechanism of Anomeric O-Alkylation.14,15 
The mild activation conditions for trichloroacetimidates has resulted in their widespread use. 
However activation conditions limits the orthogonality of these glycosyl donors. 
2.2.4 Glycals 
 The use of glycals as glycosyl donors to perform glycosylations was popularized by 
Danishefsky.16,17 Glycals can be activated by electrophilic addition onto the alkene to give a 
reactive three membered onium or epoxide intermediate which can then be attacked by a glycosyl 
donor providing the glycosidic linkage (Scheme 2.9). This method has seen extensive use in the 
area of stereoselective synthesis of O-glycosides. The harsh reaction conditions sometimes 
required to activate glycals limit their use in some cases.18 
2.2.5 Chalcogenoglycosides 
 Chalcogenoglycosides (seleno and thioglycosides) are highly stable glycosyl donors first 
championed by Ferrier, Nicolaou, Pinto, and others.19,20,21,22 High stability is afforded with both 
thioglycosides and selenoglycosides. The low reactivity of the thioglycosides (and 




selenoglycosides) requires the use of harsh reaction conditions (toxic heavy metal ions or highly 
reactive and sensitive electrophiles) for their activation (Scheme 2.10).23,24 Once these donors are  
                                                                                                                                                 
Scheme 2.10 Chalcogenoglycosides as glycosyl donors 
activated, the sulfonium/selenonium ions are expelled by the lone pair of electrons on the anomeric 
oxygen to give the oxacarbenium ion intermediate which is then attacked by a glycosyl acceptor 
to give the glycosidic linkage. While the high stability of the glycosyl donors makes them 
appealing for multistep synthesis, the harsh conditions and highly reactive reagents required to 
activate them is a major concern. 
 An alternative route to activating chalcogenoglycosides without the use of harsh reagents 
is via electrochemical activation (Scheme 2.11).25  The glycosyl donor is activated when an anode 
oxidizes the sulfur or selenium ion (by SET) resulting in sulfur or selenium radical cation.  This  
 
Scheme 2.11 Electrochemical glycosylation 
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radical cation then undergoes rapid irreversible fragmentation to give the oxacarbenium ion which 
then intercepts a glycosyl donor providing the glycosidic linkage.25 This method avoids the harsh 
reagents used in the chemical activation of these glycosyl donors but requires specialized 
equipment to perform the reactions. 
 While this discussion is not comprehensive, it highlights some of the major issues facing 
the field. Solutions to some of these issues may be accomplished by taking advantage of the 
elimination of harsh reagents (e.g. with the electrochemical activation of chalcogenoglycosides) 
with the added benefit of avoiding specialized equipment. We identified visible light 
photochemistry as a potentially viable route to accomplishing these goals. 
2.3 Visible Light Photoredox Catalysis 
 The utility of visible light photoredox catalysis in solving long standing organic problems 
was first realized by Macmillan, Yoon, Stephenson, Sanford and several others who popularized                
the field.26,27,28,29,30 The ability of excited state photocatalyst to undergo single electron transfers 
(SET) with organic substrates gives visible light photoredox catalysis exceptional versatility in 
accessing radical and radical ionic intermediates. The chemistry of these intermediates, in turn, 
has remarkable versatility. Tris(2,2’-bipyridine) ruthenium (II) (Ru(bpy)3
2+, (Figure 2.4)  is a 
commonly used photocatalyst. This catalyst is promoted from its singlet ground state to its triplet                                                                                                                                                  
Quenching Cycle excited state via absorption of a photon from a light source (e.g. blue LEDs 





character to the π* orbital with ligand character is a process called metal to ligand charge transfer 
(MTLCT) .31,32,33  Once in its excited state, the utility of this photocatalyst can be fully realized. It 
can serve dual roles as either a reducing agent (E1/2
III/II*= −0.81 V vs. the saturated calomel 
electrode (SCE) compared to the ground state E1/2
III/II = +1.29V vs. SCE) or oxidizing agent 
(E1/2
II*/I = +0.77 V vs. SCE compared to E1/2
II/I= −1.33 V vs. SCE) depending on the reagents that 
are present.33,34  This remarkable property of  Ru(bpy)3
2+ allows it to operate under a reductive or 
oxidative manifold (Figure 2.5).35 This duality of the photocatalyst gives access to bond formations 
that have been unattainable under previous methods.35 In addition to novel bond formations, visible 
light photocatalysis can provide more efficient and environmentally friendly reaction methods. 
2.4 Results and Discussion 
 Electrochemical glycosylation, as stated earlier, is a method for forming O-glycosidic 
linkages that avoids harsh reagents but requires a complicated experimental setup. The reactive 
intermediate formed in this electrochemical process is a selenium centered radical cation that then 
rapidly fragments to give an oxacarbenium ion that can then be intercepted by a glycosyl 
acceptor.25 We hypothesized that the same reactive selenium radical cation intermediate can be 
Figure 2.5 Ru(bpy)3





obtained via visible light photoredox catalysis using Ru(bpy)3
2+. Our initial hypothesis for the 
reaction as seen in Figure 2.6 shows the photocatalyst being promoted to its excited state via 
irradiation at 455nm. The excited photocatalyst then undergoes a single electron transfer to CBr4 
to provide a Ru(bpy)3
3+ complex that can then oxidize th e selenium to provide the selenium radical 
cation. The initial test of this hypothesis (Scheme 2.12) was performed by irradiating a 5 mL Pyrex  
reactor vial charged with 1 with Blue LEDs in the presence of 5 mol % Ru(bpy)3(PF6)2, 1.1 equiv 
of the electron acceptor tetrabromomethane, and 1.2 equiv of 2,6-di-tert-butyl-4-methylpyridine 
(DTBMP) as base and 3 equiv MeOH in CH3CN resulted in complete consumption of 1 and a 75% 




Figure 2.6 Proposed Ru(bpy)3
2+ catalyzed visible light glycosylation   




were synthesized under the same reaction conditions using the selenoglycoside donors and alcohol 
acceptors shown in Figure 2.7 in moderate to good yields and low selectivity.36 In the process of 
developing this reaction, an interesting control was performed wherein no catalyst was used. The 
control provided product in 30% yield although a long induction period was observed before the 
control provided product in 30% yield although a long inductio n period was observed before the 
reaction proceeded. This long induction period suggested the buildup of a species that was 
promoting the reaction. A common byproduct seen, whether or not the reaction is run in the 
presence of photocatalyst, is diphenyldiselenide, indicating that it may be important for reactivity. 
In an attempt to identify the species in question 77Se NMR studies were performed. The presence 
of PhSeBr in the 77Se NMR led to further mechanistic insight. 
 These observations led to our use of diphenyldiselenide as a promoter to accomplish 
glycosylation). The reactions were performed in a similar fashion to the experiments performed 
with Ru(bpy)3
2+, using 5 mL Pyrex reactor vials charged with 10 mol% diphenyldiselenide, 1 equiv 
Figure 2.7 Glycosyl donors, acceptors, and glycosidic products 
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of selenoglycoside donor, 3 equiv of alcohol acceptor, 1.1 equiv CBr4 and 1.2 equiv of DTBMP 
in 2 mL of solvent with blue LED irraditation.37-41 While diphenyldiselenide gives the same 
product with similar reactivity and yield, the mechanism by which the reaction proceeds is 
obviously different (Scheme 2.13). Diphenyldiselenide undergoes Se-Se bond homolysis upon 
irradiation with visible light to give two phenylselenyl radicals, that can then attack CBr4 to give 
phenylselenyl bromide (identified in 77Se NMR) and tribromomethyl radical.16 The 
Selenoglycoside donor could then attack the phenylselenyl bromide to provide an onium ion that 
could be easily expelled following attack by the glycosyl donor via an SN2-like exploded transition 
state to yield product. The feasibility of the phenylselenyl radical to abstract a bromine from CBr4  
was of concern and was studied using Gaussian 2009 calculations (6-311G** basis set). The 
calculations indicated a favorable process by (-9.3Kcal/mol).42  
 As shown in Figure 2.8 a variety of glycosyl products were synthesized using 
diphenyldiselenide as a promoter. The yields and selectivity for the reaction when performed in 
acetonitrile, where comparable to the Ru(bpy)3
2+-promoted reaction. However, when the reactions 
were performed in DCM the yields (with the exception of 10) and selectivity improved although  
 
 






Figure 2.8 Diphenyldiselenide promoted glycosylations 
Entry           Donor          “ROH” (3 equiv)          Solvent          Irradiation time         Product yield (%)        Anomeric ratio 
(α/β) 
   1                    1                Cyclohexanol          CH3CN, 4ÅMS                  5 h                           6, 65                              
1.5:1  
   2                    1                 (-)-Menthol            CH3CN, 4ÅMS                10 h                           9, 57                                 
4:1  
   3                    1                        3                        CH3CN, 4ÅMS                  8 h                         10, 33                                 
2:1 
   4                    2                  1-Octanol               CH3CN, 4ÅMS              6.5 h                         11, 65                                 
2:1 
   5                    2                         3                        CH3CN, 4ÅMS             10.5 h                       12, 50                                 
3:1    
   6                    1                   1-Octanol               CH3CN, 4ÅMS            3 days                            5, 0                                  
n/a 
   7                    1                   1-Octanol               CH2Cl2, 4ÅMS                36 h                          5, 53                               
20:1 
   8                    1                   1-Octanol                     CH2Cl2                                  12 h                          5, 72                                 
8:1  
   9                    1                 Cyclohexanol                 CH2Cl2                                  12 h                          6, 71                                 
6:1 
  10                  1                   (-)-Menthol                   CH2Cl2                                  50 h                           9, 66                               
10:1  
  11                  1                          3                               CH2Cl2                                  76 h                         10, 20                                  
4:1 
  12                  2                    1-Octanol                     CH2Cl2                       21 h                        11, 71                                 
4:1  
  13                  2                   (-)-Menthol                   CH2Cl2                                   39 h                        13, 55                                 
8:1  




long reaction times of up to 3 days (for disaccharide formation) were observed. The higher 
selectivities seen when using DCM can be attributed to the inhibition of ionic pathways commonly 
seen when acetonitrile is used as solvent (nitrile effect). 
 I have demonstrated that visible light promoted glycosylation with the promoter 
diphenyldiselenide is a mild and efficient method for performing O-glycosylations of alcohols with 
selenoglycoside donors in comparable yield and selectivity to the Ru(bpy)3
2+ promoted reactions. 
The long induction period seen in the absence of promoter suggest that the diphenyl diselenide 
being built up in the reaction is actually performing the glycosylation and Ru(bpy)3
2+ is  acting 
only as a promoter in the formation of diphenyl diselenide. The originally proposed mechanism 
for the Ru(bpy)3
2+ catalyzed reactions is, at best, a minor pathway. The PhSeSePh-promoted 
method provides multiple advantages over traditional glycosylation methods in being cost 
effective, using exceptionally mild reaction conditions and providing moderate selectivity for the 
alpha anomer especially when DCM is utilized as solvent. Diphenyldiselenide provides a much 
cheaper alternative to Ru(bpy)3(PF6)2 ($4/g and $111/g, respectively) However, the overall 
reactivity of the reaction in DCM (at times taking days to complete) leaves room for improvement.   
 In an attempt to improve the reactivity of the system while maintaining the selectivity seen 
when using DCM as solvent, several components of the reaction were studied. The first of these 
components was the Ru(bpy)3
2+ counteranion. In order to obtain the reactivity seen when running 
these glycosylations using Ru(bpy)3(PF6)2 in CH3CN the weakly coordinating BArF anion was 
used in  place of the PF6 anion to engender solubility in DCM (Figure 2.9).
43  Attempts to Increase 
the reactivity of the glycosyl donor were also made. We synthesized three new selenoglycoside 
donors: 4-methoxyphenylselenyl-2,3,4,6-tetra-O-benzyl glucopyranoside (14), 2,4-
dimethoxyphenylselenyl-2,3,4,6-tetra-O-benzyl glucopyranoside (15), and 4- 
46 
 
dimethylaminophenylselenyl-2,3,4,6-tetra-O-benzyl glucoside (16, Figure 2.10).37-41,44 The 
electron donating groups on the phenylselenyl ring lower the redox potential. We proposed that  
this would allow the selenium center to undergo oxidation at a faster rate, improving the overall 
rate of the reaction.37-41,44 To examine if these changes would improve the reactivity of the system, 
I used the original and new selenoglycoside donors and the soluble ruthenium catalyst in 
conjuction with the least reactive acceptor 3  from th e previous work under similar reaction 
conditions (Figure 2.11). The reactions were performed in 5 mL Pyrex reactor vials charged with 
1 mol % of catalyst, 1 equiv. of selenoglycoside donor, 3 equiv. of acceptor, 1.1 equiv. of CBr4 
and 1.2 equiv. of DTBMP in 2 ml of DCM and irradiated with blue LEDs.    
 Neither the catalyst nor the more reactive donors improved the overall reactivity of the 
system since long reaction times were still required (Entries 1-4). However, the conditions did 
provide a significant increase in yield and selectivity of the glycosylation. The improvement in 
Figure 2.9 BArF anion 
 
Figure 2.10 Glycosyl donors 
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selectivity and yield was a welcome improvement, but the issue of low reactivity needed to be 
addressed.  
Entry        Donor        Acceptor        Solvent        Irradiation time        Yield %         Anomeric ratio (α:β) 
      1                1                   3                 CH2Cl2                             60 h                     57                          5.5:1 
      2               14                  3                 CH2Cl2                             60 h                     56                             5:1 
      3               15                  3                 CH2Cl2                             60 h                     78                          5.5:1 
      4               16                  3                 CH2Cl2                             60 h                     74                          4.5:1 
 Having observed no improvement in reactivity using the soluble ruthenium catalyst in 
DCM, the possibility of catalyst decomposition over the course of the reaction was of concern. 
Exploring this possibility, I set up a series of small scale NMR experiments where the 
glycosylation was performed using the soluble ruthenium catalyst in CD2Cl2 in NMR tubes so that 
the reaction progress could be observed over time (Figure 2.12). The experiments revealed that, 
over the course of the reaction (3 days), the selenoglycoside starting material had not been fully 
consumed in the presence of 1 mol % Ru(bpy)3(BArF)2 and 3 equiv of glycosyl acceptor 3. 
Decomposition of the catalyst was not a factor as the catalyst could be observed in the 1H NMR 
throughout the course of the reaction. However, another species that I identified as α-
bromoglucoside 17 was present in small quantities (Entry 1).  Identifying α-bromoglucoside as a 
likely intermediate in route to formation of the glycosyl product, I hypothesized that increasing 




the rate at which this intermediate could react would increase the overall rate of the reaction.45 
performing the same NMR experiments with one equivalent of tetra-n-butylammonium bromide 
(TBABr), a species known to increase the rate of glycosylation with glycosyl bromide donors, 
provided complete consumption of the selenoglycoside starting material after three days (Entry 2), 
suggesting halide ion catalysis as a viable route to improving the rate of glycosylation. 
Figure 2.12 NMR experiments in CD2Cl2 
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 To see how efficient the process of forming the α-bromoglucoside from the 
selenoglycoside starting material was, I decided to observe the formation of the α-bromoglucoside 
(17) in the absence of TBABr and glycosyl acceptor (Entry 3). Unexpectedly, I observed the 
complete conversion of the selenoglycoside starting material to the α-bromoglucoside via NMR in 
less than 26 hours. The addition of one equivalent of TBABr shortened this process to just under 
5 hrs (Entry 4). These experiments show that the formation of α-bromoglucoside is quite efficient 
in the absence of acceptor. However, the rate at which the (17) is attacked still needed further 
investigation. This to a two-step process in which the α-bromoglucoside was generated first 
followed by addition of three equivalents of glycosyl acceptor with and without the addition of 
TBABr, resulting in the consumption of α-bromoglucoside in 22 h and 16 h, respectively (Entries 
3 and 4).  The rate at which the glycosylation proceeded was significantly increased compared to 
the previous one pot procedure that took 3 days to perform (often resulting in incomplete 
consumption of the selenoglycoside starting material). This suggested that bulky glycosyl 
acceptors like 3 inhibit the conversion of the selenoglycoside donor to the α-bromoglucoside. The 
increase in reactivity observed when using TBABr suggest that a bromide ion catalysis mechanism 
is involved. The use of more electron rich donors such as 15 in this two-step procedure provided 
no advantage (Entry 5). Through the course of these experiments there was no evidence to suggest 
that decomposition of (Ru(bpy)3
2+ was ever a factor in the glycosylation since it was always 
observed in the 1H NMR. 
 In order to obtain a quantitative assessment of the efficiency of the conversion of 
selenoglycoside donor 1 to the α-bromoglucoside, NMR experiments using 1,2,4,5-tetrachloro-3-
nitrobenzene 18 was used as an internal standard indicated that the conversion is near quantitative 
over the course of 6 h in the presence of Ru(bpy)3(BArF)2 (Entry 6). The use of 10 mol % 
50 
 
diphenyldiselenide also provides a near quantitative conversion in 6h (Entry 7). With the efficiency 
of each system being the same, the use of diphenyldiselenide is optimal since it is inexpensive and 
likely the species promoting the glycosylation in either case.  
 Encouraged by the NMR experiments suggesting a two-step approach to increase the 
reactivity of the glycosylation, a series of preparative experiments were performed to optimize this 
approach (Figure 2.13). 
     
 
 




The selenoglycoside donor 1 was irradiated with blue LEDs in the presence of  Ru(bpy)3(BArF)2 
or PhSeSePh, CBr4, TBABr and DTBMP until glycosyl donor 1 was consumed by TLC. At this 
stage, the glycosyl acceptor 3 and any additives would be added to the reaction and irradiation 




Additive Yield  
(%, isolated), 
selectivity 
1 Ru(bpy)3(BArF)2,  
5 mol% 
7h, 18h TBABr 1 equiv. 56%, 6:1 α/β 
2 PhSeSePh, 10 mol% 7h, 18h TBABr 1 equiv. 57%, 6.5:1 α/β 
3 PhSeSePh, 10 mol% 6h, 18h TBAI, 1 equiv., no 
TBABr 
23%, 5:1 α/β 
4[a] PhSeSePh, 10 mol% 6h, 18h TBAI, 1 equiv., no 
TBABr 
NA, NA  
5[b] PhSeSePh, 10 mol% 6h, 18h TBAI, 1 equiv., no 
TBABr 
6%, 5:1 α/β  
6 PhSeSePh, 10 mol% 6h, 16h 1 equiv. TBABr added 
in 2nd stage 
60%, 7:1 α/β 
7[c] PhSeSePh, 10 mol% 6h, 18h 2 equiv. TBABr added 
in 2nd stage, (3 equiv. 
total) 
83%, 7:1 α/β 
[a] TBAI was added in the second stage, after glycosyl bromide formation; rxn was kept in the 
dark during the second stage [b] conditions are the same is in Entry 4 except that N,N-
diisopropylamine replaced DTBMP [c] 0.5 equiv. of glycosyl acceptor 3 used  
Figure 2.13 Optimization of two stage approach 
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would continue until all bromoglucoside was consumed. The choice of Ru(bpy)3(BArF)2 vs 
PhSeSePh showed little difference in yield and selectivity (Entries 1 and 2) so the inexpensive 
PhSeSePh (which is likely the species promoting glycosylation regardless of promoter used)was 
used for further optimizations. The experiments required a day to complete, which is an 
improvement over the 3 day, one step protocol. The glycosylation experiment that I performed had 
used an excess of glycosyl acceptor (Entry 6) which led me to question if using the glycosyl donor 
in excess would be beneficial. This led to increased yield and selectivity for the reaction (Entry 7). 
Adding two equivalents of TBABr in the second stage of the reaction with the acceptor in excess 
did not increased the yield. In an attempt to further optimize this protocol, I decided to use one 
equivalent of tetrabutylammoniumiodide TBAI in the second stage of the reaction instead of 
TBABr (Entry 3). This change was made in to generate a glycosyl iodide intermediate which has 
been proven to have superior reactivity to the glycosyl bromides.46 Unfortunately, all attempts at 
using TBAI in the second stage of the reaction provided inferior yield and selectivity. It is known 
that visible light can promote the decomposition of glycosyl iodides, so an experiment was 
conducted where light would be excluded from the second stage of the reaction (Entry 4).47 The 
use of diisopropyl amine provided no advantage (entry 5). TBAI proved to be inferior to TBAB. 
These experiments revealed that using the glycosyl acceptor in excess while adding two additional 
equivalents of TBABr in the second stage of the reaction gave the optimal yields and selectivites.  
 The two step protocol improved the overall reactivity of the glycosylation but further 
improvement was still needed.  In an effort to improve the reactivity, we explored the use of other 
oxidants than CBr4 in the one step Ru(bpy)3
2+ promoted reactions. By using the same one step 
protocol reaction conditions (Scheme 2.12) with oxidants containing weakly coordinating anions 
like arenediazonium tetrafluroborate 19, diaryliodonium salt 20 and Umemoto’s reagent (21 
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commercially available), I hoped to avoid slow reacting intermediates like the glycosyl bromide 
and form the oxacarbenium ion from the unstable selenium radical cations that were shown in the 
original proposed glycosylation (Scheme 2.14).48 None of the oxidants provided isolatable 
quantities of glycosidic product while small quantities were seen in 1H NMR spectra. This showed 
Ru(bpy)3
2+* does not play a significant role in promoting glycosylation through the proposed SET 
process depicted in Figure 2.6. Our previously reported Ru(bpy)3
2+-promoted reaction involving 
CBr4 may just be involved in the efficient formation of an initial amount of PhSeSePh that actually 
promotes the reaction. This hypothesis is supported by the long induction periods for glycosidic 
product formation that we often witnessed in our previous protocol.  
 In accordance with the data obtained and previously reported in the literature, we proposed 
a mechanism (Scheme 2.15) in which Ru(bpy)3
2+ acts as an inefficent promoter for the formation 
of PhSeSePh, which could also be added purposely. Diphenyldiselenide undergoes Se-Se bond 
homolysis generating two phenylselenyl radicals that can abstract a bromine from CBr4 resulting 
in PhSeBr (seen in 77Se NMR) and tribromomethyl radical.  Selenoglycoside donor then attacks 
the PhSeBr to generate an onium intermediate which is either displaced by a bromide anion 
providing the α-bromoglycoside intermediate and PhSeSePh or loses PhSeSePh to form the 
Scheme 2.14 Screening of alternative oxidative quenchers to CBr4 
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oxacarbenium ion and PhSeSePh which further promotes glycosylation. The glycosidic product is 
then formed when glycosyl acceptor attacks either the α-bromoglycoside or β-bromoglycoside 
which are in equilibrium, Inter conversion of these stereoisomers is facilitated by bromide anion. 
The selectivity for the α-anomer is due to fast reaction of acceptor with β-bromoglycoside, which 
is considerably more reactive than the α-bromoglycoside. The kinetics of the reaction favor the 
formation of α-glycosides. 
Scheme 2.15 Revised mechanism 
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 It was shown that sterically demanding alcohols like glycosyl acceptor 3 inhibits the 
glycosylation, while addition of bromide added in the form of TBABr increases the rate. Glycosyl 
acceptor 3 slows the rate glycosylation by inhibiting the formation of 17. The increase in rate 
exhibited when using TBABr is attributed to the promotion of the key glycosyl bromide 
intermediate (17). The 1H NMR experiment where selenoglycoside was irradiated with 3 
equivalents of glycosyl acceptor 3 over the course of three days showed small quantities of α-
bromoglycoside which suggest that glycosyl bromide is formed slowly followed by fast 
glycosylation in the presence of 3. Reaction with the α-bromoglycoside could proceed in several 
ways, one being an SN2-like pathway which would give the minor  β-glycoside. Another reaction 
route leading to both β and α-glycoside formation is via ionization to oxacarbenium ion followed 
by attack of a glycosyl acceptor. The low selectivities seen in CH3CN may be attributed to 
ionization and nitrile attack on the oxacarbenium (nitrile effect) leading to β-glycoside formation. 
 It has been demonstrated by Lemieux and coworkers that halide ions catalyze reaction of 
α-bromoglycosides with alcohol acceptors, specifically by addition of bromide in the form of 
tetraethylammonium bromide. 45 The α selectivity observed in my glycosylation is attributed to the 
same phenomenon present in Lemieux’s glycosylation. The stable and unreactive α-
bromoglycosides generated in the reaction are in equilibrium with unstable but highly reactive β-
bromoglycoside. The conversion between the two anomers can be facilitated by addition of 
bromide ions. The β-bromoglycoside, once formed, likely reacts rapidly with alcohol acceptor via 
a corresponding twist boat conformation (Figure 2.14) to form the α-glycoside. The observed alpha 
selectivity is a perfect example of the Curtin-Hammet principle wherein the unstable isomer in 
equilibrium with the more stable isomer proves to be the most reactive under kinetic conditions 




 I originally intended to develop a mild O-glycosylation method using visible light 
photoredox catalysis. The intial method using Ru(bpy)3(PF 6)2 in CH3CN provided glycosylation 
products in reasonable yields and low selectivity. The SET process originally proposed in Figure 
2.6, however, was shown to be, at best, a minor pathway in formation of glycosidic product and 
that the Ru(bpy)3(PF6)2 “catalyst” was simply promoting the buildup of PhSeSePh, which 
promotes the reaction. This was strongly supported by our inability to obtain isolable quantities of 
product when using other oxidants that would promote the originally proposed pathway and by 
obtaining similar reactivity and yields when using PhseSePh as promoter. The selectivity of the 
glycosylation was greatly improved when using DCM as solvent, however, the reactions took 
several days and often did not completely consume starting material when using glycosyl acceptor 
3. The low reactivity showed no signs of improvement by using a more soluble ruthenium catalyst 
or more electron rich selenoglycoside donors.  
 Several NMR studies gave insight suggesting that our glycosylations were proceeding via 
a glycosyl bromide intermediate and bulky glycosyl acceptors like acceptor 3 were inhibiting the 
formation of these intermediates. These findings led to a two-step protocol in which glycosyl 
bromide was formed first followed by glycosyl acceptor addition, which gave a significant 
improvement in yield and overall reaction rate of the glycosylation. Optimization of this protocol 
resulted in the use of glycosyl donor in excess rather than acceptor and the use of TBABr as a 
halide ion catalyst. The improvements provide the highest yields and selectivities that we have 
Figure 2.14 β-bromoglycoside twist boat conformation 
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observed for this glycosylation. Our studies also suggested that the glycosylation operated under 
a mechanistic pathway similar to the one initially proposed when using PhSeSePh as a promoter, 
except that the onium ion formed is displaced by bromide instead of glycosyl acceptor, giving the 
α-glycosyl bromide which is in equilibrium with the more reactive β-bromoglycoside (facilitated 
by TBABr) which is attacked by glycosyl acceptor (Scheme 2.14). The glycosyl bromide 
intermediates can be intercepted by a glycosyl acceptor to yield product. The selectivity for the 
alpha anomer is the result of halide ion catalysis. The experimental data demonstrate that the two 
step protocol using the donor in excess with TBABr provided a very mild glycosylation with good 
yields and selectivity. While this protocol is a significant improvement in the field of visible light 
promoted glycosylation, the overall reactivity needs further improvement. 
2.6 Experimental and tabulated data 
2.6.1 General methods 
 Tris(bipyridyl)ruthenium(II) bis(hexafluorophosphate) (Ru(bpy)3(PF6)2),
1 1-
phenylselenyl-2,3,4,6-tetra-O-benzyl glucopyranoside2 and 1-phenylselenyl-2,3,4,6-tetra-O-
benzyl galactopyranoside3 were prepared as previously described.  Flash column chromatography 
was performed using 60Å silica gel. 1H NMR and 13C NMR spectroscopy were performed on a 
Bruker AV-400, DPX 400, DPX 250 or Varian 500 spectrometer. Mass spectra were obtained 
using an Agilent 6210 electrospray time-of-flight mass spectrometer. Optical rotation 
measurements were obtained using a JASCO P-2000 polarimeter. Unless otherwise noted, all 
materials were obtained from commercial suppliers and used without further purification. 
Analytical and preparative TLC were conducted on aluminum sheets (Merck, silica gel 60, F254). 
Compounds were visualized by UV absorption (254 nm) and staining with anisaldehyde. 5 mL 
Pyrex micro reaction vessels (Supelco) were used in the glycosylation reactions. All glassware 
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was flame-dried under vacuum and backfilled with dry nitrogen prior to use. Deuterated solvents 
were obtained from Cambridge Isotope Labs. All solvents were purified according to the method 
of Grubbs.50 
2.6.2 Procedures and characterization 
 Representative procedure for the addition of phenyl selenides to 2,3,4,6-tetra-O-acetyl-α-
D-glucopyranosyl bromide 
 
 To a suspension of 70.9 mg (2.92 mmol) magnesium in tertrahydrofuran 5 mL was added 
0.37 mL (2.9 mmol) 4-bromoanisole dropwise. The suspension was then heated to reflux. Once all 
the magnesium dissolved 230.2 mg (2.916 mmol) selenium was added proportion wise to maintain 
a gentle reflux. Reflux was continued for 3 h before cooling to room temperature. The solution 
was then left open to air for 13 h. Ether 20 mL was then added and the solution was gravity filtrated 
followed by extraction 4× 10 mL ether. The resulting organic extracts dried over Na2SO4 and 
filtered to obtain a red oil after evaporation of the solvent. To a solution of the crude in 3 mL of 
ethanol was add sodium borohydride 91.9 mg (2.43 mmol) at 0°C giving a clear solution. The 
reaction was the warmed to room temperature and stirred for 30 min. The solution was then cooled 
back down to 0°C and 1.00 g (2.43 mmol) 2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide was 
added. The solution was then warmed to room temperature and allowed to stir for 12 h. Water 4 
mL was then added to quench the reaction. Upon cessation of effervescence, the aqueous layer 
was separated from the organic layer and then extracted with 3x10 mL Et2O. The resulting organic 
extracts dried over Na2SO4 and filtered to obtain 1.2156 g of a pale yellow oil after evaporation of 
the solvent. Silica gel column chromatography (75 g silica gel, gradient run from 30% EtOAc in 
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hexanes to 50% EtOAc) afforded 357.7 mg of 22 (28%) of a white solid. 1H NMR (400 MHz, 
Chloroform-d) δ 7.46 (d, J = 8.6 Hz, 2H), 6.77 (d, J = 8.8, 3.0 Hz, 2H), 5.11 (t, 1H), 4.98 – 4.81 
(m, 2H), 4.72 (d, J = 10.1, 2.4 Hz, 1H), 4.11 (d, J = 3.6 Hz, 2H), 3.75 (d, J = 3.3 Hz, 3H), 3.61 (dt, 
J = 10.0, 3.5 Hz, 1H), 2.06 – 1.98 (m, 6H), 1.97 – 1.88 (m, 6H). 
Synthesis of 23 
 
 Started with 354.7 mg (14.59 mmol) magnesium, 27 mL of tertrahydrofuran, 2.10 mL (14.6 
mmol) 1-bromo-2,4-dimethoxybenzene, 1.152 g (14.59 mmol) selenium, 5.0 g (12.2 mmol)  
2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide, 460.0 mg (12.16 mmol) sodium borohydride, 
and 17 mL of ethanol. Purified to obtain 1.9698 g of 23 (30%) of a white solid. 1H NMR (400 
MHz, Chloroform-d) δ 7.43 (d, 1H), 6.45 – 6.35 (m, 2H), 5.13 (t, J = 9.2 Hz, 1H), 4.96 (dt, J = 
26.2, 9.4 Hz, 2H), 4.85 (d, J = 10.1 Hz, 1H), 4.15 (dd, J = 12.3, 4.9 Hz, 1H), 4.12 – 4.05 (m, 2H), 
3.77 (s, 6H), 2.01 (s, 3H), 1.99 (s, 3H), 1.96 (s, 3H), 1.93 (s, 3H). 
Synthesis of 24 
 
 Started with 354.7 mg (14.59 mmol) magnesium, 27 mL of tertrahydrofuran, 2.919 g 
(14.59 mmol), 4-bromo-N,N-dimethylaniline, 1.152 g (14.59 mmol) selenium, 5.0 g (12.2 mmol)  
2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide, 460.0 mg (12.16 mmol) sodium borohydride, 
and 17 mL of ethanol. Purified to obtain 1.2744 g of 24 (20%) of a pale yellow solid. 1H NMR 
(400 MHz, Chloroform-d) δ 7.39 (d, 2H), 6.57 (d, 2H), 5.11 (t, J = 9.3 Hz, 1H), 4.91 (dt, J = 23.8, 
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9.6 Hz, 2H), 4.68 (d, J = 10.0 Hz, 1H), 4.13 (d, J = 3.6 Hz, 2H), 3.60 (dt, J = 10.3, 3.6 Hz, 1H), 
2.93 (s, 6H), 2.04 (s, 3H), 2.02 (s, 3H), 1.96 (s, 3H), 1.93 (s, 3H). 
Representative procedure for Methanolysis 
 
 To a solution of 78.07 mg (1.509 mmol) 22 in methanol 19 mL was added 0.83 mL (0.83 
mmol) 1M solution of sodium methoxide in methanol. The solution was stirred for 5 h at room 
temperature. Evaporation of the solvent gave a white solid that was dissolved in methanol, dried 
over Na2SO4 and filtered. Evaporation of the solvent gave 543.9 mg of (25) crude material that 
was used without further purification. 1H NMR (400 MHz, Methanol-d4) δ 7.56 (d, 2H), 6.79 (d, 
2H), 4.67 (dd, J = 9.8, 1.5 Hz, 1H), 3.80 (dt, J = 13.9, 3.0 Hz, 1H), 3.71 (s, 3H), 3.68 – 3.60 (m, 
2H), 3.38 – 3.32 (m, 1H), 3.28 – 3.15 (m, 3H). 
Synthesis of 26 
 
 Started with 80.11 mg (1.462 mmol) 23, methanol 19 mL and 0.80 mL (0.80 mmol) 1 M 
solution of sodium methoxide in methanol. Worked up to obtain 627.9 mg of (26) crude material. 
1H NMR (400 MHz, Methanol-d4) δ 7.48 (d, J = 8.4 Hz, 1H), 6.49 – 6.42 (m, 2H), 4.75 (d, J = 9.7 
Hz, 1H), 3.76 (s, 3H), 3.75 – 3.68 (m, 4H), 3.62 (dd, J = 12.1, 4.7 Hz, 1H), 3.37 (t, 1H), 3.28 – 





Synthesis of 27 
 
 Started with 49.85 mg (0.9398 mmol) 24, methanol 12 mL and 0.52 mL (0.52 mmol) 1 M 
solution of sodium methoxide in methanol. Worked up to obtain 365.9 mg of (22) crude material. 
1H NMR (400 MHz, Methanol-d4) δ 7.48 (d, 2H), 6.59 (d, 2H), 4.60 (d, J = 9.7 Hz, 1H), 3.80 (d, 
1H), 3.66 (ddd, J = 18.6, 12.0, 5.0 Hz, 1H), 3.24 – 3.12 (m, 4H), 2.85 (s, 6H). 
Representative procedure for benzylation 
 
 To a solution of 916.9 mg (22.93 mmol) sodium hydride in 7 mL of DMF at 0°C was added 
976.1 mg (3.058 mmol) 20 in 11 mL of DMF. Benzyl bromide 2.50 mL (21.0 mmol) is was added 
dropwise and the solution was stirred for 13 h at room temperature. The solution was then cooled 
back to 0°C and 1.5 mL methanol was added to quench the reaction. The solution was then poured 
into 40 mL of H2O and extracted 3× 20 mL ethyl acetate. The organic extracts where then washed 
with water and brine. The organic extract was then dried over Na2SO4, filtered and concentrated 
to give 1.4517 g of a pale yellow crude oil. Silica gel column chromatography (80 g silica gel, 
gradient run from 10% EtOAc in hexanes to 15% EtOAc) afforded 1.3526 g of (14) (62%) a pale 
yellow solid. 1H NMR (400 MHz, Chloroform-d) δ 7.60 (d, 2H), 7.40 (d, 3H), 7.35 (d, J = 4.5 Hz, 
7H), 7.33 – 7.26 (m, 10H), 7.23 – 7.17 (m, 2H), 6.70 (d, 2H), 4.90 – 4.84 (m, 3H), 4.81 (d, J = 
11.1 Hz, 2H), 4.74 (t, J = 10.1, 8.3 Hz, 2H), 4.64 – 4.56 (m, 3H), 3.74 (s, 3H), 3.70 – 3.58 (m, 3H), 
3.50 – 3.40 (m, 2H). 
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Synthesis of 15 
 
 Started with 1.1301 g (28.265 mmol) sodium hydride, 10 mL of DMF, 1.4322 g (3.7686 
mmol) 21 in 16 mL of DMF and 3.08 mL (25.9 mmol) benzyl bromide. Purified to obtain 1.5986 
g of (15) (57%) a pale yellow solid. 1H NMR (400 MHz, Chloroform-d) δ 7.61 (d, J = 8.4 Hz, 1H), 
7.44 – 7.39 (m, 2H), 7.37 (d, J = 4.4 Hz, 1H), 7.35 – 7.23 (m, 16H), 7.21 (d, J = 2.4 Hz, 1H), 6.41 
(d, J = 2.6 Hz, 1H), 6.27 (dd, J = 8.5, 2.6 Hz, 1H), 4.92 – 4.78 (m, 5H), 4.71 (d, J = 10.0 Hz, 1H), 
4.63 – 4.43 (m, 3H), 3.76 (s, 3H), 3.73 (s, 3H), 3.69 – 3.59 (m, 3H), 3.53 (t, J = 9.8, 8.3 Hz, 1H), 
3.50 – 3.43 (m, 1H). 
Synthesis of 16 
 
 Started with 726.4 mg (18.27 mmol) sodium hydride, 6 mL of DMF, 877.6mg (2.4224 
mmol) 22 in 10 mL of DMF and 1.98 mL (16.6 mmol) benzyl bromide. Purified to obtain 1.0209 
g of (16) (58%) a pale yellow solid. 1H NMR (400 MHz, Chloroform-d) δ 7.54 (d, 2H), 7.46 – 
7.40 (m, 2H), 7.40 – 7.22 (m, 16H), 7.20 (dd, J = 7.5, 2.2 Hz, 2H), 7.17 – 7.13 (m, 2H), 6.49 (d, 
2H), 4.96 – 4.88 (m, 2H), 4.86 (d, J = 5.3 Hz, 1H), 4.81 (dd, J = 10.0, 3.2 Hz, 2H), 4.72 (t, J = 9.6 
Hz, 2H), 4.65 – 4.57 (m, 1H), 4.53 (d, J = 11.9 Hz, 1H), 3.78 (t, J = 3.1 Hz, 3H), 3.71 – 3.56 (m, 





General procedure for diphenyldiselenide catalyzed glycosylation 
 A flame dried 5 mL Pyrex reactor vial was charged with the glycosyl donor (1 equiv., 0.147 
mmol), PhSeSePh (0.1 equiv., 0.015 mmol), CBr4 (1.1 equiv., 0.165 mmol), 2,6-di-tert-butyl-4-
methylpyridine (DTBMP) (1.2 equiv., 0.180 mmol), the glycosyl acceptor (3 equiv., 0.450 mmol), 
400 mg of freshly activated 4 Å molecular sieves and 2 mL of dry solvent (acetonitrile or CH2Cl2) 
under nitrogen atmosphere. The reactor vial was placed 1-2 cm away from the blue LEDs (2 strips, 
vide supra for details, were wrapped around a 250 mL beaker and irradiated from the side. Reaction 
progress was monitored by TLC. After consumption of the glycosyl donor, the reaction mixture 
was filtered through a silica gel pad to remove molecular sieves and the crude products were 
concentrated and then purified by silica gel chromatography.  
Synthesis of n-octyl 2,3,4,6-tetra-O-benzyl-α-D-glucopyranoside 5 
 
 Started with 102.2 mg (0.15 mmol) 1-phenylselenyl-2,3,4,6-tetra-O-benzyl 
glucopyranoside, 4.7 mg PhSeSePh (0.015 mmol), 54.7 mg CBr4 (0.165 mmol), 37.0 mg 2,6-di-
tert-butyl-4-methylpyridine (DTBMP) (0.180 mmol), 0.07 mL (0.450 mmol) 1-octanol in 2 mL of 
DCM. Purified to obtain 70.68 mg (72%) colorless oil in a 8:1 α:β mixture. Alpha anomer 1H-
NMR (250 MHz, CDCl3) 0.88 (3H, t, J=6.8 Hz), 1.19-1.40 (10H, m), 1.53-1.67 (2H, m), 3.40 (1H, 
dt, J=9.9, 6.7 Hz), 3.55 (1H, dd, J=9.7, 3.5 Hz), 3.55-3.68 (3H, m), 3.72 (1H, m), 3.78 (1H, m), 
3.99 (1H, t, J=9.2 Hz), 4.47 (2H, d, J=11.5 Hz), 4.61 (1H, d, J=12.2 Hz), 4.64 (1H, d, J=12.2 Hz), 
4.76 (2H, m), 4.81 (1H, d, J=10.8 Hz), 4.83 (1H, d, J=10.8 Hz), 4.99 (1H, d, J=10.8 Hz), 7.06-
7.18 (2H, m), 7.20-7.44 (18H, m); 13C-NMR: (100 MHz, CDCl3) 14.2, 22.8, 26.3, 29.4, 29.5, 29.5, 
32.0, 68.4, 68.7, 70.4, 73.2, 73.6, 75.2, 75.8, 78.0, 80.3, 82.3, 97.0, 127.6, 127.8, 127.9, 128.0, 
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128.0, 128.1, 128.5, 128.5, 138.1, 138.4, 138.5, 139.1; HRMS m/z calcd for C42H52NaO6 (M+Na)
+ 
675.3656, found 675.3658;  
25
D = +38.6 (c= 0.46, DCM) 
Synthesis of cyclohexyl 2,3,4,6-tetra-O-benzyl-α-D-glucopyranoside 6 
 
 Started with 102.2 mg (0.15 mmol) 1-phenylselenyl-2,3,4,6-tetra-O-benzyl 
glucopyranoside, 4.7 mg PhSeSePh (0.015 mmol), 54.7 mg CBr4 (0.165 mmol), 37.0 mg 2,6-di-
tert-butyl-4-methylpyridine (DTBMP) (0.180 mmol), 0.046 mL (0.450 mmol) cyclohexanol in 2 
mL of DCM. Purified to obtain 66.49 mg (71%) colorless oil in a 6:1 α:β mixture. Alpha anomer 
1H-NMR (400 MHz, CDCl3) 1.12-1.57 (6H, m), 1.67-1.94 (4H, m), 3.55 (2H, m), 3.63 (2H, m), 
3.73 (1H, dd, J=10.6, 3.7 Hz), 3.88 (1H, dd, J=10.0, 3.0 Hz), 4.00 (1H, t, J=9.3 Hz), 4.47, (2H, 
m), 4.61 (1H, d, J=12.2 Hz), 4.65 (1H, d, J=12.0 Hz), 4.73 (1H, d, J=12.0 Hz), 4.82 (2H, m), 4.95 
(1H, d, J=2.8 Hz), 4.99 (1H, d, J=10.8 Hz), 7.09-7.18 (2H, m), 7.22-7.40 (18, m); 13C-NMR (100 
MHz, CDCl3) 24.2, 24.4, 25.6, 31.4, 33.3, 68.6. 70.1, 73.0, 73.4, 75.1, 75.3, 75.6, 77.9, 80.0, 82.1, 
94.7, 127.6, 127.8, 127.8, 127.9, 128.0, 128.1, 128.1, 128.2, 128.5, 128.5, 138.0, 138.3, 138.3, 
139.0; HRMS m/z calcd for C40H46NaO6 (M+Na)
+ 645.3187, found 645.3179; 
25
D = +52.7 (c= 
0.63, DCM). 




 Started with 102.2 mg (0.15 mmol) 1-phenylselenyl-2,3,4,6-tetra-O-benzyl 
glucopyranoside, 4.7 mg PhSeSePh (0.015 mmol), 54.7 mg CBr4 (0.165 mmol), 37.0 mg 2,6-di-
tert-butyl-4-methylpyridine (DTBMP) (0.180 mmol), 70.3 mg (0.450 mmol) (-)-menthol in 2 mL 
of DCM. Purified to obtain 67.37 mg (66%) colorless oil in a 10:1 α:β mixture. Alpha anomer 1H-
NMR (400 MHz, CDCl3) 0.70 (3H, d, J=6.9 Hz), 0.75-1.12 (9H, m), 1.20-1.40 (2H, m), 1.56-1.65 
(2H, m), 2.13 (1H, d, J=12.0 Hz), 2.37-2.46 (1H, m), 3.35 (1H, dt, J=10.6, 4.3 Hz), 3.54 (1H, dd, 
J=9.8, 3.6 Hz), 3.58-3.69 (2H, m), 3.75 (1H, dd, J=10.5, 3.8 Hz), 3.92-3.98 (1H, m), 4.01 (1H, t, 
J=9.3 Hz), 4.46 (1H, d, J=10.8 Hz), 4.47 (1H, d, J=12.0 Hz), 4.61-4.73 (3H, m), 4.82 (1H, d, 
J=10.8 Hz), 4.83 (1H, d, J=10.8 Hz), 4.97 (1H, d, J=11.0 Hz), 5.02 (1H, d, J=3.6 Hz), 7.09-7.17 
(2H, m), 7.21-7.37 (18H, m) 13C-NMR (100 MHz, CDCl3) 16.0, 21.1, 22.3, 23.1, 24.6, 31.7, 34.3, 
43.0, 48.8, 68.7, 70.3, 73.2, 73.4, 75.0, 75.5, 78.1, 80.6, 81.0, 82.0, 98.6, 127.6, 127.6, 127.7, 
128.0, 128.3, 128.4, 138.0, 138.3, 138.4, 138.9; HRMS m/z calcd for C44H54NaO6 (M+Na)
+ 
701.3813, found 701.3821;  
25
D = +92.5 (c= 0.25, CH2Cl2) 
Synthesis of methyl-O-(2,3,4,6-Tetra-O-benzyl-α-D-glucopyranosyl)-(1 6)-2,3,4-tri-O-benzyl-
α-D-glucopyranoside 10 
 
 Started with 102.2 mg (0.15 mmol) 1-phenylselenyl-2,3,4,6-tetra-O-benzyl 
glucopyranoside, 4.7 mg PhSeSePh (0.015 mmol), 54.7 mg CBr4 (0.165 mmol), 37.0 mg 2,6-di-
tert-butyl-4-methylpyridine (DTBMP) (0.180 mmol), 209.5 mg (0.450 mmol) glycosyl acceptor 
3, 400mg 4Å MS in 2 mL of CH3CN. Purified to obtain 49 mg (33%) colorless oil in a 2:1 α:β 
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mixture. Alpha anomer 1H-NMR (400 MHz, CDCl3) 3.32 (3H, s), 3.40 (1H, dd, J=9.6, 3.6 Hz), 
3.50 (2H, m), 3.58 (1H, t, J=9.0 Hz), 3.69-3.82 (3H, m), 3.87-3.99 (4H, m), 4.02 (1H, dd, J=9.3, 
3.5 Hz), 4.36 (1H, d, J=11.8 Hz), 4.43 (1H, d, J=11.9 Hz), 4.51-4.60 (4H, m), 4.65-4.75 (4H, m), 
4.75-4.82 (2H, m), 4.84 (1H, d, J=11.0 Hz), 4.93 (1H, d, J=11.5 Hz), 4.95 (1H, d, J=10.9 Hz), 4.99 
(1H, d, J=3.6 Hz), 7.18-7.36 (35H, m); 13C-NMR (100 MHz, CDCl3) 55.0, 66.4, 68.9, 69.4, 70.3, 
72.5, 72.8, 73.3, 74.7, 75.0, 75.1, 75.7, 76.5, 77.2, 78.0, 78.3, 80.2, 82.1, 97.9, 97.9, 127.3, 127.4, 
127.5, 127.6, 127.6, 127.7, 127.8, 127.9, 128.0, 128.2, 128.2, 128.2, 128.3, 128.3, 128.4, 128.4, 
138.1, 138.2, 138.4, 138.7, 138.8, 138.9, 138.9; HRMS m/z calcd for C62H66NaO11 (M+Na)
+ 
1009.4497, found 1009.4490;  
25
D = +87.2 (c= 0.55, CH2Cl2). 
Synthesis of n-octyl 2,3,4,6-tetra-O-benzyl-α-D-galactopyranoside 11 
 
 Started with 102.2 mg (0.15 mmol) 1-phenylselenyl-2,3,4,6-tetra-O-benzyl 
galactopyranoside, 4.7 mg PhSeSePh (0.015 mmol), 54.7 mg CBr4 (0.165 mmol), 37.0 mg 2,6-di-
tert-butyl-4-methylpyridine (DTBMP) (0.180 mmol), 0.07 mL (0.450 mmol) 1-octanol in 2 mL of 
DCM. Purified to obtain 66.48 mg (71%) colorless oil in a 4:1 α:β mixture. Alpha anomer 1H-
NMR (α-anomer, 400 MHz, CDCl3) 0.88 (3H, m), 1.26 (10H, m), 1.62 (2H, m), 3.43 (1H, dt, 
J=9.9, 6.6 Hz), 3.48-3.66 (3H, m), 3.91-3.98 (3H, m), 4.03 (1H, dd, J=9.3, 3.6 Hz), 4.33-4.96 (9H, 
m), 7.20-7.40 (20H, m); 13C-NMR (α-anomer, 100 MHz, CDCl3) 14.1, 22.6, 26.2, 29.2, 29.4, 31.8, 
68.2, 69.0, 69.2, 73.2, 73.4, 74.7, 75.1, 76.6, 79.1, 97.4, 127.4, 127.5, 127.6, 127.7, 127.7, 127.8, 
127.9, 128.1, 128.1, 128.2, 128.2, 128.3, 128.3, 128.4, 138.0, 138.5, 138.7, 138.9; HRMS m/z 
calcd for C42H52NaO6 (M+Na)
+ 675.3656, found 675.3660;  
25
D = +33.5 (c= 1.65, CH2Cl2)    
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Synthesis of methyl-O-(2,3,4,6-Tetra-O-benzyl-α-D-glucopyranosyl)-(1 6)-2,3,4-tri-O-benzyl-
α-D-galactopyranoside 12 
 
 Started with 102.2 mg (0.15 mmol) 1-phenylselenyl-2,3,4,6-tetra-O-benzyl 
galactopyranoside, 4.7 mg PhSeSePh (0.015 mmol), 54.7 mg CBr4 (0.165 mmol), 37.0 mg 2,6-di-
tert-butyl-4-methylpyridine (DTBMP) (0.180 mmol), 209.5 mg (0.450 mmol) glycosyl acceptor 
3, in 2 mL of DCM. Purified to obtain 72.73 mg (49%) colorless oil in a 5.5:1 α:β mixture. Alpha 
anomer 1H-NMR (400 MHz, CDCl3) 3.29 (3H, s), 3.41 (1H, dd, J=9.6, 3.6 Hz), 3.46-3.55 (2H, 
m), 3.58 (1H, t, J=9.1 Hz), 3.63 (1H, m), 3.70-3.82 (3H, m), 3.88-4.00 (3H, m), 4.03 (1H, dd, 
J=9.5, 3.5 Hz),  4.36 (1H, d, J=11.8), 4.43 (1H, d, J=11.8 Hz), 4.52-4.61 (4H, m), 4.67-4.75 (4H, 
m), 4.77-4.82 (2H, m), 4.85 (1H, d, J=11.0 Hz), 4.93 (1H, d, J=11.2 Hz), 4.95 (1H, d, J=11.2 Hz), 
4.99 (1H, d, J=3.6 Hz), 7.15-7.45 (35H, m); 13C-NMR (100 MHz, CDCl3) 55.0, 66.4, 68.9, 69.7, 
70.5, 72.5, 72.8, 73.3, 73.5, 74.7, 75.0, 75.1, 75.7, 76.5, 78.0, 78.2, 80.2, 82.1, 97.9, 97.9, 127.5, 
127.6, 127.7, 127.8, 127.8, 127.8, 127.9, 128.1, 128.3, 128.4, 128.4, 128.5, 128.5, 138.0, 138.2, 
138.4, 138.7, 138.8, 138.9; HRMS m/z calcd for C62H66NaO11 (M+Na)
+ 1009.4497, found 
1009.4490;  
25






Synthesis of Menthyl 2,3,4,6-tetra-O-benzyl-α-D-galactopyranoside 13 
 
 Started with 102.2 mg (0.15 mmol) 1-phenylselenyl-2,3,4,6-tetra-O-benzyl 
galactopyranoside, 4.7 mg PhSeSePh (0.015 mmol), 54.7 mg CBr4 (0.165 mmol), 37.0 mg 2,6-di-
tert-butyl-4-methylpyridine (DTBMP) (0.180 mmol), 70.3 mg (0.450 mmol) (-)-menthol in 2 mL 
of DCM. Purified to obtain 56.14 mg (55%) colorless oil in a 8:1 α:β mixture. Alpha anomer 1H-
NMR (500 MHz, CDCl3) 0.69 (3H, J=6.9 Hz), 0.81 (3H, d, J=6.9 Hz), 0.82 (3H, d, J=6.0 Hz), 
0.75-0.97 (2H, m), 1.02 (1H, q, J=12.0 Hz), 1.20-1.40 (2H, m), 1.53-1.63 (2H, m), 2.08 (1H, d, 
J=12.0 Hz), 2.41 (1H, m), 3.33 (1H, td, J=10.8, 4.5 Hz), 3.54 (2H, m), 3.96 (1H, dd, J=10.1, 2.8 
Hz), 3.99 (1H, m), 4.02 (1H, dd, J=10.1, 3.7 Hz), 4.10 (1H, t, J=9.3 Hz), 4.42 (1H, d, J=11.9 Hz), 
4.48 (1H, d, J=11.9 Hz), 4.57 (1H, d, J=11.5 Hz), 4.67 (1H, d, J=11.7 Hz), 4.74 (1H, d, J=11.8 
Hz), 4.80 (1H, d, J=11.5 Hz), 4.81 (1H, d, J=12.0 Hz), 4.95 (1H, d, J=11.5 Hz), 5.02 (1H, d, J=3.7 
Hz), 7.23-7.39 (20H, m); 13C-NMR (125 MHz, CDCl3) 16.0, 21.1, 22.3, 22.9, 24.5, 31.8, 34.3, 
42.9, 48.9, 69.2, 69.3, 72.7, 73.4, 73.6, 74.7, 75.1, 79.3, 80.2, 99.3, 127.4, 127.5, 127.6, 127.7, 
128.1, 128.3, 138.1, 138.8, 138.9; HRMS m/z calcd for C44H54NaO6 (M+Na)
+ 701.3813, found 
701.3832;  
25
D = +58.3 (c= 0.15, CH2Cl2) 
General procedure for two diphenyldiselenide catalyzed glycosylation with TBAB additive 
 A flame dried 5 mL Pyrex reactor vial was charged with the glycosyl donor (1 equiv., 0.15-
4 mmol), PhSeSePh (0.1 equiv., 0.015 mmol), CBr4 (1.1 equiv., 0.165 mmol), 2,6-di-tert-butyl-4-
methylpyridine (DTBMP) (1.2 equiv., 0.180 mmol), TBAB (1 equiv., 0.150 mmol) and 400 mg 
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of freshly activated 4 Å molecular sieves and 2 mL of dry solvent of CH2Cl2 under nitrogen 
atmosphere. The reactor vial was placed 1-2 cm away from the blue LEDs (2 strips, vide supra for 
details, were wrapped around a 250 mL beaker and irradiated from the side for 6 hrs. The glycosyl 
acceptor (0.5 equiv., 0.0752 mmol) and TBAB (2 equiv., 0.301 mmol) was added and irradiation 
continued for 18 hrs Reaction progress was monitored by TLC. After consumption of the glycosyl 
bromide, the reaction mixture was filtered through a silica gel pad to remove molecular sieves and 
the crude products were concentrated and then purified by silica gel chromatography.  
Synthesis of methyl-O-(2,3,4,6-Tetra-O-benzyl-α-D-glucopyranosyl)-(1 6)-2,3,4-tri-O-benzyl-
α-D-glucopyranoside 10 
 
 Started with 102.2 mg (0.150 mmol) 1-phenylselenyl-2,3,4,6-tetra-O-benzyl 
glucopyranoside, 4.7 mg PhSeSePh (0.015 mmol), 54.7 mg CBr4 (0.165 mmol), 37.0 mg 2,6-di-
tert-butyl-4-methylpyridine (DTBMP) (0.180 mmol) and 400mg 4Å MS in 2 mL of  DCM and 
irradiated for 6 hrs. 35.0 mg (0.0752 mmol) glycosyl acceptor 3 and 96.7 mg (0.300 mmol) were 
then added and irradiation continued for 18 hrs. Purified to obtain 60 mg (83%) colorless oil in a 
7:1 α:β mixture. Alpha anomer 1H-NMR (400 MHz, CDCl3) 3.32 (3H, s), 3.40 (1H, dd, J=9.6, 3.6 
Hz), 3.50 (2H, m), 3.58 (1H, t, J=9.0 Hz), 3.69-3.82 (3H, m), 3.87-3.99 (4H, m), 4.02 (1H, dd, 
J=9.3, 3.5 Hz), 4.36 (1H, d, J=11.8 Hz), 4.43 (1H, d, J=11.9 Hz), 4.51-4.60 (4H, m), 4.65-4.75 
(4H, m), 4.75-4.82 (2H, m), 4.84 (1H, d, J=11.0 Hz), 4.93 (1H, d, J=11.5 Hz), 4.95 (1H, d, J=10.9 
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Hz), 4.99 (1H, d, J=3.6 Hz), 7.18-7.36 (35H, m); 13C-NMR (100 MHz, CDCl3) 55.0, 66.4, 68.9, 
69.4, 70.3, 72.5, 72.8, 73.3, 74.7, 75.0, 75.1, 75.7, 76.5, 77.2, 78.0, 78.3, 80.2, 82.1, 97.9, 97.9, 
127.3, 127.4, 127.5, 127.6, 127.6, 127.7, 127.8, 127.9, 128.0, 128.2, 128.2, 128.2, 128.3, 128.3, 
128.4, 128.4, 138.1, 138.2, 138.4, 138.7, 138.8, 138.9, 138.9; HRMS m/z calcd for C62H66NaO11 
(M+Na)+ 1009.4497, found 1009.4490;  
25
D = +87.2 (c= 0.55, CH2Cl2). 
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CHAPTER 3: A METAL-FREE, VISIBLE LIGHT-PROMOTED O-GLYCOSYLATION 
WITH A THIOGLYCOSIDE DONOR 
3.1 Introduction 
 One of the most frequently used class of glycosyl donors for performing chemical O-
glycosylation is the thioglycosides.1 Thioglycosides are extremely stable species (giving them a 
long shelf life) whose structure can be manipulated to provide a wide range of reactivity.1 These 
advantages have fostered an effective methodology to form glycosidic linkages which are of 
significant interest to the glycoscience community.1,2 The high stability of thioglycosides, which 
is arguably their greatest attribute, is also their biggest drawback, since harsh activation (strong 
electrophiles) are required to activate them. Strong electrophiles like NIS/HOTf, DMTST, NBS, 
PhSOTf, and benzenesulfonylpiperidine/Tf2O used for activation of thioglycosides are highly 
reactive, unstable species, making O-glycosylation with thioglycosides a nontrivial task for those 
inexperienced in the field. By contrast, growing demand for O-glycosides necessitates chemical 
glycosylation methods that can be performed easily and requiring little skill from the 
experimentalist.3 Such a method would require easily handled and bench stable reagents that can 
be used at ambient temperatures while providing high yields and selectivities. This provides a 
significant challenge to O-glycosylation method development that is worth addressing. Steps have 
been taken towards this goal, including the use gold catalysts, and iodine (III) and bismuth (V) 
reagents to activate the thioglycoside donors (Scheme 3.1).4  




 Another approach that I and others have been exploring is to irradiate with light, often 
visible light, to provide the energy necessary to activate thio- and selenoglycosides under easily 
performed, mild reaction conditions.5  Photons emitted by a light source provide the energy of 
activation that is a substitute for the harsh reaction conditions described earlier. Many of these 
photochemical glycosylation involve a mechanism (Scheme 3.2) where a S/Se centered radical 
cation is formed as a reactive intermediate either directly or indirectly from a photoinduced 
electron transfer. The reactive intermediate fragments, giving the commonly-proposed 
oxacarbenium intermediate that can then be intercepted by a glycosyl acceptor. A recent method 
in which p-methoxyphenylthioglycosides were irradiated with visible light in the presence of an 
iridium photosensitizer showed some promise.5  However, only moderate yields were seen when 
attempting to form difficult glycosidic linkages (a common issue in photochemical glycosylation).5 
The development of a photochemical glycosylation that is easy to perform and provides 
synthetically difficult glycosidic linkages is a challenge that is still being explored and which I 
address herein.  
3.2 Results and discussion 
 While the studies I performed using selenoglycosides under visible light photochemical 
conditions to provide O-glycosylation was successful, the use of thioglycosides under the same 
Scheme 3.2 Common mechanism for photochemical glycosylation 
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conditions provided no glycosylation.5,6 This can be attributed to the lower reactivity of 
thioglycosides compared to selenoglycosides. In hopes of activating thioglycosides, the Fukuzumi 
catalyst was used in conjunction with a stoichiometric oxidant (Scheme 3.3). The catalyst, upon 
excitation by blue light (455 nm), is converted to a strongly oxidizing species (Ered= 1.88V vs 
SCE)  that could then undergo a single electron transfer from thioglycosides to provide the reactive 
S-centered radical cation which then undergoes fragmentation en route to the glycosidic linkage.7 
The catalyst is then regenerated by another SET to the stoichiometric oxidant. While this method 
showed substantial promise with selenoglycosides (Scheme 3.4), all attempts at thioglycoside 
activation proved unsuccessful (Scheme 3.5). This study, along with other literature reports, 
resulted in our conclusion that the formation of sulfur centered radical cations is a non-trivial task 
under visible light irradiation. With the attempts at oxidizing thioglycosides via SET from the  
             
                 




sulfur being unproductive, an alternative route at activating the thioglycosides that doesn’t require 
the formation of a sulfur centered radical cation was postulated. 
  Frasier-Reid’s use of n-pentenyl glycosides was of particular interest to us (Scheme 3.6).8 
The terminal alkene of the n-pentenyl side chain reacts with molecular bromine forming a 
bromonium ion. The glycosidic oxygen attacks the bromonium ion, changing what was once a 
poor leaving group into an excellent leaving group that leaves to form the oxacarbenium ion.8 In a 
similar fashion, I wanted to “unburden” sulfur from a difficult SET process by capitalizing on its 
Scheme 3.4 Glycosylation of selenoglycosides using Fukuzumi catalyst 
Scheme 3.5 Attempt at glycosylation of thioglycosides using Fukuzumi catalyst 
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nucleophilicity while avoiding the unreactive glycosyl bromides commonly encountered when 
using n-pentenyl glycosides with molecular bromine. With the idea of sulfur acting as a 
nucleophile, I took inspiration from recent work done on the visible light photocatalytic 
oxytrifluromethylation of styrenes.9 This work utilizes the reactivity of styrenes to intercept 
trifluromethyl radicals resulting in a benzylic radical that can then be oxidized via SET followed 
by nucleophilic attack of an oxygen nucleophile on the resulting carbocation. I envisioned 
thioglycosides containing an S-alkyl chain with a terminal styrene that would react similarly in the 
presence of trifluromethyl radicals (generated by the SET of Ru(bpy)3
2+* to Umemoto’s reagent) 
ultimately resulting in a benzylic radical that would be oxidized by Ru(bpy)3
3+ to the carbocation. 
The nucleophilic sulfur could then attack the carbocation and generate a good leaving group 
(sulfonium). The leaving group would then be expelled, giving the oxonium ion that would then 
be attacked by a glycosyl acceptor to provide the glycosidic linkage (Scheme 3.7). This would 
provide an exceptionally mild method for forming O-glycosidic linkages with thioglycosides that, 
we reasoned, could be activated in the presence of other thioglycosides, providing orthogonality. 
The reagents used would be stable and easily handled on a bench top ideal for non-experts unlike 
n-pentenyl which use molecular bromine and often result in unreactive glycosyl bromide 
intermediates.10 The orthogonality would also provide a method to form oligosaccharides with a 
one-pot approach. 
Scheme 3.6 n-pentenyl glycoside-based glycosylation mechanism 
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 I initially decided to explore this reaction by first synthesizing thioglycosides 5a-5e which 
included benzyl-protected 5a, acetyl-protected 5b,  and aryl- and alkylthioglycosides 5c-e.11 The 
p-methoxy styrene used in 5a-5b was synthesized with the idea that an electron rich styrene would 
be more susceptible to attack by the electrophilic trifluromethyl radical than an electron deficient 
or electroneutral styrene. Thioglycoside 5a was subjected to the initial reaction conditions 
involving irradiation with blue LED’s in the presence of Ru(bpy)3(BArF)2, Umemoto’s reagent, 
DTBMP, excess acceptor 6 and 4ÅMS in DCM to give the glycosidic product 7a in 55% yield as 
a mixture of  anomers. After this exciting result, the reaction was further studied (Figure 3.1). A 
solvent screen yielded no significant improvement in yield or selectivity for the reaction (Entries 
1-6). With no improvement seen in the first attempts at optimization, the reaction was further 
explored using thioglycosides 5a-5e (Figure 3.2). Controls performed with thioglycosides 5a 
without light and also without Umemoto’s reagent showed that the reaction depends on both to 
proceed (Entries 2, 3). However, a control in which no Ru(bpy)3
2+ was used, to my surprise,  
Scheme 3.7 Proposed mechanism for Ru(bpy)3
2+ catalyzed glycosylation of thioglycosides 
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provided a similar yield and selectivity for formation of 7a (Entry 4), suggesting that catalyst is 
not needed for the glycosylation to proceed. This led me to omit catalyst in further studies. 
Increasing the concentration of the reaction did nothing to increase the yield of the reaction. 
However, using glycosyl donors in excess (rather than an excess of glycosyl acceptor 6) in 
conjunction with increasing the concentration gave a significant increase in the yield, (from 55% 
to 76% yield) (Entry 5). Omission of DTBMP resulted in no change to the reaction yield (Entry 6) 
as long as 4ÅMS were present, but when neither DTBMP nor 4ÅMS were used, the glycosylation 
resulted in complex mixtures and difficult purifications (data not shown). Lowering the 
temperature of the reaction to -20°C also resulted in no significant improvement to the reaction 
Entry Solvent 












3 DCE 60 1.2:1 
4 DMF 20 3:1 
5 THF 57 1.2:1 
6 trifluorotoluene 55 1.4:1   
7b,d,e         DCM                       70                                              0.98:1 
8c,d,e         DCM                       72                                                                                             1:1 
a) isolated yields, b) performed at -20°C, C) performed with 0.15 equiv TEMPO, d) no 
catalyst and DTBMP, e) 0.5 equiv of acceptor used 
Figure 3.1 Initial screening and optimization 
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(Entry 6 Figure 3.1). Interestingly, the addition of TEMPO, a common radical trapping reagent, 
did not shut down the reaction, providing a similar yield and selectivity to the reaction without 
TEMPO. This suggest that this reaction is not a radical chain process (Entry 7 Figure 3.1). 
 The optimal glycosylation conditions using no catalyst, no DTBMP, excess glycosyl donor 
and high concentration were used with glycosyl donors 5b-5e and acceptor 6 to test the 
Figure 3.2 Glycosylation optimization 
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orthogonality of our conditions toward various thioglycosides. Orthogonality is important when 
forming glycosidic bonds between thioglycosides and other thioglycoside-containing alcohol 
acceptors. Control over which thioglycoside is activated determines the glycosidic product 
obtained. The selective activation of different thioglycosides could lead to an effective method to 
synthesize oligosaccharides in one pot. Glycosylation using the acetylated thioglycosides 5b 
resulted in no consumption of the glycosyl donor 5b while some decomposition of Umemoto’s 
reagent was seen via 1H NMR after 24 hrs of irradiation. This is not surprising when considering 
that the sulfur in 5b is far more difficult to oxidize and less nucleophilic compared to the sulfur in 
thioglycosides 5a and suggest that sulfur is not an innocent bystander in the incipient activation of 
5a.1,12 Thioglycosides 5c-5d were unreactive, demonstrating the orthogonality of our conditions 
toward various alkyl- and arylthioglycosides. Under typical conditions for thioglycoside 
activation, thioglycoside 5c would be considered a highly reactive donor, but it does not react 
under our conditions.1 The possibility of an outer sphere SET from the sulfur in 5a in previous 
reactions is not likely given the facile SET oxidation of the electron rich arylthioglycosides 5e.12 
 With optimized reaction conditions for the visible light-promoted O-glycosylation in hand 
a wide range of glycosyl acceptors were screened (Figure 3.3) to probe the substrate scope of this 
method. The glycosylation of the structurally simple alcohol acceptors 1-octanol, cyclohexanol 
and (-)- menthol with glycosyl donor 5a  provided high yields of glycosidic products as mixtures 
of anomers (Enties 1-3). The formation of more difficult disaccharide linkages was also successful 
using glucose and galactose-derived acceptors resulting in good yields (albeit with little 
stereochemical control) (Entries 4 and 5). Glycosylation of the sterically hindered tertiary alcohol 
acceptor 1-adamantanol also proceeded in high yield (Entry 6). The ability to form glycosidic 
linkages with alkylthioglycoside-bearing acceptors (Entry 4) shows that activation of 
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thioglycoside donor 5a in the presence of other alkylthioglycoside acceptors is possible 
(demonstrating the orthogonality of the method). 
 The use of thioglycoside donor 5a provided good to excellent yields of glycosidic products. 
However, the stereoselectivity in all cases was close to 1:1 alpha/beta. The presence of an acetate 
at the 2-position (thioglycoside donor 5f) provided a completely stereoselective glycosylation for 
the beta anomer due to the neighboring group participation of this group (Entry 7). This was the 
Figure 3.3 Glycosylation substrate scope 
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case when forming simple glycosidic linkages and disaccharide linkages (galactose diacetonide, 
1-octylthioglucoside and others) while continuing to show orthogonality (Enties 8-11,13, and 14). 
The sterically hindered 1- adamantanol was also glycosylated, providing just the beta anomer 
(Entry 12). 
 The formation of glycosidic product 18 (Entry 11) is of particular interest since the bulky 
silyl-protecting groups on the glycosyl acceptor force the compound to adopt a twist boat 
conformation.13 The twist boat conformation (observed by NMR of the species) forces the oxygens 
on the carbohydrate moiety into a pseudoaxial position which provides stabilization of 
oxacarbenium ion due to electrostatic interactions.13 The stabilization of the oxacarbenium ions of 
the silyl-protected glycosyl acceptor renders this species 20 times more reactive than the analogous 
tetrabenzyl-protected thioglycoside.14 The fact that this highly reactive acceptor is not activated 
under our conditions and does not oligomerize with itself is noteworthy and is the best example of 
the orthogonality exhibited by this glycosylation. The conventional method to build 
oligosaccharides from thioglycosides in one pot is to couple them in decreasing order of glycosyl 
donor reactivity.1 The most reactive species is activated first. The glycosylation I have developed 
could potentially remove this limitation, providing a novel way to build oligosaccharides in one 
pot where our photochemical approach could be used alone or in conjunction with conventional 
methods for thioglycoside activation. The selective activation of the thioglycoside donors like 
5a/5f  under my visible light promoted glycosylation conditions could also be useful in multistep 
synthesis of oligosaccharides. 
 While the glycosylation provided good to excellent yields and complete selectivity when 
using glycosyl donor 5f, the mechanism under which the reaction proceeds needed further 
investigation. When examining the crude 1H NMR spectra of the glycosylation reactions, 
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considerable quantities of an unidentified species were present. The species was isolated along 
with dibenzothiophene by collecting early eluting fractions from column chromatography. Further 
purification using preparative thin layer chromatography provided the product as a single 
diastereomer (+/-)- 22 (Figure 3.4) as determined by mass spectrometry, polarimetry and 
comparison of 1H NMR coupling constants with previously reported tetrahydrothiphenes.15 This 
supports a mechanistic pathway similar to that proposed in Scheme 3.7 although, Ru(bpy)3
2+ is not 
involved.  
 It was stated early on that the addition of 0.15 equivalents of the radical trapping reagent 
TEMPO had no effect on the glycosylation as it proceeded in comparable yield. This suggests that 
the reaction does not proceed via a radical chain process but didn’t rule out the possibility of 
radicals being present.16 In order to further investigate the possibility of a chain process, an NMR 
experiment was conducted where the reaction was allowed to proceed in the presence and absence 
of light over a 10 hr period. The percent consumption of starting glycosyl donor 5a in the light 
on/light off experiment (Figure 3.5) showed that the reaction required continuous irradiation to 
proceed as absence of light shuts down the reaction. The experiment further corroborates that the 
reaction is most likely not proceeding by a radical chain process. However, the possibility of 
radical intermediates and short chain processes cannot be completely ruled out.16,17  
 The realization that the glycosylation does not require Ru(bpy)3
2+ was a pleasant surprise. 
However, it raised the question of how the reaction is actually proceeding, mechanistically. Insight 
Figure 3.4 Tetrahydrothiophene By-product 
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into the mechanistic process was first realized by the observation that solutions of Umemoto’s 
reagent and glycosyl donors 5a/b in DCM and acetonitrile produced a yellow color upon mixture 
that is not observed when mixing glycosyl donors 5c-e with Umemoto’s reagent. The p-
methoxystyrene terminus of glycosyl donors 5a/b was deemed necessary for color change, since a 
mixture of Umemoto’s reagent and p-methoxystyrene also produced the same yellow color seen 
in the previous mixture. There is recent literature that shows that several synthetic transformations 
can be performed via activation of electron donor-acceptor complexes (EDAs also known as 
charge transfer complexes).18 Theses complexes result in color change when the electron donor 
and acceptor are mixed together in solution and exhibit new absorbance bands as often observed 
by UV-vis spectrophotometry. UV-vis spectra showed that a putative EDA complex absorbance 
trailed well into the visible region with a measurable extinction at 455 nm (blue LED λmax= 455 
nm). I obtained UV-vis spectra of mixtures of 26.6 mM Umemoto’s reagent and differing 
concentrations of glycosyl acceptor 5a in acetonitrile (Figure 3.6). The absorbance strongly 
suggest the presence of an EDA complex via interaction of 5a/b and Umemoto’s reagent. In order 



























Figure 3.5 Light on/off experiment 
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system consisting of the complex of styrene and 4-methoxystyrene with the S-
trifluoromethyldibenzothiophenium cation of Umemoto’s Reagent (Figure 3.7). The electronic 
structure calculations at the DFT level of theory on the ground state complex for each system 
showed that the charge transfer for low-lying isomers of the methoxystyrene-Umemoto’s reagent 
complex was substanially higher (around 50%)  than that of the styrene complex. The complexs 
all had interplanar distances around 3Å which is consitent with values reported in literature.19 The 





















Glycosyl donor 5a (25
mM)
Figure 3.6 Titration experiment, evidence for EDA complex  




systems where it complexes with non styreneic species, further suggesting the feasibility of 
Umemoto’s reagent in an EDA complex as a prerequisite to glycosylation.19  
 The presence of an EDA complex is strongly suggested by the data collected, however, the 
role, if any, of the EDA complex in the reaction mechanism was still undetermined. If the EDA 
complex is required for the reaction to occur, a similar glycosyl donor that does not form an EDA 
complex under the same reaction conditions would not be able to undergo O-glycosylation. 
Glycosyl donor 23 did not form a yellow color upon dissolution with Umemoto’s reagent and 
showed no new absorbance in the UV-vis spectra. Thus the hypothesis was tested by performing 
the glycosylation with glycosyl donor 23 (Scheme 3.8). The glycosylation did not proceed, 
indicating that the EDA complex plays a role in the reaction mechanism. This idea was further 
investigated by subjecting glycosyl donor 5c to the normal reaction conditions with the addition 
of p-methoxylstyrene to the reaction mixture. Despite the formation of yellow color, the glycosyl 
donor 5c was not converted, suggesting that activation must occur intramolecularly. 
 The experimental and computational data suggest a mechanism shown in Scheme 3.9.  The 
EDA complex of 5a (or 5f) is formed via π-π stacking of p-methoxystyrene moiety with the S-




trifluoromethyldibenzothiophenium cation of Umemoto’s reagent and absorbes a photon. The 
addition of trifluoromethyl and the intramolecular addition of the sulfur of 5a/5f across the styrenic 
double bond result in the direct formation of either 24 (pathway 1) or 25 + 22 (pathway 2) which 
is then intercepted by acceptor. During the conversion of EDA complex to 24/25, S-
trifluoromethyldibenzothiophenium may undergo reduction by photoinduced electron transfer 
from thioglycoside sulfur to generate trifluoromethyl radical and dibenzothiophene. 
 3.3 Conclusion 
 I have developed an exceptionally mild, visible light-promoted O-glycosylation method 
using 4-methoxyphenyl-3-butenylthioglucoside donors in the presence of easily handled and 
bench stable Umemoto’s reagent. The reaction conditions are selective for the glycosyl donors  
5a/5f which were employed in the presence of other thioglycosides that proved to be orthogonal. 
It is strongly suggested that the reaction proceeds through a mechanism involving the EDA 
complex formed via interaction of glycosyl donor 5a/b and Umemoto’s reagent. Alcohol acceptors 
ranging from primary to tertiary were used, providing moderate to high yields and complete 
selectivity for the beta anomer when using glycosyl donor 5f. This glycosylation is the mildest 




visible light-promoted O-glycosylation method in the literature and may be useful for future 
attempts at synthesizing oligosaccharides due to its orthogonality. 
3.4 Experimental 
3.4.1 General Methods 
 Reagents were purchased from Sigma Aldrich and used as received.  Flash column 
chromatography was performed using 60Å silica gel purchased from Sigma Aldrich. 1H NMR and 
13C NMR spectroscopy were performed o n a Bruker AV-400 and AV- 500 spectrometer. Mass 
spectra were obtained using an Agilent 6210 electrospray time-of-flight mass spectrometer.  UV-
vis spectrophotometry was performed on a Varian Cary50 UV/vis spectrophotometer.  Analytical 
and preparative TLC were conducted on aluminum sheets (Merck, silica gel 60, F254). 
Compounds were visualized by UV absorption (254 nm) and staining with anisaldehyde. 5 mL 
Pyrex micro reaction vessels (Supelco) were used in the glycosylation reactions. The triflate salt 
of Umemoto’s reagent was used in all glycosylations. All glassware was flame-dried under 
vacuum and backfilled with dry nitrogen prior to use. Deuterated solvents were obtained from 
Cambridge Isotope Labs. All solvents were purified according to the method of Grubbs.20 
3.4.2 Procedures and characterization 
Procedure for glycosylations performed in presence of Ru(bpy)3(BArF)2 
 A flame-dried 5 mL Pyrex reactor vial was charged with the glycosyl donor (1 equiv., 
0.150 mmol), Ru(bpy)3(BArF)2
21 (1 mol %, 1.5 μmol), 2,6-di-tert-butyl-4-methylpyridine 
(DTBMP, 1.2 equiv., 0.180 mmol), Umemoto’s reagent (1.07 equiv., 0.160 mmol), the glycosyl 
acceptor (3 equiv., 0.450 mmol), 300 mg of freshly activated 4 Å molecular sieves and 2 mL of 
dry solvent under nitrogen atmosphere. The reactor vial was placed 1-2 cm away from the light 
source (4W blue LEDs, 2 strips, Sapphire Blue LED Flex Strips from Creative Lighting Solutions, 
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were wrapped around a 150 × 75 Pyrex crystalizing dish (Figure 3.8), and irradiated from the side 
for 24 hours. The reaction mixture was then filtered to remove molecular sieves and the crude 
products were concentrated and then purified by gradient silica gel chromatography to afford a 
mixture of anomeric products.   
Procedure for Optimized glycosylation conditions 
 A flame-dried 5 mL Pyrex reactor vial was charged with the glycosyl donor (1 equiv., 
0.150 mmol), Umemoto’s reagent (1.07 equiv., 0.160 mmol), the glycosyl acceptor (0.5 equiv., 
0.0752 mmol), 150 mg of freshly activated 4 Å molecular sieves and 1 mL of dry dichloromethane 
under nitrogen atmosphere. The reactor vial was placed 1-2 cm away from the light source (4W 
blue LEDs, 2 strips, Sapphire Blue LED Flex Strips from Creative Lighting Solutions, were 
wrapped around a 150 × 75 Pyrex crystalizing dish, Figure S1) and irradiated from the side for 24 
hours. The reaction mixture was then filtered to remove molecular sieves and the crude products 
were concentrated and then purified by gradient silica gel chromatography to afford a mixture of 
anomeric products. 
Determination of anomeric ratios 
 The anomeric ratio (α/β) was determined based on the integration of key resonances 
identified with the assistance of published 1H NMR data.  In the cases where spectral data was 













 A 250 mL round bottom flask was charged with 6.00 g (18.0 mmol) of (E)-4-(4-
methoxyphenyl)but-3-en-1-yl-p-toluenesulfonate22 10.3 g (68.7 mmol) of sodium iodide and 49 
mL of acetone under nitrogen atmosphere. Reaction progress was monitored by TLC. After 
consumption of the tosylate (16 hrs) the solution was filtered through a pad of Celite using a fritted 
Buchner funnel. The filter cake was washed with pentane. The filtrate was then washed with 175 
mL each of water and brine. The organic layer was then dried over Na2SO4, filtered and 
concentrated to give 4.86 g (94 % yield) of a yellow solid. 1H NMR (500 MHz, Chloroform-d) δ  
7.29 (d, J = 9.0 Hz, 2H), 6.84 (d, J = 8.5 Hz, 2H), 6.41 (d, J = 15.8 Hz, 1H), 6.00 (dt, J = 15.7, 7.0 
Hz, 1H), 3.80 (s, 3H), 3.23 (t, J = 7.3 Hz, 2H), 2.75 (qd, J = 7.1, 1.5 Hz, 2H). 13C NMR (126 MHz, 
CDCl3) δ 159.31, 131.88, 130.08, 127.53, 126.52, 114.22, 55.52, 37.29, 5.60. HRMS m/z Calcd 
for C11H13IO (M+H)
+  289.0084, found 289.0076. 
Figure 3.8 Experimental setup 
92 
 
Synthesis of glycosyl donors 5a and 5b 
 
Glycosyl donor 5b ((E)-4-(4-methoxyphenyl)-3-butenyl -D-1-thio-2,3,4,6-tetra-O-
acetylglucopyranoside) 
 
 A 100 mL round bottom flask was charged with 3.70 g (10.2 mmol) of 2,3,4,6-Tetra-O-
acetyl-1-mercapto-β-D-glucopyranosid23 and 23 mL of toluene under nitrogen atmosphere. 1.53 
mL (10.2 mmol) of 1,8-diazabicycloundec-7-ene was added to the reaction mixture at -10°C 
followed by 2.94 g (10.2 mmol) of (E)-1-iodo-4-(4-methoxyphenyl)-3-butene dissolved in 7 mL 
of toluene. After consumption of starting material as observed by TLC (1.5 hrs), the reaction was 
quenched with 36 mL of H2O and the layers were separated. The aqueous layer was then extracted 
with 2 × 115 mL of DCM followed by dilution with 350 mL of DCM. The organic layer was then 
washed with 150 mL each of                                                                                                                                                            
1M H2SO4, saturated NaHCO3, and brine.  The organic layer was then dried over Na2SO4, filtered 
and concentrated to give 4.97 g of crude material. Purified by gradient silica gel chromatography 
20% → 40% ethyl acetate in hexanes to give 4.65 g (87% yield) white solid. 1H NMR (500 MHz, 
Chloroform-d) δ 7.27 (d, J = 8.8 Hz, 2H), 6.84 (d, J = 8.6 Hz, 2H), 6.38 (d, J = 15.8 Hz, 1H), 6.05 
(dt, J = 15.8, 6.9 Hz, 1H), 5.26 – 5.20 (m, 1H) , 5.07 (dt, J = 17.4, 9.7 Hz, 2H), 4.52 (d, J = 10.0 
Hz, 1H), 4.25 (dd, J = 12.4, 5.0 Hz, 1H), 4.14 (dd, J = 12.4, 2.4 Hz, 1H), 3.80 (s, 3H), 3.71 (ddd, 
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J = 10.0, 4.9, 2.3 Hz, 1H), 2.80 (tdd, J = 20.1, 9.7, 6.0 Hz, 2H), 2.57 – 2.40 (m, 2H), 2.07 (s, 3H), 
2.04 (s, 3H), 2.03 (s, 3H), 2.01 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 171.27,  170.78, 170.32, 
169.56, 159.12, 131.15, 130.21, 127.34, 125.81, 114.12, 83.76, 76.07, 74.04, 70.02, 68.49, 62.32, 
55.44, 33.43, 30.03, 20.90, 20.87, 20.77, 20.74. HRMS m/z Calcd for C25H32NaO10S (M+Na)
+  
547.1608, found 547.1613.  
25
D = -40.3 (c= 1, DCM). 
Glycosyl donor 5a ((E)-4-(4-methoxyphenyl)-3-butenyl -D-1-thio-2,3,4,6-tetra-O-
benzylglucopyranoside) 
 
 A 250 mL round bottom flask was charged with 4.65 g (8.86 mmol) of glycosyl donor 5b 
and 100 mL of methanol under a nitrogen atmosphere. 4.87 mL (4.87 mmol) of a 1M NaOMe 
solution was added via a syringe at once and the reaction was stirred for 15 hrs. The solvent was 
then removed giving 3.3 g of deprotected thioglucoside. 3 g of the crude product was then 
transferred to a 250 mL round bottom flask with 620 mg (1.68 mmol) of tetrabutylammonium 
iodide and 85 mL of DMF under a nitrogen atmosphere. 2.525 g (63.2 mmol) of sodium hydride 
(60% in mineral oil) was added to the solution at 0°C and the suspension was stirred for 30 minutes.  
6.9 mL (57.8 mmol) of benzyl bromide was then added dropwise via a syringe to the suspension 
at 0°C. The suspension was then allowed to warm to 23°C and stir for 16 hrs. The reaction was 
then quenched with 60 mL of saturated ammonium chloride at 0°C followed by extraction with 2 
× 65 mL Et2O. The organic layer was washed with brine, dried over Na2SO4, filtered and 
concentrated to give 3.78 g of crude material. Purified by gradient silica gel chromatography 8% 
→ 18% ethyl acetate in hexanes to give 3.42 g (54% yield over 2 steps) white solid. 1H NMR (500 
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MHz, Chloroform-d) δ 7.40 – 7.20 (m, 20H), 7.17 (d, J = 7.5 Hz, 2H), 6.82 (d, J = 8.6 Hz, 2H), 
6.37 (d, J = 15.8 Hz, 1H), 6.09 (dt, J = 15.7, 6.9 Hz, 1H), 4.92 (d, J = 10.6 Hz, 2H), 4.88 – 4.78 
(m, 2H), 4.74 (d, J = 10.2 Hz, 1H), 4.64 – 4.52 (m, 3H), 4.49 (d, J = 9.7 Hz, 1H), 3.80 (s, 3H), 3.75 
(dd, J = 10.9, 1.9 Hz, 1H), 3.71 – 3.65 (m, 2H), 3.65 – 3.59 (m, 1H), 3.51 – 3.39 (m, 2H), 2.95 – 
2.76 (m, 2H), 2.56 (qd, J = 7.3, 1.4 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 159.10, 138.73, 
138.41, 138.26, 138.18, 130.94, 130.47, 128.67, 128.65, 128.62, 128.60, 128.57, 128.54, 128.21, 
128.19, 128.06, 128.02, 128.00, 127.98, 127.94, 127.93, 127.88, 127.80, 127.44, 127.43, 126.43, 
114.14, 86.87, 85.52, 82.03, 79.35, 78.19, 75.98, 75.74, 75.28, 73.70, 69.37, 55.51, 33.84, 31.08. 
HRMS m/z Calcd for C45H48NaO6S (M+Na)
+ 739.3064, found 739.3073.  
25
D = -11.5 (c= 1, DCM). 
Synthesis of glycosyl donor 5f 
 
Glycosyl donor 5f ((E)-4-(4-methoxyphenyl)-3-butenyl -D-1-thio-2-O-acetyl-3,4,6-tri-O-
benzylglucopyranoside) 
 
 A 50 mL round bottom flask was charged with 1.803 g (3.545 mmol) 2-O-acetyl-3,4,6-tri-
O-benzyl-1-deoxy-1-mercapto-β-D-glucopyranoside23 and 8 mL of toluene under nitrogen 
atmosphere. 0.54 mL (3.545 mmol) of 1,8-diazabicycloundec-7-ene was added to the reaction 
mixture at -10°C followed by 1.021 g (3.545 mmol) of (E)-1-iodo-4-(4-methoxyphenyl)-3-butene 
dissolved in 3 mL of toluene. After consumption of starting material as observed by TLC (2 hrs), 
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the reaction was quenched with 13 mL of H2O. The solution was then extracted with 2 × 39 mL 
of DCM followed by dilution with 121 mL of DCM. The organic layer was then washed with 80 
mL each of 1M H2SO4, saturated NaHCO3, and brine. The organic layer was then dried over 
Na2SO4, filtered and concentrated to give 1.38 g of crude material. Purified by gradient silica gel 
chromatography 7% → 10% ethyl acetate in hexanes to give 992.8 mg (42% yield) white solid. 
1H NMR (500 MHz, Chloroform-d) δ 7.41 – 7.22 (m, 15H), 7.19 (d, J = 3.8 Hz, 2H), 6.82 (d, J = 
8.5 Hz, 2H), 6.35 (d, J = 15.8 Hz, 1H), 6.05 (dt, J = 16.0, 6.9 Hz, 1H), 5.09 – 5.02 (m, 1H) , 4.79 
(dd, J = 11.1, 5.7 Hz, 2H), 4.68 (d, J = 11.5 Hz, 1H), 4.64 – 4.49 (m, 3H), 4.38 (d, J = 10.0 Hz, 
1H), 3.78 (s, 3H), 3.76 – 3.64 (m, 4H), 3.50 (ddd, J = 9.7, 4.3, 2.0 Hz, 1H), 2.84 (ddd, J = 12.4, 
8.4, 6.7 Hz, 1H), 2.76 (dt, J = 12.4, 7.5 Hz, 1H), 2.49 (dt, J = 11.1, 7.1 Hz, 2H), 1.96 (s, 3H). 13C 
NMR (126 MHz, CDCl3) δ 169.82, 159.01, 138.34, 138.28, 138.05, 130.84, 130.40, 128.60, 
128.54, 128.20, 128.03, 127.92, 127.90, 127.83, 127.75, 127.35, 126.31, 114.06, 84.53, 83.64, 
79.66, 78.01, 75.37, 75.27, 73.64, 71.91, 69.03, 55.42, 33.60, 29.66, 21.14. HRMS m/z Calcd for 
C40H44NaO7S (M+Na)
+ 691.2700 , found 691.2710.   
25
D = -20.3 (c= 1, DCM). 
Synthesis of glycosyl donor 21 




 A 100 mL round bottom flask was charged with 1.40 g (3.84 mmol) of 2,3,4,6-tetra-O-
acetyl-1-mercapto-β-D-glucopyranoside23 and 11.4 mL of toluene under nitrogen atmosphere. 0.58 
mL (3.87 mmol) of 1,8-diazabicycloundec-7-ene was added to the reaction mixture at -10°C 
followed by 1.00 g (3.87 mmol) of (E)-1-Iodo-4-phenyl-3-butene1 dissolved in 2.4 mL of toluene. 
After consumption of starting material as observed by TLC (2 hrs), the reaction was quenched 
with 15 mL of H2O. The solution was then extracted with 2 × 45 mL of DCM followed by dilution 
with 135 mL of DCM. The organic layer was then washed with 36 mL each of 1M H2SO4, saturated 
NaHCO3, and brine. The organic layer was then dried over Na2SO4, filtered and concentrated to 
give 3.39 g of crude material. Purified by gradient silica gel chromatography 20% → 30% ethyl 
acetate in hexanes to give 820 mg (43% yield) white solid. 1H NMR (500 MHz, Chloroform-d) δ 
7.34 (d, J = 7.2 Hz, 2H), 7.29 (t, J = 7.6 Hz, 2H), 7.21 (t, J = 7.2 Hz, 1H), 6.44 (d, J = 15.8 Hz, 
1H), 6.20 (dt, J = 15.8, 6.9 Hz, 1H), 5.26 - 5.18 (m, 1H), 5.14 - 5.00 (m, 2H), 4.52 (d, J = 10.1 Hz, 
1H), 4.25 (dd, J = 12.4, 5.0 Hz, 1H), 4.15 (dd, J = 12.4, 2.3 Hz, 1H), 3.72 (ddd, J = 10.1, 5.0, 2.4 
Hz, 1H), 2.91 - 2.74 (m, 2H), 2.59 - 2.45 (m, 2H), 2.07 (s, 3H), 2.04 (s, 3H), 2.03 (s, 3H), 2.01 (s, 
3H). 13C NMR (126 MHz, CDCl3) δ 170.75, 170.30, 169.53, 137.39, 131.80, 128.68, 128.02, 
127.40, 126.22, 83.75, 76.12, 74.05, 70.01, 68.51, 62.32, 33.41, 29.84, 20.88, 20.85, 20.75, 20.72. 
HRMS m/z Calcd for C24H30NaO9S (M+Na)
+ 517.1503, found 517.1499. = -40.3 (c= 1, DCM). 
Glycosyl donor 21 ((E)-4-phenyl-3-butenyl -D-1-thio-2,3,4,6-tetra-O-benzylglucopyranoside) 
 
 A 100 mL round bottom flask was charged with 523 mg (1.06 mmol) of tetraacetyl-21 and 




was added via a syringe at once and the reaction was stirred for 15 hrs. The solvent was then 
removed giving the deprotected thioglucoside which was then transferred to a 100 mL round 
bottom flask with 78.1 mg (0.21 mmol) of tetrabutylammonium iodide and 11 mL of DMF under 
a nitrogen atmosphere. 316.9 mg (7.93 mmol) of sodium hydride (60% in mineral oil) was added 
to the solution at 0°C and the suspension was stirred for 30 minutes.  0.86 mL (7.23 mmol) of 
benzyl bromide was then added dropwise via a syringe to the suspension at 0°C. The suspension 
was then allowed to warm to 19°C and stir for 16 hrs. The reaction was then quenched with 10 mL 
of saturated ammonium chloride at 0°C followed by extraction with 2 × 10 mL Et2O. The organic 
layer was dried over Na2SO4, filtered and concentrated to give 1.03 g of crude material. Purified 
by gradient silica gel chromatography 5% → 10% ethyl acetate in hexanes to give 456 mg (63% 
yield over 2 steps) white solid. 1H NMR (500 MHz, Chloroform-d) δ 7.39 - 7.14 (m, 25H), 6.43 
(d, J = 15.8 Hz, 1H), 6.24 (dt, J = 15.8, 6.9 Hz, 1H), 4.92 (d, J = 10.7 Hz, 2H), 4.86 - 4.79 (m, 
2H), 4.74 (d, J = 10.2 Hz, 1H), 4.62 - 4.53 (m, 3H), 4.49 (d, J = 9.7 Hz, 1H), 3.75 (dd, J = 10.9, 
1.9 Hz, 1H), 3.71 - 3.65 (m, 2H), 3.61 (m, J = 9.4 Hz, 1H), 3.50 - 3.43 (m, 2H), 2.94 - 2.80 (m, 
2H), 2.59 (q, J = 6.7 Hz, 2H).13C NMR (126 MHz, CDCl3) δ 138.67, 138.35, 138.21, 138.11, 
137.56, 131.52, 128.63, 128.58, 128.56, 128.54, 128.51, 128.47, 128.12, 127.98, 127.93, 127.91, 
127.85, 127.80, 127.72, 127.27, 126.26, 86.81, 85.45, 81.97, 79.31, 78.14, 75.90, 75.67, 75.20, 
73.64, 69.33, 33.77, 30.86. HRMS m/z Calcd for C44H46NaO5S (M+Na)
+ 709.2958, found 
709.2977. = -7.5 (c= 1, DCM). 





Glycosyl donor 5c (octyl β-D-1-thio-2,3,4,6-tetra-O-benzylglucopyranoside) 
 
 A 100 mL round bottom flask was charged with 1.07 g (3.47 mmol) of octyl β-D-1-
thioglucopyranoside, 222 mg (0.600 mmol) of tetrabutylammonium iodide and 30 mL of DMF 
under a nitrogen atmosphere. 0.900 g (22.5 mmol) of sodium hydride (60% in mineral oil) was 
added to the solution at 0°C and the suspension was stirred for 30 minutes.  2.5 mL (21 mmol) of 
benzyl bromide was then added dropwise via a syringe to the suspension at 0°C. The suspension 
was allowed to warm to 23°C and stirred for 16 hrs. The reaction was then quenched with 22 mL 
of saturated ammonium chloride at 0°C followed by extraction with 2 × 25 mL Et2O. The organic 
layer was washed with 35 mL of brine, dried over Na2SO4, filtered and concentrated to give 1.56 
g of crude material. Purified by gradient silica gel chromatography 5% → 10% ethyl acetate in 
hexanes to give 1.25 g (54% yield) white solid.  1H NMR (500 MHz, Chloroform-d) δ 7.40 – 7.35 
(m, 2H), 7.35 – 7.22 (m, 16H), 7.16 (dd, J = 7.5, 2.1 Hz, 2H), 4.92 (dd, J = 10.6, 5.4 Hz, 2H), 4.89 
– 4.78 (m, 2H), 4.74 (d, J = 10.2 Hz, 1H), 4.63 – 4.51 (m, 3H), 4.44 (d, J = 9.7 Hz, 1H), 3.74 (dd, 
J = 11.0, 2.0 Hz, 1H), 3.71 – 3.64 (m, 2H), 3.65 – 3.58 (m, 1H), 3.50 – 3.39 (m, 2H), 2.82 – 2.61 
(m, 2H), 1.71 – 1.59 (m, 2H), 1.46 – 1.33 (m, 2H), 1.33 – 1.18 (m, 8H), 0.88 (t, J = 6.9 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 138.65, 138.35, 138.18, 138.13, 128.54, 128.52, 128.50, 128.45, 
128.09, 127.95, 127.89, 127.88, 127.81, 127.77, 127.68, 86.79, 85.38, 81.95, 79.25, 78.09, 75.87, 
75.62, 75.15, 73.56, 69.23, 31.96, 31.01, 30.04, 29.35, 29.32, 29.07, 22.80, 14.28. HRMS m/z 
Calcd for C42H52NaO5S (M+Na)
+ 691.3428, found 691.3457.  
25




Synthesis of Glycosyl donor 5e 
 
Glycosyl donor 5e (2,4-dimethoxyphenyl β-D-1-thio-2,3,4,6-tetra-O-benzylglucopyranoside) 
 
 4.00 g (9.73 mmol) of -1-bromoglucose tetraacetate was placed in a 100 mL round bottom 
flask and 20 mL of CH3CN was added under a nitrogen atmosphere.  1.54 mL (10.7 mmol) of 2,4-
dimethoxybenzenethiol and then 2.71 mL (19.4 mmol) of triethylamine were then added to the 
solution which was stirred for 16 h at 25oC. The solution was then diluted with 250 mL of DCM 
and washed with 3 × 350 mL water. The organic layer was then dried over Na2SO4, filtered and 
concentrated to give 4.54 g of crude material. Purified by gradient silica gel chromatography 30% 
→ 70% ethyl acetate in hexanes to give 4.29 g (88 %) of a white solid (2,4-
dimethoxyphenylthioglucose tetraacetate). All 4.29 g (8.57 mmol) of the product was placed in a 
250 mL round bottom flask and dissolved in 94 mL of methanol under a nitrogen atmosphere. 4.71 
mL (4.71 mmol) of a 1M NaOMe solution was added via a syringe at once and the reaction was 
stirred for 15 hrs at 25oC. The solvent was then removed resulting in 3.07 g of crude 2,4-
dimethoxyphenylthioglucoside. 2.85 g of this crude product was then transferred to a 250 mL 
round bottom flask with 634 mg (1.72 mmol) of tetrabutylammonium iodide and 86 mL of DMF 
was added under a nitrogen atmosphere. 2.572 g (64.3 mmol) of sodium hydride (60% in mineral 
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oil) was added to the solution at 0°C and the suspension was stirred for 30 minutes.  7.0 mL (58.9 
mmol) of benzyl bromide was then added dropwise via a syringe to the suspension at 0°C. The 
suspension was allowed to warm to 23°C and stir for 16 hrs. The reaction was then quenched with 
65 mL of saturated ammonium chloride at 0°C followed by extraction with 2 × 70 mL Et2O. The 
organic layer was washed with brine, dried over Na2SO4, filtered and concentrated to give 5.38 g 
of crude material. Purified by gradient silica gel chromatography 10% → 20% ethyl acetate in 
hexanes to give 4.79 g (81 %) white solid. 1H NMR (500 MHz, Chloroform-d) δ 7.57 (dd, J = 8.5, 
1.4 Hz, 1H), 7.46 (d, J = 7.4 Hz, 2H), 7.35 – 7.25 (m, 18H), 7.22 – 7.17 (m, 2H), 6.42 (d, J = 2.6 
Hz, 1H), 6.32 (dd, J = 8.5, 2.5 Hz, 1H), 4.97 (d, J = 10.1 Hz, 1H), 4.91 (d, J = 10.8 Hz, 1H), 4.87 
– 4.79 (m, 2H), 4.73 (d, J = 10.1 Hz, 1H), 4.64 – 4.57 (m, 2H), 4.57 – 4.46 (m, 2H), 3.78 (s, 3H), 
3.75 (s, 3H), 3.73 – 3.66 (m, 1H), 3.63 – 3.57 (m, 1H), 3.54 – 3.42 (m, 2H). 13C NMR (126 MHz, 
CDCl3) δ 161.29, 160.00, 138.67, 138.61, 138.46, 138.26, 136.07, 128.65, 128.62, 128.58, 128.54, 
128.48, 128.15, 128.05, 127.99, 127.97, 127.90, 127.67, 112.43, 105.23, 99.18, 87.05, 86.97, 
81.43, 79.34, 78.10, 76.03, 75.53, 75.23, 73.65, 69.41, 55.96, 55.59. HRMS m/z Calcd for 
C42H44NaO7S (M+Na)
+ 715.2700, found 715.2714.  
25
D = -10.5 (c= 1.5, DCM).  




 A 50 mL round bottom flask was charged with 1.1 g (1.907 mmol) of octyl 2,3-di-O-
benzyl-4,6-O-benzylidene-β-D-1-thioglucopyranoside,24 11.4 mL of 70% TFA (aq) under a 
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nitrogen atmosphere. The reaction was then stirred at 23°C for 2 h during which starting material 
was consumed. The reaction mixture was then concentrated to give 868.5 mg of crude material. 
Purified by gradient silica gel chromatography 5% → 40% ethyl acetate in hexanes to give 454.8 
mg (49% yield) colorless oil. 1H NMR (500 MHz, Chloroform-d) δ 7.44 – 7.27 (m, 10H), 4.96 
(dd, J = 10.9, 4.3 Hz, 2H), 4.72 (dd, J = 10.9, 9.1 Hz, 2H), 4.48 (d, J = 9.6 Hz, 1H), 3.87 (dd, J = 
11.9, 3.5 Hz, 1H), 3.75 (dd, J = 11.9, 5.2 Hz, 1H), 3.60 – 3.54 (m, 1H), 3.52 – 3.46 (m, 1H), 3.41 
– 3.36 (m, 1H), 3.33 (ddd, J = 9.1, 5.1, 3.5 Hz, 1H), 2.72 (qt, J = 12.5, 7.4 Hz, 2H), 2.19 (s, 2H), 
1.71 – 1.55 (m, 2H), 1.45 – 1.34 (m, 2H) , 1.34 – 1.18 (m, 8H), 0.88 (t, J = 6.8 Hz, 3H). 13C NMR 
(126 MHz, CDCl3) δ 138.59, 138.01, 128.88, 128.70, 128.66, 128.62, 128.57, 128.53, 128.22, 
128.18, 128.14, 128.08, 86.12, 85.85, 81.76, 79.21, 75.62, 75.58, 70.72, 62.92, 32.00, 31.43, 30.11, 
29.38, 29.37, 29.07, 22.85, 14.29. HRMS m/z Calcd for C28H40NaO5S (M+Na)
+ 511.2493 , found 
511.2489.  
25
D = -37.8 (c= 1, DCM). 




 A 100 mL round bottom flask equipped with a reflux condenser was charged with 1 g 
(3.242 mmol) of octyl-β-D-thioglucopyranoside (Sigma Aldrich), 71.3 mg (0.584 mmol) of 
DMAP and 37 mL of pyridine under a nitrogen atmosphere. 5.36 mL (23.34 mmol) of tert-
butyldimethylsilyl trifluoromethanesulfonate was then added to the solution at 0°C. The solution 
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was heated to 60°C and stirred for 24 hrs. The reaction was then allowed to cool to 23°C and 
quenched with 13 mL of methanol. The mixture was diluted with 110 mL of ethyl acetate followed 
by washing with 200 mL each of water, 1M HCl and brine. The organic layer was dried over 
Na2SO4, filtered and concentrated to give 2.543 g of crude material. Purified by silica gel 
chromatography (20% ethyl acetate in hexanes) to give 2.34 g (94% yield) colorless oil. 1H NMR 
(500 MHz, Chloroform-d) δ 4.67 (d, J = 8.0 Hz, 1H), 3.98 – 3.92 (m, 1H), 3.82 (d, J = 3.1 Hz, 1H), 
3.77 – 3.70 (m, 1H), 3.62 (d, J = 8.0 Hz, 1H), 2.68 (ddd, J = 12.6, 8.0, 6.4 Hz, 1H), 2.58 (dt, J = 
12.6, 7.5 Hz, 1H), 1.68 – 1.54 (m, 2H), 1.45 – 1.33 (m, 2H), 1.33 – 1.21 (m, 10H), 0.92 – 0.87 (m, 
39H), 0.16 – 0.02 (m, 24H). 13C NMR (126 MHz, CDCl3) δ 83.75, 83.56, 78.37, 70.24, 64.47, 
32.07, 31.01, 30.09, 29.44, 29.41, 29.17, 26.30, 26.18, 26.06, 22.87, 18.57, 18.34, 18.18, 18.08, 
14.31, -3.84, -3.91, -4.00, -4.18, -4.46, -4.49, -5.02, -5.04. HRMS m/z Calcd for C38H84NaO5SSi4 
(M+Na)+ 787.5009 , found 787.5005.  
25
D = - 9.4 (c= 1.1, DCM). 
octyl -D-1-thio-2,3,4-tri-O-tert-butyldimethylsilylglucopyranoside 
 
 A 15 mL round bottom flask was charged with 300.0 mg (0.392 mmol) of octyl -D-1-
thio-2,3,4,6-tetra-O-tert-butyldimethylsilylglucopyranoside, 6.5 mg (20 µmol) of CBr4 and 3.9 mL 
of methanol under a nitrogen atmosphere. The solution was irradiated with a 4-watt UVGL-15 UV 
lamp for 30 min. The reaction was then stirred at 23°C for 4 hrs and concentrated giving 220.5 mg 
of crude material. Purified by gradient silica gel chromatography 3% → 5% ethyl acetate in 
hexanes to give 169.8 mg (67% yield) colorless oil. 1H NMR (500 MHz, Chloroform-d) δ 4.64 (d, 
J = 6.6 Hz, 1H), 3.81 (dd, J = 6.5, 3.3 Hz, 1H), 3.80 – 3.76 (m, 1H), 3.75 – 3.65 (m, 2H), 2.69 
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(ddd, J = 12.7, 8.0, 6.6 Hz, 1H), 2.61 (dt, J = 12.7, 7.5 Hz, 1H), 2.30 (dd, J = 7.5, 4.5 Hz, 1H), 1.68 
– 1.54 (m, 2H), 1.44 – 1.33 (m, 2H), 1.34 – 1.20 (m, 10H), 0.96 – 0.80 (m, 30H), 0.17 – 0.04 (m, 
18H). 13C NMR (126 MHz, CDCl3) δ 85.22, 83.19, 77.50, 76.30, 71.46, 64.35, 32.04, 31.66, 30.14, 
29.42, 29.40, 29.12, 26.21, 26.07, 26.04, 22.86, 18.29, 18.21, 18.12, 14.31, -4.04, -4.05, -4.11, -
4.19, -4.71. HRMS m/z Calcd for C32H70NaO5SSi3 (M+Na)
+ 673.4144 , found 673.4141.  
25
D = -
34.8 (c= 1, DCM). 
Synthesis of 4-chlorophenyl -D-1-thio-2,3,4-tri-O-benzylglucopyranoside 
4-chlorophenyl 4,6-O-benzylidene-β-D-1-thio-2,3-di-O-benzylglucopyranoside 
 
 A 50 mL round bottom flask was charged with 500.0 mg (1.27 mmol) of 4-chlorophenyl 
4,6-O-benzylidene-β-D-1-thioglucopyranoside,25 46.5 mg (0.126 mmol) of tetrabutylammonium 
iodide and 14 mL of DMF under a nitrogen atmosphere.  624.3 mg (15.62 mmol) of sodium 
hydride (60% in mineral oil) was added to the solution at 0°C and the suspension was stirred for 
30 minutes.  0.37 mL (3.1 mmol) of benzyl bromide was then added dropwise via a syringe to the 
suspension at 0°C. The suspension was warmed to 23°C and stirred for 16 hrs. The reaction was 
then quenched with 10 mL of saturated ammonium chloride at 0°C followed by extraction with 2 
× 11 mL Et2O. The organic layer was washed with 50 mL of brine, dried over Na2SO4, filtered and 
concentrated to give 856 mg of crude material. Purified by gradient silica gel chromatography 10% 
→ 20% ethyl acetate in hexanes to give 656 mg (90% yield) white solid. 1H NMR (500 MHz, 
104 
 
Chloroform-d) δ 7.59 – 7.46 (m, 4H), 7.46 – 7.29 (m, 15H), 5.63 (s, 1H), 4.99 (d, J = 11.2 Hz, 
1H), 4.87 (s, 2H), 4.82 (d, J = 11.2 Hz, 1H), 4.75 (d, J = 9.8 Hz, 1H), 4.42 (dd, J = 10.5, 5.0 Hz, 
1H), 3.93 – 3.77 (m, 2H), 3.78 – 3.67 (m, 1H), 3.57 – 3.44 (m, 2H). 13C NMR (126 MHz, CDCl3) 
δ 138.39, 138.06, 137.35, 134.42, 134.02, 131.59, 129.36, 129.21, 128.62, 128.60, 128.47, 128.37, 
128.31, 128.14, 128.00, 126.17, 101.35, 88.34, 83.10, 81.62, 80.58, 76.11, 75.50, 70.46, 68.82. 
HRMS m/z Calcd for C33H31ClNaO5S (M+Na)
+ 597.1473 , found 597.1490.  
25




 A 50 mL round bottom flask was charged with 950.0 mg (1.652 mmol) of 4-chlorophenyl 
4,6-O-benzylidene-β-D-1-thio-2,3-di-O-benzylglucopyranoside, and 8.26 mL (8.26 mmol) of a 
1M solution of borane in tetrahydrofuran under a nitrogen atmosphere. 29.9 mg (82.7 µmol) of 
copper (II) triflate was then added to the solution under a flow of nitrogen. The reaction was stirred 
for 3.5 hrs at which time 0.29 mL of triethylamine was added. 5 mL of methanol was then added 
dropwise into the solution (H2 gas evolved). The mixture was concentrated to give 746 mg of crude 
material. Purified by gradient silica gel chromatography (10% → 30% ethyl acetate in hexanes) to 
give 656 mg (69% yield) white solid. 1H NMR (500 MHz, Chloroform-d) δ 7.43 (d, J = 8.5 Hz, 
2H), 7.42 – 7.15 (m, 17H), 4.95 – 4.81 (m, 4H), 4.77 (d, J = 10.3 Hz, 1H), 4.66 (dd, J = 10.4, 5.6 
Hz, 2H), 3.87 (ddd, J = 12.0, 6.0, 2.6 Hz, 1H), 3.78 – 3.62 (m, 2H), 3.62 – 3.53 (m, 1H), 3.50 – 
3.41 (m, 1H) , 3.37 (ddd, J = 9.7, 4.6, 2.6 Hz, 1H), 1.84 (t, J = 6.7 Hz, 1H). 13C NMR (126 MHz, 
CDCl3) δ 138.41, 137.94, 134.18, 133.46, 132.06, 129.40, 128.75, 128.70, 128.68, 128.38, 128.27, 
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128.24, 128.20, 128.00, 127.98, 87.74, 86.70, 81.21, 79.57, 77.63, 76.05, 75.80, 75.35, 62.26. 
HRMS m/z Calcd for C33H33ClNaO5S (M+Na)
+ 599.1629 , found 599.1636.   
25
D = +3.1 (c= 1, 
DCM).  
octyl 2,3,4,6-tetra-O-benzyl-D-glucopyranoside 8 26 
 
 Started with 107.8 mg (0.150 mmol) of glycosyl donor 5a, 64.4 mg (0.160 mmol) of 
Umemoto’s reagent, 11.9 µL (0.0752 mmol) 1-octanol, and 150 mg of 4Å MS in 1 mL of DCM. 
Purified to obtain 45.6 mg (93%) colorless oil in a 1:1 α:β mixture. Spectral data matched that 
previously reported in literature.26 
cyclohexyl 2,3,4,6-tetra-O-benzyl-D-glucopyranoside 9 27   
 
 Started with 107.8 mg (0.150 mmol) of glycosyl donor 5a, 64.4 mg (0.160 mmol) of 
Umemoto’s reagent, 7.8 µL (0.0752 mmol) cyclohexanol, 150 mg of 4Å MS, in 1 mL of  DCM. 
Purified to obtain 42.2 mg (90%) colorless oil in a 1:1.8 α:β mixture. Spectral data matched that 







menthyl 2,3,4,6-tetra-O-benzyl-D-glucopyranoside 10 27 
 
 Started with 107.8 mg (0.150 mmol) of glycosyl donor 5a, 64.4 mg (0.160 mmol) of 
Umemoto’s reagent, 11.8 mg (0.0755 mmol) (-)-menthol, 150 mg of 4Å MS, in 1 mL of DCM. 
Purified to obtain 38.4 mg (75%) white solid in a 1.5:1 α:β mixture. Spectral data matched that 
previously reported in literature.27 
methyl-O-(2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl)-(1 6)-2,3,4-tri-O-benzyl-α-D-
glucopyranoside 7a 28 
 
 Started with 107.8 mg (0.150 mmol) of glycosyl donor 5a, 64.4 mg (0.160 mmol) of 
Umemoto’s reagent, 35.0 mg (0.0753 mmol) of methyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside, 
150 mg of 4Å MS, in 1 mL of DCM. Purified to obtain 56 mg (75%) colorless oil in a 1.6:1 (α:β) 






synthesis of disaccharide 11 
 
 Started with 107.8 mg (0.150 mmol) of glycosyl donor 5a, 64.4 mg (0.160 mmol) of 
Umemoto’s reagent, 36.7 mg (0.0751 mmol) of octyl β-D-1-thio-2,3-di-O-benzylglucopyranoside, 
150 mg of 4Å MS, in 1 mL of DCM. Purified to obtain 45.7 mg (60%) colorless oil in a 1.1:1 (α:β) 
mixture. α anomer1H NMR (500 MHz, Chloroform-d) δ 7.42 – 7.19 (m, 28H), 7.12 (d, J = 7.3, 2.3 
Hz, 2H), 4.94 (d, J = 10.8 Hz, 1H), 4.92 – 4.74 (m, 6H), 4.69 (dd, J = 11.1, 9.4 Hz, 2H), 4.60 (d, J 
= 12.1 Hz, 1H), 4.50 – 4.40 (m, 2H), 3.99 – 3.90 (m, 2H), 3.83 (ddd, J = 10.2, 3.7, 2.0 Hz, 1H), 
3.75 – 3.54 (m, 6H), 3.54 – 3.48 (m, 1H) , 3.46 (dt, J = 9.7, 5.0 Hz, 1H), 3.34 – 3.25 (m, 1H) , 3.11 
(s, 1H), 2.71 (dt, J = 12.5, 7.2 Hz, 1H), 2.63 (dt, J = 12.5, 7.5 Hz, 1H), 1.67 – 1.51 (m, 4H , 1.40 – 
1.16 (m, 10H), 0.86 (t, J = 6.9 Hz, 3H).  13C NMR (126 MHz, CDCl3) δ 138.97, 138.54, 138.32, 
138.32, 138.24, 138.09, 128.72, 128.68, 128.63, 128.60, 128.57, 128.54, 128.50, 128.20, 128.15, 
128.12, 128.08, 128.04, 127.99, 127.94, 127.89, 127.80, 127.77, 97.92, 86.21, 85.37, 82.26, 81.37, 
80.04, 77.69, 75.93, 75.67, 75.65, 75.17, 73.65, 73.41, 73.15, 70.55, 68.89, 68.61, 32.03, 31.03, 
29.98, 29.44, 29.40, 29.08, 22.87, 14.31. HRMS m/z Calcd for C62H74NaO10S (M+Na)
+ 1033.4895 
, found 1033.4928.  
25
D = +23.8 (c= 0.87, DCM).  β anomer 1H NMR (500 MHz, Chloroform-d) δ 
7.43 – 7.19 (m, 28H), 7.16 – 7.12 (m, 2H), 4.93 (dd, J = 21.6, 10.9 Hz, 3H), 4.82 – 4.75 (m, 2H) , 
4.76 – 4.67 (m, 2H), 4.60 (d, J = 12.2 Hz, 1H), 4.55 – 4.48 (m, 3H), 4.43 (d, J = 9.7 Hz, 1H), 4.13 
(dd, J = 11.3, 3.3 Hz, 1H), 3.86 (dd, J = 11.3, 5.8 Hz, 1H), 3.74 – 3.63 (m, 2H), 3.63 – 3.53 (m, 
3H), 3.52 – 3.40 (m, 4H), 3.40 – 3.30 (m, 1H),2.71 – 2.59 (m, 2H), 2.57 (s, 1H), 1.63 – 1.48 (m, 
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4H), 1.36 – 1.15 (m, 10H), 0.86 (t, J = 7.0 Hz, 3H).  13C NMR (126 MHz, CDCl3) δ 138.82, 138.78, 
138.62, 138.29, 138.28, 138.18, 128.79, 128.59, 128.57, 128.51, 128.40, 128.16, 128.15, 128.12, 
128.11, 128.08, 128.03, 128.02, 127.99, 127.96, 127.90, 127.86, 127.82, 127.80, 103.98, 86.16, 
85.55, 84.90, 82.24, 81.64, 78.82, 77.96, 75.90, 75.63, 75.58, 75.22, 75.01, 75.00, 73.70, 71.78, 
69.73, 69.00, 32.03, 31.10, 29.92, 29.43, 29.12, 22.87, 14.32. HRMS m/z Calcd for C32H74NaO10S 
(M+Na)+ 1033.4895 , found 1033.4893.  
25
D = - 7 (c= 0.58, DCM). 
synthesis of disaccharide 14 29 
 
 Started with 100.6 mg (0.150 mmol) of glycosyl donor 5f, 64.4 mg (0.160 mmol) of 
Umemoto’s reagent, 35 mg (0.0753 mmol) of methyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside, 
150 mg of 4Å MS, in 1 mL of DCM. Purified to obtain 59.3 mg (84%) colorless oil. Spectral 
data matched that previously reported in literature.29 
synthesis of disaccharide 18 
 
 Started with 100.6 mg (0.150 mmol) of glycosyl donor 5f, 64.4 mg (0.160 mmol) of 
Umemoto’s reagent, 49 mg (0.0753 mmol) of octyl -D-1-thio-2,3,4-tri-O-tert-
butyldimethylsilylglucopyranoside, 150 mg of 4Å MS, in 1 mL of DCM. Purified to obtain 53.3 
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mg (63%) colorless oil. 1H NMR (500 MHz, Chloroform-d) δ 7.38 – 7.22 (m, 13H), 7.16 (d, J = 
7.2, 2.4 Hz, 2H), 4.99 (dd, J = 9.6, 8.0 Hz, 1H), 4.77 (dd, J = 11.0, 5.5 Hz, 2H), 4.69 – 4.65 (m, 
1H), 4.63 (d, J = 9.8 Hz, 1H), 4.61 – 4.52 (m, 2H), 4.53 – 4.45 (m, 2H), 3.94 (dd, J = 10.0, 5.6 Hz, 
1H), 3.91 – 3.84 (m, 1H), 3.81 – 3.72 (m, 2H) , 3.72 – 3.59 (m, 4H), 3.43 (d, J = 9.9, 3.9, 1.9 Hz, 
1H), 2.68 (ddd, J = 12.6, 8.0, 6.3 Hz, 1H), 2.57 (dt, J = 12.6, 7.5 Hz, 1H), 1.97 (s, 3H), 1.68 – 1.54 
(m, 2H), 1.45 – 1.32 (m, 2H), 1.33 – 1.19 (m, 10H), 0.95 – 0.77 (m, 30H), 0.15 – 0.02 (m, 18H). 
13C NMR (126 MHz, CDCl3) δ 169.69, 138.41, 138.31, 138.24, 128.62, 128.58, 128.54, 128.51, 
128.14, 127.98, 127.96, 127.85, 127.74, 101.54, 83.74, 83.39, 81.91, 78.13, 77.68, 77.51, 76.51, 
75.25, 75.21, 75.16, 73.63, 73.38, 71.15, 68.85, 32.04, 30.78, 29.99, 29.48, 29.42, 29.17, 26.23, 
26.07, 26.01, 22.85, 21.24, 18.29, 18.14, 18.03, 14.29, -3.91, -3.96, -4.07, -4.21, -4.48, -4.69. 
HRMS m/z Calcd for C61H100NaO11SSi3 (M+Na)
+ 1147.6186 , found 1147.6188.  
25
D = -69.6 (c= 
2.55, DCM). 
synthesis of disaccharide 15  
 
 Started with 100.6 mg (0.150 mmol) of glycosyl donor 5f, 64.4 mg (0.160 mmol) of 
Umemoto’s reagent, 36.7 mg (0.0751 mmol) of octyl β-D-1-thio-2,3-di-O-benzylglucopyranoside, 
150 mg of 4Å MS, in 1 mL of DCM. Purified to obtain 41.5 mg (57%) colorless oil. 1H NMR (500 
MHz, Chloroform-d) δ 7.44 – 7.21 (m, 23H), 7.13 (dd, J = 7.0, 2.6 Hz, 2H), 5.02 (dd, J = 9.3, 8.0 
Hz, 1H), 4.95 – 4.81 (m, 3H), 4.81 – 4.70 (m, 3H), 4.66 (d, J = 11.4 Hz, 1H), 4.61 (d, J = 12.2 Hz, 
1H), 4.55 – 4.46 (m, 2H), 4.46 – 4.39 (m, 1H), 4.00 (dd, J = 11.3, 3.5 Hz, 1H), 3.82 (dd, J = 11.3, 
5.0 Hz, 1H), 3.69 (q, J = 4.0, 3.1 Hz, 2H), 3.67 – 3.57 (m, 2H), 3.54 – 3.44 (m, 2H), 3.36 (ddd, J 
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= 9.8, 8.5, 4.4 Hz, 2H), 2.92 (s, 1H), 2.78 – 2.58 (m, 2H), 1.97 (s, 3H), 1.71 – 1.56 (m, 4H), 1.45 
– 1.34 (m, 2H), 1.34 – 1.17 (m, 8H), 0.87 (t, J = 6.8 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 
169.75, 138.97, 138.31, 138.24, 137.97, 137.95, 128.67, 128.62, 128.54, 128.20, 128.12, 128.07, 
128.04, 128.00, 127.94, 127.91, 100.62, 86.02, 85.44, 83.09, 81.49, 78.72, 77.84, 75.64, 75.59, 
75.29, 75.24, 75.11, 73.71, 72.67, 71.66, 68.49, 67.87, 32.03, 31.04, 29.89, 29.42, 29.09, 22.86, 
21.14, 14.31. HRMS m/z Calcd for C57H70NaO11S (M+Na)
+ 985.4531 , found 985.4543.  
25
D = -
31.8 (c= 1.85, DCM). 
synthesis of disaccharide 17 
 
 Started with 100.6 mg (0.150 mmol) of glycosyl donor 5f, 64.4 mg (0.160 mmol) of 
Umemoto’s reagent, 43.4 mg (0.0752 mmol) of 4-chlorophenyl -D-1-thio-2,3,4-tri-O-
benzylglucopyranoside, 150 mg of 4Å MS, in 1 mL of DCM. Purified to obtain 58.2 mg (74%) 
white solid. 1H NMR (500 MHz, Chloroform-d) δ 7.49 (d, J = 8.5, 1.8 Hz, 2H), 7.40 – 7.20 (m, 
30H), 7.18 (d, J = 8Hz, 2H), 5.11 – 5.01 (m, 1H), 4.92 – 4.74 (m, 6H), 4.73 – 4.64 (m, 2H), 4.63 
– 4.53 (m, 4H), 4.50 (d, J = 12.2 Hz, 1H), 4.44 (d, J = 8.0, 1.8 Hz, 1H), 4.11 (d, J = 11.1, 1.9 Hz, 
1H), 3.78 – 3.59 (m, 6H), 3.56 – 3.38 (m, 4H), 1.86 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 169.45, 
138.44, 138.29, 138.18, 138.08, 138.06, 138.01, 133.81, 133.25, 132.42, 129.39, 128.65, 128.62, 
128.59, 128.57, 128.52, 128.25, 128.18, 128.02, 127.96, 127.90, 127.87, 127.85, 127.75, 101.00, 
87.49, 86.67, 83.21, 80.67, 78.82, 78.14, 77.77, 77.77, 75.90, 75.54, 75.41, 75.27, 75.24, 75.18, 
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75.08, 73.70, 73.13, 68.90, 67.88, 21.07. HRMS m/z Calcd for C62H63ClNaO11S (M+Na)
+ 
1073.3672 , found 1073.3644.  
25
D = -31.2 (c= 2.5, DCM). 
1-adamantyl-2,3,4,6-tetra-O-benzyl-D-glucopyranoside 13 30 
 
 Started with 107.8 mg (0.150 mmol) of glycosyl donor 5a, 64.4 mg (0.160 mmol) of 
Umemoto’s reagent, 11.4 mg (0.0752 mmol) of 1-adamantanol, 150 mg of 4Å MS, in 1 mL of 
DCM. Purified to obtain 43.3 mg (85%) colorless oil in a 1.1:1 α:β mixture. Spectral data 
matched that previously reported in literature.30 
Synthesis of disaccharide 1230 
 
 Started with 107.8 mg (0.150 mmol) of glycosyl donor 5a, 64.4 mg (0.160 mmol) of 
Umemoto’s reagent, 19.6 mg (0.0752 mmol) of 1,2,3,4-di-O-isopropylidene-D-galactopyranose, 
150 mg of 4Å MS, in 1 mL of DCM. Purified to obtain 51.2 mg (87%) colorless oil in a 1.3:1 α:β 





Synthesis of disaccharide 1631 
 
 Started with 100.6 mg (0.150 mmol) of glycosyl donor 5f, 64.4 mg (0.160 mmol) of 
Umemoto’s reagent, 19.6 mg (0.0752 mmol) of 1,2,3,4-di-O-isopropylidene-D-galactopyranose, 
150 mg of 4Å MS, in 1 mL of DCM. Purified to obtain 50.6 mg (92%) colorless oil. Spectral data 
matched that previously reported in the literature.31 
(1-adamantyl)-2-O-acetyl-3,4,6-tri-O-benzyl--D-glucopyranoside 19 
 
 Started with 100.6 mg (0.150 mmol) of glycosyl donor 5f, 64.4 mg (0.160 mmol) of 
Umemoto’s reagent, 11.4 mg (0.0752 mmol) of 1-adamantanol, 150 mg of 4Å MS, in 1 mL of 
DCM. Purified to obtain 25.4 mg (54%) colorless oil. 1H NMR (500 MHz, Chloroform-d) δ 7.39 
– 7.22 (m, 13H), 7.20 (dd, J = 7.6, 1.9 Hz, 2H), 4.94 (dd, J = 9.4, 7.9 Hz, 1H), 4.78 (dd, J = 11.2, 
9.1 Hz, 2H), 4.73 – 4.51 (m, 4H), 3.74 (dd, J = 10.9, 2.0 Hz, 1H), 3.71 – 3.54 (m, 2H), 3.48 (ddd, 
J = 9.7, 5.6, 2.0 Hz, 1H), 2.20 – 2.07 (m, 3H), 1.96 (s, 3H), 1.83 (dq, J = 11.9, 2.4 Hz, 3H), 1.76 – 
1.65 (m, 3H), 1.67 – 1.53 (m, 8H). 13C NMR (126 MHz, CDCl3) δ 169.51, 138.57, 138.51, 138.22, 
128.61, 128.60, 128.49, 128.21, 128.08, 128.01, 127.87, 127.80, 127.68, 94.18, 83.54, 78.54, 
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75.16, 75.13, 73.77, 73.62, 69.48, 42.71, 36.43, 30.85, 21.26. HRMS m/z Calcd for C39H46NaO7 
(M+Na)+ 649.3136 , found 649.3123.  
25




 Started with 107.8 mg (0.150 mmol) of glycosyl donor 5a, 64.4 mg (0.160 mmol) of 
Umemoto’s reagent, 35.0 mg (0.0752 mmol) of methyl-3,4,6-tri-O-benzyl-α-D-glucopyranoside,13 
150 mg of 4Å MS, in 1 mL of DCM. Purified to obtain 60.0 mg (81%) colorless oil in a 2:1 (α:β) 
mixture. α anomer 1H NMR (500 MHz, Chloroform-d) δ 7.40 – 7.19 (m, 27H), 7.18 – 7.06 (m, 
6H), 7.00 (m, , 2H), 4.94 (ddd, J = 15.8, 13.1, 10.5 Hz, 4H), 4.88 – 4.74 (m, 5H), 4.71 (d, J = 12.2 
Hz, 1H), 4.61 (d, J = 12.1 Hz, 1H), 4.57 – 4.41 (m, 4H), 4.32 (d, J = 12.1 Hz, 1H), 4.08 (td, J = 
9.4, 7.9 Hz, 2H), 4.00 (dt, J = 10.3, 2.5 Hz, 1H), 3.84 (dd, J = 9.9, 3.4 Hz, 1H), 3.79 (ddd, J = 10.4, 
3.9, 2.0 Hz, 1H), 3.75 – 3.55 (m, 6H), 3.53 (dd, J = 10.9, 3.0 Hz, 1H), 3.45 (s, 3H). 13C NMR (126 
MHz, CDCl3) δ 138.97, 138.91, 138.66, 138.53, 138.36, 138.18, 138.13, 128.72, 128.67, 128.63, 
128.61, 128.58, 128.55, 128.51, 128.49, 128.37, 128.26, 128.24, 128.21, 128.17, 128.13, 128.08, 
128.06, 128.03, 127.88, 127.85, 127.81, 127.79, 127.75, 127.70, 127.57, 96.56, 94.34, 82.36, 
80.96, 79.23, 78.20, 77.80, 76.43, 75.88, 75.16, 75.06, 74.90, 73.72, 73.54, 73.04, 70.42, 70.30, 
68.76, 68.30, 55.06 HRMS m/z Calcd for C62H66NaO11 (M+Na)
+ 1009.4497, found 1009.4504. 
 25D = 79.4 (c= 0.85 , DCM). β anomer 1H NMR (500 MHz, Chloroform-d) δ 7.42 – 7.06 (m, 35H), 
5.05 – 4.95 (m, 2H), 4.93 – 4.74 (m, 4H), 4.75 – 4.56 (m, 4H), 4.50 (ddd, J = 19.7, 10.8, 6.3 Hz, 
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4H), 4.07 – 3.99 (m, 1H), 3.86 (dd, J = 9.8, 3.5 Hz, 1H), 3.81 (dt, J = 10.5, 2.8 Hz, 1H), 3.78 – 
3.56 (m, 10H), 3.55 – 3.49 (m, 1H), 3.41 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 138.78, 138.64, 
138.40, 138.31, 138.25, 138.20, 128.65, 128.58, 128.53, 128.51, 128.49, 128.39, 128.31, 128.19, 
128.18, 128.16, 128.11, 128.08, 128.06, 128.02, 127.98, 127.96, 127.93, 127.88, 127.83, 127.73, 
127.53, 127.47, 104.18, 99.95, 85.01, 82.26, 81.98, 78.83, 78.50, 77.97, 75.81, 75.35, 75.19, 74.94, 
73.73, 73.71, 70.20, 69.01, 68.80, 55.37. HRMS m/z Calcd for C62H66NaO11 (M+Na)
+ 1009.4497, 
found 1009.4522.  
25




 Started with 100.6 mg (0.150 mmol) of glycosyl donor 5f, 64.4 mg (0.160 mmol) of 
Umemoto’s reagent, 35.0 mg (0.0752 mmol) of methyl-3,4,6-tri-O-benzyl-α-D-glucopyranoside,13 
150 mg of 4Å MS, in 1 mL of DCM. Purified to obtain 31.0 mg (44%) white solid as the β anomer. 
1H NMR (500 MHz, Chloroform-d) δ 7.38 – 7.19 (m, 26H), 7.20 – 7.13 (m, 2H), 7.06 (dd, J = 6.7, 
3.0 Hz, 2H), 5.11 (dd, J = 9.4, 8.0 Hz, 1H), 4.97 (d, J = 3.5 Hz, 1H), 4.87 – 4.79 (m, 2H), 4.79 – 
4.72 (m, 2H), 4.70 (d, J = 11.3 Hz, 1H), 4.68 – 4.58 (m, 2H), 4.56 (d, J = 5.1 Hz, 1H), 4.55 – 4.46 
(m, 2H), 4.44 (d, J = 10.8 Hz, 1H), 3.98 – 3.91 (m, 1H), 3.79 – 3.59 (m, 6H), 3.46 (ddd, J = 9.7, 
4.4, 2.1 Hz, 1H), 3.36 (s, 3H), 1.63 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 169.55, 138.99, 138.40, 
138.25, 138.17, 138.11, 137.98, 128.64, 128.62, 128.60, 128.57, 128.55, 128.52, 128.48, 128.26, 
128.16, 128.10, 128.06, 128.00, 127.96, 127.93, 127.90, 127.87, 127.82, 127.79, 127.60, 127.55, 
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102.38, 99.73, 83.39, 81.17, 81.15, 78.07, 78.05, 75.26, 75.20, 75.18, 73.72, 73.69, 73.12, 70.07, 
69.01, 68.71, 55.44, 20.86 HRMS m/z Calcd for C57H62NaO12 (M+Na)
+ 961.4133, found 
961.4145.  
25
D = 37.7 (c= 1.1 , DCM). 
Tetrahydrothiophene by-product (+/-) - 22 
 
 The compound was purified from early-eluting column chromatography fractions from an 
O-glycosylation procedure using preparative TLC with hexanes as eluent. 1H NMR (500 MHz, 
Chloroform-d) δ 7.32 (d, J = 8.7 Hz, 2H), 6.85 (d, J = 8.7 Hz, 2H), 4.55 (d, J = 8.6 Hz, 1H), 3.79 
(s, 3H), 3.19 (ddd, J = 10.8, 8.9, 6.3 Hz, 1H), 3.03 (ddd, J = 11.2, 7.1, 4.3 Hz, 1H), 2.93 (dtd, J = 
9.5, 8.2, 6.4 Hz, 1H), 2.54 (dtd, J = 12.9, 6.4, 4.4 Hz, 1H), 2.30 (dtd, J = 13.1, 9.3, 7.1 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 159.02, 132.43, 129.13 (q, J= 165.06 Hz) 128.84, 113.96, 55.33 
(q, J= 26.46 Hz) 55.24, 50.60, 32.25, 31.15. m/z Calcd for C12H14F3OS (M+H)
+ 263.0712 , found 
263.0707.  
Light on/off experiment 
 A reaction of donor 5a with acceptor 6 was performed at one half the scale of the typical 
O-glycosylation procedure under dry N2 in an NMR tube using CD3CN as solvent.  Umemoto’s 
reagent dissolved completely under these conditions (CH2Cl2 does not).  
1H NMR was recorded at 
2 h intervals after periods of irradiation with blue LEDs or being kept in the dark.  The experiment 
was conducted for a total of 10 hrs.  The integration of the styrenic resonances of 5a were compared 
using the CD2HCN proton signal at 1.93 ppm as an internal standard to monitor reaction progress.  
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Hours 0-2, 4-6 and 8-10 comprised periods of irradiation while the NMR tube was kept in the dark 
for hours 2-4 and 4-8 (Figure 3.9). 
 
Photograph of Yellow EDA complex Figure 3.10 
 
left NMR tube:  25 mM 5a    center:  26.6 mM Umemoto’s reagent    right:  mixture of both 




























Figure 3.9 Light on light off experiment 
Figure 3.10 Yellow EDA complex 
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Spectrophotometry (Figures 3.11-3.15) 
   
 






































Glycosyl donor 5a (25 mM,CH3CN) 
Figure 3.11 Umemoto’s reagent UV-Vis 


























Glycosyl donor 5a (25 mM) and Umemoto's 



















p-methoxystyrene (25 mM, CH3CN)
Figure 3.13 Glycosyl donor 5a and Umemoto’s reagent mix UV-Vis 




 In order to see the effect of concentration on the formation of the charge transfer complex, 
a series of UV-vis spectra was obtained by varying the concentration of p-methoxystyrene and 




















p-methoxystyrene (25 mM) and Umemoto's 
















Titration experiment : 26.6 mM Umemoto's reagent, p-




Umemoto's reagent (26.6 mM)
p-methoxystyrene (25 mM)
Figure 3.15 p-methoxystyrene and Umemoto’s reagent mix UV-Vis 
Figure 3.16 p-methoxystyrene and Umemoto’s reagent titration experiment  
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 In order to see the effect of concentration on the formation of the charge transfer complex, 
a titration was performed by varying the concentration of glycosyl donor 5a and keeping the 
Umemoto’s reagent concentration steady at 26.6 mM in CH3CN.  


















Titration experiment: 26.6 mM Umemoto's reagent, 



























Glycosyl donor 21 (25 mM)
Umemoto's reagent (26.6
mM) and glycosyl donor 21
(25 mM)
Figure 3.17 Glycosyl donor 5a and Umemoto’s reagent titration experiment  
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 The biosynthesis of molecules is complex. Nature utilizes synthetic pathways that are either 
unattainable or difficult for synthetic chemists to duplicate in the lab. One of these pathways is the 
activation and functionalization of aliphatic C-H bonds.1 Unactivated C-H bonds (like those 
present in alkanes) are stable bonds that are unreactive under most reaction conditions. The 
synthetic manipulation of unactivated C-H bonds was first reported in the 1800’s.9 The activation 
of the C-H bonds often required the use of harsh conditions (decomposition of the molecule) that 
resulted in low yields and selectivites.2 C-H bond functionalization can be performed in high yield 
by mimics enzymes, however it is not a viable solution since enzyme mimickers are expensive and 
often are selective for a very specific C-H bond.3 These issues have led to the development of 
several methods for aliphatic C-H functionalization in the past two decades providing higher yields 
and selectivities that may prove useful in the synthesis of complex molecules.4 
 There are several advantages that can be utilized when incorporating C-H functionalization 
in the area of total synthesis. The typical method for building complex molecules is by performing 
reactions on the functional groups of the molecule to slowly build the compound while the aliphatic 
C-H bonds are untouched, often resulting in undesirable step-, atom- and redox-economy.5  
Synthetic efficiency is improved when using aliphatic C-H bonds as a synthetic handle rather then 
regarding them as unproductive bystanders.5 The reduction of synthetic steps and overall 




 Strategies used for the functionalization of aliphatic C-H bonds fall into two classes: non-
directed and directed.6,7 Non-directed C-H functionalization relies on the inherent reactivity of the 
C-H bond.6 Directed C-H functionalization utilizes a specific functionality that is attached to the 
molecule to direct either the inner sphere of a transition metal or a metal-oxo species to a specific 
C-H bond.7 Another approach to directed C-H functionalization is to install a functionality that, 
upon  thermal, chemical, or photochemical activation, will produce a radical that abstracts 
hydrogen from a C-H bond lying in a remote position of  the same molecule (referred to as a  
radical translocation event).8  
4.1.1 Literature Examples of Radical Translocation 
 Hofmann, Lӧffler, and Freytag discovered radical translocation in the late 1800s and 
continued to explore the area until the early 1900s.9 The radical translocation characterizing the 
Hoffman-Lӧffer-Freytag reaction was not acknowledged until 1950 with work published by 
Wawzonek and Thelen (Scheme 4.1). The mechanism proposed by the authors was supported by 
the work of Corey and Hertler in 1960.9 
Scheme 4.1 Wawzonek and Thelen’s proposed radical translocation mechanism 
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 The reaction begins with protonation of the N-chloroamine with sulfuric acid followed by 
bond homolysis (promoted by light or heat) of the N-Cl bond. The resulting nitrogen centered 
radical cation abstracts a hydrogen intramolecularly (uncommon 1,6-H-abstraction) from a 
secondary carbon atom resulting in a secondary carbon centered radical. The radical participates 
in a chain process by abstracting chlorine from another substrate molecule. The subsequent base-
promoted cyclization then proceeds via an SN2 pathway. The 1,6-H abstraction is rare in 
comparison to the 1,5-H abstraction exemplified by Baton’s nitrite ester photolysis (Scheme 4.2) 
which is mechanistically similar to the Hoffman-Lӧffer-Freytag reaction .10 
 In the 1970s, a method of guided C-H functionalization using radical translocation was 
reported by Breslow and coworkers.11 Esterification of benzophenone acids and cholestanols 
provided intermediates where the benzophenone triplet diradical would be orientated to abstract 
the hydrogen on carbon 14 of the steroid D ring (for example, Scheme 4.3) upon photochemical 
activation with UV light.11 The selectivity of the radical translocation for the hydrogen on carbon 
14 in this reaction was a testament to the selectivity that can be afforded with radical translocation. 
Scheme 4.2 Barton’s nitrile ester photolysis 
hν 
Scheme 4.3 Breslow’s light promoted remote desaturation 
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 A recent remote desaturation method developed by Baran and coworkers involved radical 
translocation as a key step.12 Baran developed a unique aryl radical precursor termed the Tzo group. 
This group is easily installed by reacting various alcohols and amines with the requisite aryl 
sulfonyl chloride TzoCl (o-tosyl triazene sulfonyl chloride, Scheme 4.4). 
 Once the Tzo group is installed, the resulting substrate is subjected to Baran’s reaction 
conditions and proceeds through the proposed mechanism shown in Scheme 4.5. The reaction 
begins with acid-promoted liberation of aryl diazonium salt from triazene. TEMPO then reduces 
the redox-active aryl diazonium ion which loses N2 providing an aryl radical that undergos an 
(unusual 1, 7) intramolecular hydrogen abstraction yielding a stable tertiary radical. The tertiary 
radical is then oxidized to the carbocation by nitroxonium (TEMPO+) followed by elimination to 
 
Scheme 4.5 Baran’s proposed remote desaturation mechanism 
Scheme 4.4 Installation of Tzo directing group 
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provide the alkene product. The product of the reaction also bears a tosyl group that can be 
subsequently displaced by a nucleophile.  
4.2 Results and Discussion  
 The development of a selective, mild and easily performed C-H functionalization method 
that would allow various functionalities to be added to unreactive C-H positions was desired. We 
belived that this could be accomplished in a similar manner to Baran’s work but using photoredox 
catalysis (Scheme 4.6). This would involve a radical translocation followed by oxidation of the 
intermediate radical to the carbocation that would undergo nucleophilic attack providing different 
functional groups at the unreactive C-H position. Various nucleophiles such as alcohols 
(hydroxylation), carboxylic acids (esterification), amines (Ritter amidation) and halides among 
others could be explored to provide a variety of useful functionalities. 
 We proposed that proceeding through a favorable radical translocation from an unstable 
electron poor aryl radical to a more stable alkyl radical would be a facile process. Similar 
translocations from unreactive aryl radicals to stable alkyl radicals have been demonstrated.6-9,12,13 
The easily oxidized alkyl radical could then undergo SET oxidation under mild conditions to form 
hν 
Scheme 4.6 Proposed remote functionalization 
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the carbocation that could be attacked by a nucleophile.14 This proposed process is shown in 
Scheme 4.6. 
 Like Baran, we decided to use substrates containing the Tzo group which, upon treatment 
with 2 equivalents of acid, produces an arenediazonium cation. The arenediazonium, which has a 
typical reduction potential (Ered) of -0.1 to +0.5 V vs. SCE, could then undergo a SET reduction 
from an excited state photocatalyst like fac-Ir(ppy)3
* to generate N2 and aryl radical. The excited 
fac-Ir(ppy)3
* is an excellent reducing agent with a reduction potential E° of -1.73 vs. SCE.15,16 The 
unstable aryl radical would then abstract hydrogen from the attached alkyl moiety to form a more 
stable alkyl radical. The alkyl radical (Eox= 0-0.75 V vs. SCE) could then undergo SET oxidation 
from the oxidatively quenched photocatalyst (Ir(ppy)3
+ E°= +0.77 V vs. SCE) regenerating catalyst 
and providing a carbocation that can be attacked by a nucleophile to provide product.14,15 
 Initial experimentation revealed several interesting aspects of this reaction. It was shown 
that the reaction required a nucleophile that does not undergo hydrogen abstraction easily with the 
radicals that are formed in the course of the reaction. This led to the use of water as a nucleophile 
in nitromethane (Scheme 4.7). As water and nitromethane are only slightly miscible, the reaction 
requires vigorous stirring. 
 With the use of water as a nucleophile, 57% of product 2 was afforded. The Reaction was 
optimized (Figure 4.1). The use of fac-Ir(ppy)3 was  required for reaction as all other photocatalysts  
Scheme 4.7 Standard remote hydroxylation conditions 
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 ((Ru(phen)3(BArF)2, Ir[dF(CF3)ppy]2(dtbbpy)(PF6), ethyl eosin, and Ru(bpy)3(PF6)2)  proved 
unproductive. The high catalyst loading of 10 mol % fac-Ir(ppy)3 was also required to provide 
good yield as use of one and five mol % resulted in poor yield. The concentration of the reaction 
and the use of TFA in place of HBF4 showed little effect on the yield. Interestingly, the reaction 
also works in the absence of light but in lower yields suggesting that ground state fac-Ir(ppy)3 may 
have the ability to undergo SET  reduction to substrate diazonium (Scheme 4.8). Such a process is 
coupled to the irreversible loss of nitrogen and energetically favorable.17 
 The optimized conditions never provide product in higher than 60% yield. This is likely 
due to side reactions (Scheme 4.9) producing trivial reduction and elimination side products. The 
electron deficient diazonium formed during the reaction may also be undergoing hydrolysis thus 
affecting the yield (Scheme 4.9). With the optimized conditions, various substrates were screened 
providing yields in 31-63%. Some of the substrates screened are highlighted in Figure 4.2. The 
citronellol derivative underwent remote hydroxylation in 38% yield (Figure 4.2, product 4) while 
Entry 
Deviation from Std. 
Cond Irradiation time (h) % yield 
1 18.5h irradiation 18 57 
2 5 mol% fac-Ir(ppy)3 18 12 
3 1 mol% fac-Ir(ppy)3 18 4 
4 light excluded 18 50 
5 Conc. 48.8 mM  18 40 
6 Conc. 10 mM  18 57 
7 TFA replaces HBF4 18 54 
Scheme 4.8 Generation of diazonium by ground state fac-Ir(ppy)3 
Figure 4.1 Optimization of the remote hydroxylation reaction conditions 
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the benzylic Tzo ester underwent hydroxylation in 63 and 56% yield (Figure 4.2 products 6 and 8). 
This demonstrated that the hydroxylation method was applicable to a range of substrates. 
 The ability of the reaction to proceed in the dark but in lower yields using substrate 1 led 
us to believe that light plays a limited role in the reaction. A SET from ground state fac-Ir(ppy)3 
initiating the reaction may be the major reaction pathway (Scheme 4.10). To study this hypothesis 
multiple substrates were submitted to the original reaction conditions (Scheme 4.7) without the 
light. The reaction provided product for all of the substrates in comparable yields to the irradiated 
Scheme 4.9 Side reactions of intermediates formed in the remote hydroxylation reaction 
Figure 4.2 Substrate scope for remote hydroxylation 
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reactions (Figure 4.3). This showed that SET by ground state fac-Ir(ppy)3 could be sufficient for 
Scheme 4.10 Proposed remote hydroxylation reaction in the dark 
Figure 4.3 Substrate scope for light excluded remote hydroxylation 
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the reaction to proceed and suggests that the increase in yield when irradiating may be attributed 
to a minor photochemical reaction pathway that also provides product.  
4.3 Conclusion  
 The functionalization of aliphatic C-H bonds is a challenging process perfected by nature 
and growing in significance in the organic synthesis community. The majority of organic 
molecules possess aliphatic C-H bonds and the ability to selectively functionalize them would 
provide a more efficient synthesis of drugs and other molecules.  Previous methods for performing 
C-H bond functionalization required the use of expensive enzyme mimics or harsh reaction 
conditions. We have developed a method that helps to resolve some of these issues and proceeds 
under mild reaction conditions with a wide range of substrates. The reaction is efficient without 
the presence of light and is easily performed on a bench top. 
4.4 Experimental 
4.4.1 General methods 
 1H NMR and 13C NMR spectroscopy was conducted using a Bruker AV-400 or AV-500 
spectrometer. Mass spectra were attained using an Agilent 6210 electrospray time-of-flight mass 
spectrometer. Optical rotation was measured using a JASCO P-2000 polarimeter. All materials 
were received from commercial suppliers and used without further purification. Flash column 
chromatography was accomplished using high purity grade 60 Å silica gel (Fluka® Analytical). 
Qualitative TLC was performed on aluminum sheets (Merck, silica gel, F254) and observed via 
UV absorption (254 nm) and staining with anisaldehyde or KMnO4. Deuterated solvents were 
acquired from Cambridge Isotope Labs. TzoCl and CH3NO2 (reagent grade, 96%) were received 
from Sigma-Aldrich. Unless otherwise noted, all Tzo -containing compounds were synthesized 
according to literature procedure.1 All reactions were carried out under an atmosphere of dry 
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nitrogen. Photocatalyzed remote hydroxylation reactions were conducted in round bottom flasks 
and irradiated with 4W blue LEDs (Creative Lighting Solutions, λmax=455 nm) which were 
wrapped around a beaker or crystallizing dish. 
4.4.2 Procedures and characterization  
 Representative procedure for remote hydroxylation - synthesis of 2 
 To a vigorously stirred 20oC solution of 100.0 mg (0.2929 mmol) triazene 4.5 and 19.2 mg 
(0.0293 mmol) fac-Ir(ppy)3 in 10 mL CH3NO2 and 2 mL deionized H2O was added 87 77 μL (0.59 
mmol) 48% HBF4 via gas-tight syringe. After 4 minutes, irradiation of the solution with blue LEDs 
(λmax=455 nm) commenced and the reaction mixture was stirred vigorously for 18.5 h. 10 mL of 
5% NaHCO3(aq.) was then added at once followed by 10 mL CH2Cl2 and the resulting layers were 
separated. The aqueous layer was extracted with an additional 2 x 10 mL CH2Cl2. The combined 
organic layers were dried over Na2SO4, filtered and concentrated to yield 117.3 mg of a brown 
residue. Silica gel chromatography (gradient run from 20% EtOAc in hexanes to 30% EtOAc in 
hexanes) of the residue afforded 43.4 mg (57%) of a yellow oil. 1H NMR (400 MHz, CDCl3) δ 
7.79 (d, J = 8.2 88 Hz, 2H), 7.34 (d, J = 8.0 Hz, 2H), 4.20 (t, J = 6.8 Hz, 2H), 2.44 (s, 3H), 1.85 (t, 
J = 6.8 Hz, 2H), 1.67 (br s, 1H), 1.21 (s, 6H); 13C NMR (101 MHz, CDCl3) δ 145.0, 133.1, 130.1, 
128.0, 69.8, 67.8, 41.8, 29.8, 21.8; HRMS (m/z) calcd for C12H18NaO4S [M+Na]








Synthesis of 1 
 
 Started with 2000.0 mg (6.902 mmol) TzoCl, 486.7 mg (5.521 mmol) isoamyl alcohol, 
1349.0 mg (11.04 mmol) DMAP and 11.1 mL CH2Cl2.  Silica gel chromatography 30 g silica gel, 
(gradient run from 10% EtOAc in hexanes to 20% EtOAc in hexanes) afforded 1724.3 mg (91%) 
of a yellow oil.  1H NMR (500 MHz, CDCl3): δ 7.81 (d, J = 8.1 Hz, 1H), 7.34 (s, 1H), 6.96 (d, J = 
8.1 Hz, 1H), 4.02 (t, J = 6.6 Hz, 2H), 3.80 (q, J = 7.2 Hz, 4H), 2.36 (s, 3H), 1.66 (m, 1H), 1.48 (q, 
J = 6.7 Hz, 2H), 1.32 (t, J = 7.3 Hz, 3H), 1.24 (t, J = 7.3 Hz, 3H), 0.80 (d, J = 7.0 Hz, 6H);  13C 
NMR (125 MHz, CDCl3): δ 149.25, 145.05, 130.46, 125.98, 124.99, 118.35, 68.68, 49.30, 42.24, 
37.58, 24.37, 22.14, 21.65, 14.48, 11.29; HRMS m/z calcd for C16H27N3NaO3S (M+Na)
+ 
364.1665, found 364.1658. 
Synthesis of 3 
 
 Started with 500.0 mg (1.73 mmol) TzoCl, 0.25 mL (1.4 mmol)  Citronellol, 337 mg (2.76 
mmol) DMAP and 2.8 mL CH2Cl2. Silica gel chromatography, (20% DCM, 5% Et2O in hexanes) 
afforded521 mg (91%) of a red oil. 1H NMR (400 MHz, CDCl3) δ 7.85 (d, J = 8.1 Hz, 1H), 7.37 
(s, 1H), 7.00 (d, J = 8 Hz 1H), 5.02 (t, J= 7.2Hz, 1H), 4.13 – 3.99 (m, 2H), 3.83 (q, J = 7.2 Hz, 
4H), 2.39 (s, 3H), 1.98-1.79 (m, 2H), 1.78-1.46 (m, 2H), 1.66 (s, 3H), 1.56 (s, 3H), 1.45-1.19 (m, 
2H), 1.36 (t, 3H), 1.27 (t, 3H), 1.16 – 1.02 (m, 1H), 0.80 (d, J = 6.6 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ 149.4, 145.2, 131.5, 130.7, 126.3, 125.3, 124.6, 118.5, 68.8, 49.5, 42.5, 37.0, 36.0, 29.1, 




Synthesis of 5 
 Started with 350.0 mg (1.208 mmol) TzoCl , 0.15 mL (0.97 mmol) 3-Phenyl-1-butanol, 
294.9 mg (2.414 mmol) 4-Dimethylaminopyridine and 1.9 mL of CH2Cl2. Silica gel 
chromatography, (gradient run from 8% EtOAc in hexanes to 10% EtOAc in hexanes)  afforded 
261.5 mg (67%) of a red oil. 1H NMR (400 MHz, CDCl3) δ 7.79 (d, J = 8.0 Hz, 1H), 7.39 (s, 1H), 
7.20 (t, J = 7.4 Hz, 2H), 7.14 (d, J = 6.9 Hz, 1H), 7.04 (d, J = 8 Hz, 2H), 6.95 (d, J = 8 Hz, 1H), 
3.99 (dt, J = 9.7, 6.0 Hz, 1H), 3.92 – 3.85 (m, 1H), 3.81 (q, J = 7.2 Hz, 4H), 2.81 (q, J = 7.2 Hz, 
1H), 2.38 (s, 3H), 1.92 – 1.81 (m, 2H), 1.33 (t, J = 7.3 Hz, 3H), 1.26 (t, J = 7.2 Hz, 3H), 1.17 (d, J 
= 6.9 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 149.3, 145.8, 145.2, 130.6, 128.5, 126.9, 126.3, 
126.0, 125.1, 118.4, 68.6, 49.4, 42.4, 37.3, 35.8, 21.9, 21.8, 14.6, 11.4; HRMS (m/z): [M+H] + 
calcd for C21H30N3O3S 404.2002, found 404.2000. 
Synthesis of 7 
 
 Started with 350.0 mg (1.208 mmol) TzoCl, 0.19 mL (0.97 mmol) 3,3-diphenyl-1- 
propanol, 294.9 mg (2.414 mmol) DMAP and 1.9 mL of CH2Cl2. Silica gel chromatography (20% 
DCM and 5% Et2O in hexanes) afforded 307.9 mg (68%) of a red oil. 1H NMR (500 MHz, CDCl3) 
δ 7.76 (d, J = 8.1 Hz, 1H), 7.38 (s, 1H), 7.20 (dd, J = 8.3, 6.7 Hz, 4H), 7.17 – 7.11 (m, 2H), 7.08 
(d, J = 7.5 Hz, 4H), 6.95 (d, J = 7.8 Hz, 1H), 4.05 – 3.96 (m, 3H), 3.80 (dq, J = 13.9, 7.3 Hz, 4H), 
2.40 (s, 3H), 2.34 (dt, J = 7.8, 6.2 Hz, 2H), 1.33 (t, J = 7.3 Hz, 3H), 1.24 (t, J = 7.2 Hz, 3H); 13C 
NMR (126 MHz, CDCl3) δ 149.4, 91 145.3, 143.7, 130.8, 128.7, 128.0, 126.6, 126.3, 125.3, 118.6, 
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68.6, 49.5, 46.9, 42.6, 35.0, 21.9, 14.7, 11.6; HRMS (m/z) calcd for C26H32N3O3S [M+H]
+ 
466.2159, found 466.2156. 
Synthesis of 4 
          Started with 112 mg (0.293 mmol) of 3, 19.2 mg (0.0293 mmol) of fac-Ir(ppy)3, 77 µL 
(0.585 mmol) HBF4 (48% in H2O), and 2 mL deionized H2O and 10 mL CH3NO2. Irradiated for 
18 h. Silica gel chromatography, (gradient run from 10% EtOAc in hexanes to 30% EtOAc in 
hexanes afforded 19.3 mg (22%) of a clear oil. 1H NMR (500 MHz, CDCl3) δ 7.79 (d, J = 8.5 Hz, 
2H), 7.35 (d, J = 8.0 Hz, 2H), 5.07 (t, J = 7 Hz, 1H), 4.20 (tq, J = 5.5, 3.0 Hz, 2H), 2.45 (s, 3H), 
2.00 (q, J = 7.7 Hz, 2H), 1.85 (q, J = 6.9 Hz, 2H), 1.68 (s, 3H), 1.59 (s, 3H), 1.48 – 1.42 (m, 3H), 
1.16 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 145.0, 133.2, 132.5, 130.1, 128.1, 124.0, 71.9, 67.6, 
42.4, 40.2, 27.1, 25.9, 22.8, 21.9, 17.9; HRMS (m/z): [M+Na]+ calcd for C17H26NaO4S 349.1444, 
found 349.1443, and 5 mg (6%) of the trivial reduction product, a colorless oil. Spectral data 
matched that previously reported in literature.18 
Synthesis of 6 
 Started with 118.0 mg (0.292 mmol) of 6, 19.2 mg (0.0293 mmol) of fac-Ir(ppy)3, 77 µL 
(0.585 mmol) HBF4 (48% in H2O), 2 mL deionized H2O and 10 mL of CH3NO2. Irradiated for 18 
h. Silica gel chromatography, (gradient run from 15% EtOAc in hexanes to 30% EtOAc in hexanes 
afforded 59.1 mg (63%) of a white solid. 1H NMR (400 MHz, CDCl3) δ 7.68 (d, J = 8.4 Hz, 2H), 
7.35 – 7.18 (m, 7H), 4.10 (dt, J = 10.1, 7.1 Hz, 1H), 3.95 (dt, J = 10.0, 6.6 Hz, 1H), 2.43 (s, 3H), 
2.19 (td, J = 6.9, 1.9 Hz, 2H), 2.06 (s, 1H), 1.53 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 146.5, 
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144.9, 133.0, 130.0, 128.5, 128.0, 127.1, 124.6, 73.6, 67.7, 42.5, 31.0, 21.8; HRMS (m/z): [M+H]+ 
calcd for C17H21O4S 321.1155, found 321.1154. 
Synthesis of 8 
           Started with 136.4 mg (0.2929 mmol) of 7, 19.2 mg (0.0293 mmol) of fac-Ir(ppy)3, 77 µL 
(0.585 mmol) HBF4 (48% in H2O), 2 mL deionized H2O and 10 mL CH3NO2. Irradiated for 18 h.   
Silica gel chromatography, (gradient run from 10% EtOAc in hexanes to 20% EtOAc in hexanes 
afforded  63.2 mg (56%) of a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.66 (d, J = 7.9 Hz, 2H), 
7.34 – 7.16 (m, 12H), 4.08 (t, J = 7.3 Hz, 2H), 2.69 (t, J = 7.4 Hz, 2H), 2.42 (s, 3H), 2.39 (s, 1H); 
13C NMR (100 MHz, CDCl3) δ 145.9, 144.9, 133.0, 130.0, 128.5, 128.0, 127.4, 125.8, 77.0, 67.9, 
40.7, 21.8; HRMS (m/z): [M+Na]+ calcd for C22H22NaO4S 405.1131, found 405.1125 
Synthesis of 10 
 Started with 107.6 mg (0.2929 mmol) 9, 19.2 mg (0.0293 mmol) fac-Ir(ppy)3, 77 µL (0.586 
mmol) HBF4 (48% in H2O), 2 mL millipore H2O and 10 mL CH3NO2.  It was irradiated for 18 h. 
Silica gel chromatography (14 g silica gel, gradient run from 100% hexanes to 25% ethyl acetate 
in hexanes) afforded 34.2 mg (41%) of a pale yellow oil.  1H NMR (500 MHz, CDCl3): δ 7.79 (d, 
J = 8.2 Hz, 2H), 7.35 (d, J = 8.1 Hz, 2H), 4.24 (t, J = 6.8 Hz, 2H), 2.45 (s, 3H), 1.97 (t, J = 7.3 Hz, 
2H), 1.76 (m, 2H), 1.64 (m, 4H), 1.55 (m, 2H); 13C NMR (125 MHz, CDCl3): δ 144.7, 133.0, 
129.8, 127.8, 80.5, 68.0, 40.0 (2C’s), 39.7, 23.4 (2C’s), 21.6; HRMS m/z calcd for C14H20NaO4S 
(M+Na)+ 307.0975, found 307.0974, and 14.6 mg (19%) of an inseparable mixture of desaturation 
and reduced products (3.5:1). Spectral data matched that previously reported in literature.12 
138 
 
Synthesis of 12 
  
 
 Started with 120.0 mg (0.2929 mmol) 11, 19.2 mg (0.0293 mmol) fac-Ir(ppy)3, 77 µL 
(0.586 mmol) HBF4 (48% in H2O), 2 mL millipore H2O and 10 mL CH3NO2.  Silica gel 
chromatography (14 g silica gel, 20% EtOAc in hexanes) afforded 30.0 mg (31%) of a yellow oil.  
1H NMR (500 MHz, CDCl3) δ 7.80 (d, J = 8.0 Hz, 2H), 7.33 (d, J = 8.0 Hz, 2H), 4.83 (td, J = 10.8, 
4.3 Hz, 1H), 2.56 (s, 1H), 2.43 (s, 3H), 2.20 (d, J = 11.8 Hz, 1H), 1.92 (m, 1H), 1.67 (m, 2H), 1.48 
(m, 1H), 1.25 (s, 2H) 1.20 (s, 3H), 1.16 (s, 3H), 1.05 (qd, J = 13.1, 3.5 Hz, 1H), 0.88 (d, J = 6.5 
Hz, 3H);  13C NMR (125 MHz, CDCl3) δ 145.00, 134.91, 130.00, 127.60, 84.66, 72.66, 52.34, 
42.32, 33.99, 31.69, 28.87, 27.34, 25.86, 21.77, 21.75; HRMS m/z calcd for C17H26NaO4S 
(M+Na)+ 349.1444, found 349.1446, and 19.9 mg (22%) desaturation product as a white solid. 
Spectral data matched that previously reported in literature.12 
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